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Biomimetic nanoparticles (NPs) are bio-inspired inorganic nanoscale materials that 
replicate some biological nanostructures functionalities including self-assembly, catalysis, and 
enzyme inhibition. These functionalities are being investigated for and, in some cases, are being 
utilized in optics and electronics such as chemical sensors, superhydrophobic coatings, and 
antireflective surfaces. This thesis examines the utilization of biomimetic inorganic NPs for 
various problems in biomedical engineering. 
Specifically, the first part of this thesis addresses the problem on controversial explanations 
of the antibacterial and other biological activity of zinc oxide NPs that are frequently utilized in 
cosmetics, textiles, and biomedical fields. The second part of the thesis explores the self-
organization of NPs into biomimetic supraparticles (SPs) for nucleic acid delivery that can be 
exploited as drug delivery agents. 
NPs have been considered as antimicrobials for a long time; however, their antibacterial 
mechanism of action against different types of bacteria remains unclear and, in many cases, 
misinterpreted. Most of the studies on antimicrobial NPs suggest reactive oxygen species (ROS) 
formation, ion release, and membrane damage as the primary source of antibacterial activity. In 
Chapter 2, we show that the mechanism of antibacterial activity for Staphylococcus aureus is 
remarkably more complex than generating ROS or the release of Zn2+ ions. Gene expression 
analysis demonstrated that ZnO-NPs significantly affect carbohydrate metabolism and cell 
energetics, where the uridine monophosphate (UMP) biosynthesis pathway is highly upregulated. 
In Chapter 3, we explore the ZnO-NP mode of entry into S. aureus and the cell metabolism. Here, 
 xxviii 
we showed that NPs enter the cells within 5 minutes of exposure and induce minimal membrane 
damage. We note that cells do not depolarize until 60 min post-NPs exposure. Thereby, we 
highlight that membrane damage is not the primary mechanism of action but rather a downstream 
effect of ZnO-NPs exposure to bacterial cells. Taken together, causing minimal ROS production 
and significant changes in carbohydrate metabolism and bioenergetics along with cell entry 
without immediate membrane damage imply the biomimetic function of these NPs. However, 
further investigation into the antimicrobial mechanisms of these biomimetic NPs is essential for 
future clinical translation.  
Over the past few decades, there has been considerable interest in developing nanoscale 
constructs as effective delivery tools for high molecular weight drugs. In chapter 4, we investigate 
the self-assembly of NPs into compartmentalized SPs, which mimics the structure of a virus to 
deliver nucleic acid into cells. The time-dependent self-assembly mechanism reveals that these 
SPs are formed from nanocup intermediates. We found that this intermediate stage is essential for 
the utilization of SP compartments. Nucleic acid is added to the system at this stage before SP 
formation, and high encapsulation is achieved. Similar to virus infections, once cells uptake the 
SP, SP disassociates in endosomes and releases the cargo. 
Overall, the work presented in this thesis investigates and highlights the strong potential of 





1.1  Motivation: Biomimetic Nanoparticles  
“There’s Plenty of Room at the Bottom” is the title of Richard P. Feynman’s talk where he put his 
thoughts on today’s technology with the statement “tiny machines ” in 19591 long before the term 
nanotechnology was used. He implies that as we go down in scale, we get new properties of 
materials and would be able to control individual atoms and molecules; and construct tiny 
machines that behave like biological entities1. Since then, research in nanotechnology has been 
highly active and leads to new knowledge and innovations that were not possible before, from drug 
delivery to energy-saving technologies, from next-generation antibiotics to surface coatings2–6. 
Among those, biomimetic nanoparticles have become extremely important in many applications.  
Biomimetic is the imitation of nature’s structures, materials, and functions to solve complex 
human problems7–11. For example, small pillars on the surface of the cicada wings provide self-
cleaning properties, or microscopic hair bundles on gecko feet provide wet or dry adhesion12. 
Engineering similar structures from nature provide similar properties that can be utilized in various 
applications such as optics, electronics, automotive and even buildings. Scientists have followed 
biomimetic engineering "learning from nature" for a long time, and nanoparticles are the most 
commonly used material in biomimetic engineering13–16. 
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1.2 Background 
Nanoparticles (NPs) are a broad class of materials with at least one dimension less than 100nm17. 
Nano is the scientific term meaning one‐billionth (1/1,000,000,000), and it comes from a Greek 
word meaning “dwarf.” For better comparison, a fingernail grows one nanometer every second, or 
a human hair is roughly 50,000 to 100,000 nanometers across18. These small structures are 
engineered for various applications. Specifically, biomimetic nanoparticles become extremely 
important in biomedical applications since they offer flexibility to materials and behave like 
complex biological systems similar to tiny machines, as Feynman mentioned decades ago15,19,20. 
These nanoparticles were engineered and designed by imitating the structure and function of 
nature21. For example, lipid-based NPs are commonly used to imitate cell membranes since they 
have a similar structure, lipid bilayer, and similar function, protecting the internal area from the 
harsh environment22. Similarly, inorganic NPs, another example, are used to mimic the similar 
function of nature, such as enzyme inhibition23; even though the overall shape may not be identical, 
the size and material of the NP allow imitation of the function. There are a large variety of materials 
that can be used as the building blocks for the engineering of biomimetic NPs. Based on the 
material, biomimetic NPs can be categorized into organic NPs, inorganic NPs, and hybrid NPs.   
1.2.1 Organic Nanoparticles 
Organic NPs are engineered from proteins, carbohydrates, lipids, and other organic compounds. 
Organic NPs can be exemplified in peptide-based NPs, lipid-based NPs, or polymer-based NPs.  
Peptide-Based NPs are self-assembled NPs composed of peptides such as surfactant-like 
peptides or polypeptides such as viral structural proteins, capsids24–26. They can have different 
morphologies, including nanotubes, nanovesicles, and nanofibers27. While there is a remarkable 
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potential of these NPs, they still have some disadvantages like non-specific immunogenicity to the 
components of NPs28,29. 
Lipid-Based NPs are self-assembled NPs composed of natural or synthetic phospholipids 
with one or more bilayers, including lipids, liposomes, or emulsions22. Their hydrophilic and 
hydrophobic compounds allow them to carry various therapeutic substances. Their size may vary 
with anionic or cationic surfaces30. The most common applications of lipid-based NPs are 
drug/gene delivery31,32 and vaccine applications33. High-production cost is the main disadvantage 
of lipid-based NPs34. 
Polymer-Based NPs composed of synthetic and natural polymers include poly-l-lysine, poly 
ethylenimine, dendrimers, chitosan, cyclodextrin, poly (lactic-co-glycolic) NPs. Compared to 
other organic NPs, they have poor solubility at physiological pH35. However, this does not affect 
their application in various fields. 
1.2.2 Inorganic Nanoparticles 
Biomimetic NPs engineered from inorganic materials have been widely investigated. These NPs 
are similar to proteins in size, shape, and, most notably, function, making them biomimetic NPs. 
Similar to proteins, these nanoparticles can self-assemble, form complex structures, inhibit 
enzymes and catalyze 36. Based on the overall shape, inorganic NPs can be 0D, 1D, 2D, or 3D37, 
and show unique chemical and physical properties different than the bulk material such as optical, 
magnetic, thermodynamic, electrochemical, and catalytic 38. Common inorganic NPs are metal 
NPs, silica NPs, carbon-based NPs, and metal-oxide NPs. 
1.2.2.1 Metal Nanoparticles 
Metal NPs are purely made of the metal precursors such as gold, silver, copper39. Metal NPs 
synthesis has great control on the surface properties, facet, size, and shape of the NPs 40,41. This 
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controlled synthesis allows NPs to play a crucial role in developing cutting-edge materials for 
different applications42–47. Metal NPs hold unique advanced optical and physicochemical 
properties due to their surface plasmon resonance properties, making them specifically valuable in 
imaging, diagnostics, electronics, chemical sensors, and biosensors 45,48–52. While metal NPs have 
many advantages, the disadvantages of their use specifically in the biomedical field include lack 
of biodegradability, poor clearance, the potential for long-term toxicity, and biomolecule 
adsorption on their surfaces 53,54. 
1.2.2.2 Silica Nanoparticles 
Silica NPs are inorganic, nonmetallic NPs composed of silicon dioxide and can be found in 
amorphous, crystalline, poly-crystalline, porous, or hollow forms39,55. The most commonly utilized 
silica NPs are mesoporous silica NPs with honeycomb-like structural features and many empty 
channels56–62. While silica NPs have been used in a wide range of applications such as imaging, 
and delivery applications63,64, it has been shown that silica is toxic with showing hemolytic 
activity65. 
1.2.2.3 Carbon-Based Nanoparticles 
Carbon-based NPs are an emerging class of NPs includes fullerenes, carbon nanotubes, graphene 
and its derivatives, graphene oxide, and carbon-based quantum dots66. Carbon-based NPs are 
unique for the combination of lightweight, chemical resistance, superb mechanical properties67. 
They have been utilized in various applications, including scaffolds in tissue engineering, 
biosensors, imaging, drug/gene delivery due to their physical, mechanical, electrical, optical, and 
thermal properties 50–57. Despite the continued applications, carbon-based NPs carry some 
drawbacks, including a lack of biodegradability and high in-vivo toxicity74,75. 
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1.2.2.4 Metal-Oxide Nanoparticles 
Earth’s crust consists of many metal oxides; therefore, the most significant advantage among other 
materials is high availability and low cost. Metal oxide NPs can have semiconducting nature due 
to the bandgap of the NPs and can be found various shape and size that gives them different 
properties23,76–79 Iron oxide NPs, for example, can also carry magnetic, superparamagnetic 
depending on the crystal type and size80. Due to their easy preparation, magnetic susceptibility, 
and biodegradability, metal-oxide NPs are widely investigated in various applications. These 
applications can be exemplified in biosensing applications81, targeted drug delivery 82,83, contrast 
agents in magnetic resonance imaging (MRI) 78,84, photocatalytic activities85, antibacterial 86and 
antifungal activities87.  
1.2.3 Hybrid Nanoparticles 
Hybrid NPs are composed of both organic and inorganic materials. The inorganic part may form 
the core or the shell of the hybrid NPs27. In either case, hybrid NPs have a synergetic effect of both 
materials for multifunctional properties 88–91. For example, inorganic NPs can be coated with 
different types of organic materials to improve the delivery and therapeutic efficacy or increase 
circulation time in blood 27,92,93. Gold NPs deposited polystyrene NPs can be utilized for surface-
enhanced Raman scattering94.  
1.3 Thesis Overview  
Among others, inorganic NPs are specifically become popular for biomimetic approaches because 
of their outstanding physical and chemical properties and, more importantly, their similarities with 
proteins 95–98. Furthermore, their easy preparation, tunable size, charge, and surface functional 
groups make them suitable for various applications, including but not limited to biosensing, 
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bioimaging, wound dressing27,39,99,100. Specifically, the high potential antimicrobial activity and 
cargo delivery make inorganic NPs popular for addressing the need for next-generation biomedical 
challenges.  
1.3.1 Biomimetic Inorganic NPs as Antibacterial Agent 
The first antibiotic, penicillin, was discovered in 1928. Since then, we have seen a significant 
improvement in global health and longevity. Unfortunately, emerging antimicrobial resistance is 
becoming one of the greatest threats to global human health101. Less than two decades after 
discovering penicillin, Alexander Fleming noted that microbes become “educated” to resist 
penicillin 101,102. Improper use of antibiotics has led to a widespread increase in the occurrence of 
drug-resistant and multidrug-resistant bacteria103. As more and more pathogenic bacteria develop 
resistance to multiple classes of antibiotics, previously treatable illnesses will become lethal. 101,102. 
Infections caused by antibiotic-resistant bacteria are associated with higher mortality rates and 
result in prolonged hospital stays and increased healthcare costs104. The COVID-19 pandemic has 
also put a spotlight on the need for new types of antimicrobials, not just specifically against the 
SARS-CoV-2 coronavirus but against hospital-acquired infections as well. Studies suggest that 
severe illnesses and death during the pandemics are attributed to secondary bacterial infections by 
S. aureus and P. aeruginosa105–111. Consequently, there is an imperative need for new 
antimicrobials with a novel mechanism of action to avoid resistance. Inorganic biomimetic NPs 
are a viable alternative to antibiotics to solve the problem of multi-drug resistance since nanoscale 
engineering of surfaces and particles provides new paths for antibacterial drug design 112,113. 
Multiple inorganic metals and metal oxide nanomaterials, exemplified by Ag, Cu, Zn, Ni, Ag2O, 
CuO, MgO, TiO2, and ZnO NPs, inhibit bacterial growth 114–129.  
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Zinc oxide NPs (ZnO-NPs) are one of the most investigated NPs for antibacterial 
activity23,130–134. Zinc is the second most abundant metal on Earth 135. Therefore, ZnO-NPs have 
become popular due to their simplicity, eco-friendly, and ability to apply in varied applications 135. 
ZnO-NPs are highly used in cosmetics, textiles, and biomedical fields because of prominent 
antibacterial activity and UV-A & UV-B protection 136–138. 
Several factors affect the NPs antibacterial activity, such as size, shape, charge, surface chemistry. 
Moreover, environmental conditions, the bacterial strain, and the exposure time are other major 
factors influencing the antibacterial effects of NPs23,77,131,139–142. Understanding the NPs’ 
mechanism of action on bacteria is essential for clinical translation.  
1.3.1.1 Understanding ZnO-NPs Mechanism of Action on Bacterial Cell for Engineering 
Next-Generation Antibiotics 
ZnO-NPs have extensive documentation of their antimicrobial abilities121,143,144.  The success of 
clinical studies of these antibacterial NPs primarily relies on the interaction ability of NPs with the 
biological environment145, and therefore there is a tremendous amount of research going on for 
engineering biomimetic NPs. Understanding the actual mechanism of action is important not just 
for clinical translations but also for engineering new next-generation antibiotics. 
Multiple mechanisms of action of ZnO-NPs are commonly proposed from the action of 
Zn2+ ion release, generation of reactive oxygen species, biomolecules, and membrane damage121. 
It is well documented that ZnO-NPs inhibit enzyme function66,171,172; however, the prevailing 
hypotheses’ of the ZnO-NPs mechanism by which this occurs is controversial. One proposed 
mechanism of action of ZnO-NPs is Zn2+ ion release. It is proposed that Zn2+ ions released by 
ZnO-NPs in solution with bacteria interfere with metabolic processes and disturb enzyme 
function23,148,149. However, given the low solubility of ZnO, the concentration of free Zn2+ ions is 
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expected to be low in aqueous suspensions. In Chapter 2, we explore this hypothesis by comparing 
ZnO-NP conditioned media and ZnCl2 dissolution in media. Another commonly reported 
mechanism of action is the production of reactive oxygen species (ROS)101,114,123,150–152. In Chapter 
2, we also look into if ZnO-NP’s antimicrobial activity is due to ROS generation by comparing its 
potency to Hydrogen Peroxide (H2O2)101,121. The final proposed mechanism of ZnO-NPs involves 
direct action on the bacterial cell membrane153–157as the positively charged surfaces of the NPs 
interact with the negatively charged bacterial membrane. In Chapter 3, we further explore the 
mechanism of action of ZnO-NPs on cell membranes and how bacterial metabolism is affected. 
1.3.2 Biomimetic NPs as Delivery Tools - Artificial Virus  
Over the past few decades, there has been considerable interest in developing biomimetic NPs as 
effective delivery tools 39,158.  In contrast with small-molecule therapeutics159, naked nucleic acid 
itself cannot effectively enter the cell 159–161.  Controlled delivery of nucleic acid to target cells -
also known as transfection - is essential for developing next-generation nucleic acid delivery tools 
160,162. The success of transfection largely depends on delivery vectors163. These vectors should 
protect genetic material from nucleases and other environmental agents and facilitate cellular 
uptake with minimal toxicity159,164. Nanoparticles that mimic virus formation and their transfection 
ability will be the most promising vectors. Vectors in literature are engineered from various 
materials and divided into two main categories: viral and non-viral vectors 159,160. Viral vectors 
such as modified retro and adenoviruses provide efficient delivery 160; however, they impose 
serious risks such as the possibility of recombination, strong immunogenicity, carcinogenicity, and 
inflammation 165–169 Alternative to viral vectors, non-viral vectors such as inorganic NPs 160, lipid-
based NPs 147, and polymer-based NPs 167,171 have been broadly used for nucleic acid delivery 
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(Table 1). However, a low transfection rate is still the most significant limitation when compared 
to viral vectors 172.  
Table 1 Advantages and Disadvantages of Non-Viral Vectors (Table is formatted from 173) 
Type of NPs Advantages Disadvantages Ref. 
Inorganic NPs Short time of transfection, easy 
preparation, wide availability, rich 
functionality, high transfection 
efficiency, potential capability for 
targeted delivery, and controlled release 
Most are unstable, toxic 
and non-biocompatible 
174–176 
Polymer-based NPs Small size, narrow distribution, more 
stability, high protection against 
enzymatic degradation, low toxicity, 





Safe preparation, low immunogenicity 






1.3.2.1 Challenges in Delivery Systems 
The engineering of a non-viral vector requires a rational design for addressing related challenges 
associated with efficient nucleic acid delivery. 
Packaging and Protection of Cargo 
The foremost challenge related to vectors is packaging the cargo. Whether it is DNA, RNA, or a 
drug, the first stage of the effective transfection is packing the cargo in the vector. Here, the cargo 
and vector should have balanced interactions. The vector must protect the cargo from the 
environment and release it in ambient conditions. Strong interactions between the cargo and the 
vector affect the release and transfection capacity similar to cationic polymers22. It is essential to 
understand the packaging capacity and efficiency of a vector.  
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Cellular Uptake   
Once the cargo is packed, the vector needs to penetrate the cells for cargo delivery. NPs can enter 
cancer cells via different types of endocytosis181. Besides cellular level challenges, there is an 
important barrier to the stability of the vector and targeting issue. The vector must be stable enough 
for extended plasma circulation and deliver the cargo to the specific target. 
Cargo Release  
Upon uptake, the vector needs to escape from endocytosis and release the cargo into the cell. If 
vector enters the cells via endosome, stability in low pH is vital. Releasing efficiency is also 
another challenge in vector systems179,182.  
1.3.2.2 Self-Assembly of Biomimetic Supraparticles as Delivery Tools 
To overcome these challenges, numerous NPs have been studied in nucleic acid delivery. In 
biological systems, proteins and other biomolecules self-assemble into complex super-structures 
that efficiently overcome these challenges, such as viral nanoshells formation. Inspired by these 
structures, scientists developed hierarchical assemblies, namely biomimetic supraparticles (SPs), 
that present properties and functionalities similar to nature173,183. The formation of SPs typically 
occurs through electrostatic and van der Waals interactions between uniformly shaped NPs and 
the environment 184,185. These self-organized NPs can be engineered for obtaining desired physical, 
chemical, and optical properties 183,186–189. Even though changing size, shape, and surface 
chemistry will also change the properties of the NPs, choosing the materials that are highly 
available, eco-friendly, and biocompatible is vital for engineering NPs for overcoming further 
challenges. Due to the natural existence of iron and sulfur in the human body 190, virus-like iron 
sulfide SPs appear promising for efficient and safe nucleic acid delivery. Chapter 4 shows that L-
cysteine stabilized iron sulfide NPs can self-assemble into multi-compartment supraparticles 
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(SPs). The transmission electron microscopy results showed that NPs initially produce ~55nm cup-
like structures and mature into ~75nm SPs with ca.190 interconnected compartments. The color 
change of the solution from black to yellow suggests the SP formation. The results of selected area 
electron diffraction and energy dispersive X-ray spectroscopy confirm SPs are formed from FeS2 
and Fe2O3 NPs. Elemental mapping showed that Fe2O3 NPs are located on the surface of the SP 
and protecting FeS2 and compartments from the surroundings. These compartmentalized particles 

















Unexpected Insights into Antibacterial Activity of Zinc Oxide Nanoparticles Against 
Methicillin Resistant Staphylococcus aureus (MRSA) 
2.1 Abstract  
Zinc oxide nanoparticles (ZnO-NPs) are attractive as broad-spectrum antibiotics, however, their 
further engineering as antimicrobial agents and clinical translation is impeded by controversial 
data about their mechanism of activity. It is commonly reported that ZnO-NP's antimicrobial 
activity is associated with the production of reactive oxygen species (ROS). Here we disprove this 
concept by comparing the antibacterial potency of ZnO-NPs and their capacity to generate ROS 
with hydrogen peroxide (H2O2). Then, using gene transcription microarray analysis, we provide 
evidence for a novel toxicity mechanism. Exposure to ZnO-NPs resulted in over three-log 
reduction in colonies of methicillin resistant S. aureus with minimal increase in ROS or lipid 
peroxidation. The amount of ROS required for the same amount of killing by H2O2 was much 
greater than that generated by ZnO-NPs. In contrast to H2O2, ZnO-NP mediated killing was not 
mitigated by the antioxidant, N-acetylcysteine. ZnO-NPs caused significant up-regulation of 
pyrimidine biosynthesis and carbohydrate degradation. Simultaneously, amino acid synthesis in S. 
aureus was significantly downregulated indicating a complex mechanism of antimicrobial action 
involving multiple metabolic pathways. The results of this study point to the importance of specific 
experimental controls in the interpretation of antimicrobial mechanistic studies and the need for 
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targeted molecular mechanism studies. Continued investigation on the antibacterial mechanisms 
of biomimetic ZnO-NPs is essential for future clinical translation.  
2.2 Introduction  
Zinc oxide NPs have extensive documentation of their antimicrobial abilities121,143,144. Multiple 
mechanisms of action of ZnO-NPs are commonly proposed. A prevailing hypothesis is that ZnO-
NPs spontaneously produce reactive oxygen species (ROS) and enhance intracellular oxidative 
stress in bacteria leading to their death 114,123,150,151,191–193. ROS include hydroxyl radicals OH•, 
superoxide ions O2 _•, H2O2, and hydroperoxyl radicals 114,151.  ROS are proposed to cause 
membrane damage by lipid peroxidation113 triggering cell leakage, loss of energy metabolism, and 
cell death 129,150,191.  While being plausible and widely reported, this hypothesis requires closer 
evaluation. The factual support of oxidative stress as the antimicrobial mechanism in case of ZnO-
NPs and other nanoscale antimicrobials is controversial. In many studies, ZnO-NPs were first 
excited by ultraviolet (UV) light and then exposed to bacteria for ROS detection 194,195 . It is well-
known that UV excitation creates oxygen vacancies and ROS on the semiconductor surfaces and 
therefore antibacterial activity can be associated with UV radiation 194.  At the same time, several 
studies suggested significant antibacterial effects without UV illumination 196,197 however, strong 
ROS generating positive controls have not been used in parallel to evaluate the respective NP ROS 
generating capacity.  Notably, many of ZnO-NP antibacterial experiments were conducted on 
nonpathogenic, laboratory strains that are devoid of multiple defense/survival mechanisms (i.e., E. 
coli K12) 151,191 and thus elevated ROS concentrations can originate from their native metabolic 
state rather than from the NPs.  Contrarily, pathogenic strains of S. aureus are known to have 
multiple mechanisms for scavenging ROS 198–200; they can cope with large amounts of ROS even 
if NPs can inherently generate them. Finally, spontaneous production of ROS by ZnO-NPs would 
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act indiscriminately and therefore have significant toxicity for mammalian cells.  However, studies 
have demonstrated that ZnO-NPs have selective toxicity for prokaryotic cells over eukaryotic cells 
122,201. Therefore, we sought to conclusively evaluate the oxidative stress hypothesis for ZnO-NP 
mediated antibacterial effect.  
Despite the poor solubility of ZnO in aqueous media, many studies have attributed 
antibacterial activity to release of toxic Zn2+ ions 202,203.  The basis of this toxicity is related to the 
specificity of certain essential proteins/enzymes for certain metal cofactors such as zinc 148.  Toxic 
levels of any of these metal ions lead to mis-metalation of these enzymes leading to loss of function 
and ultimately lysis.  As with ROS, bacteria have evolved complex regulatory processes to 
maintain intracellular metal ion homeostasis through a wide range of environmental concentrations 
148.  Given the low solubility of ZnO, the concentration of free Zn2+ ions are expected to be low in 
aqueous suspensions.  However in the growth media, ZnO dissolution is complicated by Zn 
speciation with various components – amino acids and peptides – in the media 202,204,205. Since 
most growth media is undefined soy digest products, it is difficult to predict ZnO dissolution 
kinetics and resulting complexes. However, studies dedicated to evaluation of ZnO dissolution in 
a defined bacteria growth media are required for more focused description of the resulting 
complexes generated from dissolution and beyond the scope of this work. We chose S. aureus 
COL, a methicillin resistant strain, as our model organism because of its prevalence in human 
infections, virulence, ROS scavenging abilities, and clinical relevance as an antibiotic resistant 
organism.  The ROS generating potential of two ZnO-NP preparations and the resulting effect on 
S. aureus were evaluated.  Specifically, we examined a commercially available ZnO-NP 
previously reported to generate ROS 194 and one synthesized in our laboratory known to inhibit 
planktonic and biofilm growth of methicillin resistant S. aureus (MRSA) 141,206. Oxidative stress 
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was evaluated by multiple experimental techniques including fluorescent detection of ROS as well 
as resulting lipid peroxidation.  Comparison was made with an equivalent degree of antibacterial 
activity by hydrogen peroxide (H2O2), which was chosen for its well-studied mechanism of ROS-
mediated toxicity 207,208.  The dissolution of Zn2+ ions or catalysis of otherwise undefined toxic but 
soluble species was also considered in this study. Finally, in the abscess of definitive evidence 
from these specific phenotypic studies, a comprehensive gene transcription microarray analysis 
was performed to provide new insight into the mechanism of ZnO-NP staphylococcal toxicity.  
2.3 Materials and Methods 
2.3.1 Bacterial Strain, Media and Growth Conditions 
Methicillin-resistant Staphylococcus aureus sub-strain COL was used in all experiments due to its 
strong ROS scavenging abilities 198,200. A glycerol stock of the strain was maintained at −80°C and 
was plated on tryptic soy agar. Single colony inoculates were grown in tryptic soy broth + 1% 
glucose w/v (TSBG) under shaking conditions at 37°C. Mid-log, optical density of 0.45-0.55 at 
600nm (OD600), cultures were used in all experiments. 
2.3.2 ZnO Nanoparticles 
ZnO nanopyramids with hexagonal base (ZnO-NPYs) synthesized in our laboratory and 
commercially available ZnO nanospheres (ZnO-NSPs) were investigated.  Both of these NPs have 
been extensively characterized previously206,209, which predicated our choice of the model 
nanoscale antimicrobials. ZnO-NPYs were synthesized without the use of surfactants or capping 
agents as previously described206,209.  Briefly, pyramids were synthesized by first mixing 0.2 g 
potassium hydroxide with 5.5 g Zn(Ac)2∙2H2O before adding anhydrous methanol and refluxing 
for 48h.  After synthesis, the white precipitate was purified by washing three times with methanol, 
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and then frozen in Milli-Q® water to be lyophilized for 24 hours.  ZnO-NSP were purchased from 
Nanostructured & Amorphous Materials, Inc (Houston, Texas) 194   
2.3.3 ZnO-NP Characterization 
ZnO-NPs were characterized by transmission electron microscopy (TEM), selected area electron 
diffraction (SAED), photoluminescence spectroscopy (PL), Fourier transformed infrared 
spectroscopy (FTIR), and nanoparticle tracking analysis (NTA). A JOEL 2010 transmission 
electron microscope was used for NP visualization.  TEM samples were prepared by adding 10µL 
of 167µg/ml ZnO-NPs sonicated in Milli-Q® water solution to a carbon TEM grid and drying at 
room temperature.  The nanocrystalline structure of ZnO-NPs was confirmed by SAED from TEM 
samples on the same microscope.  NP surface chemistry was evaluated by PL (Jobin Yvon Horiba 
Fluoromax-3 instrument) and FTIR (JASCO FT/ IR-4100 instrument). PL samples were prepared 
by sonicating 167ug/ml ZnO-NPs in Milli-Q® water for 3 mins.  PL spectra of the aqueous 
dispersions were obtained using an excitation wavelength of 320nm at room temperature.  
Lyophilized ZnO-NP powder was used for FTIR with attenuated total reflection crystals.  Particle 
aggregate distributions were obtained by NTA (Malvern NanoSight NS300) on aqueous 
dispersions prepared like PL samples.  
2.3.4 ZnO-NP Dose Response and Bacterial Killing 
To prepare NP dispersions for bacterial killing in planktonic conditions, ZnO-NP powder was 
sonicated into Milli-Q® water for 3 minutes to ensure a stable dispersion. Concentrations of ZnO-
NPs included: 8, 80, 160, 400, and 800µg/ml. H2O2 was used as a positive control of a bacterial 
toxin whose mechanism of action involves the production of ROS.  Concentrations of H2O2 
included: 0.25, 0.50, 0.75, and 1.0 mM. These concentrations were chosen as they generated a 
similar degree of dose-dependent killing as the ZnO-NPs.  Mid-log cultures of S. aureus grown 
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under aerobic conditions were pelleted by centrifugation and resuspended in aqueous dispersions 
of ZnO-NPs or solutions of H2O2.  After 30 minutes, samples were serially diluted and plated on 
tryptic soy agar for colony enumeration (CFUs). Actual exposure times included 30 minutes in 
planktonic dispersion followed by multiple 10-fold dilutions and 36 hours on agar plate.  
Therefore, the concentration of dispersed ZnO-NPs and dissolved H2O2 were quickly diluted 
below toxic concentrations after just 30 minutes.  It is possible that serial dilutions would not 
reduce the local concentration of ZnO if the NPs are complexed with the cells.  However, this is 
not dissimilar from H2O2 which can readily diffuse through the cell membrane and is immediately 
reacted to form other ROS (e.g., hydroxyl radicals) which are unable to diffuse back out and remain 
with the cell despite dilution of the media.    
2.3.5 ROS Detection  
The presence of ROS was quantified by the fluorescence of 3ʹ-(p-aminophenyl) fluorescein (APF; 
ThermoFisher Scientific, Waltham, Massachusetts) and 2',7'-dichlorodihydrofluorescein diacetate 
(H2DCFDA; ThermoFisher Scientific, Waltham, Massachusetts).  Both dyes detect the presence 
of a variety of ROS including but not limited to peroxyl and hydroxyl radicals, peroxynitrite anion, 
and hypochlorite anion.  The excitation/emission peaks for APF and H2DCFDA are 490/515 nm 
and 517/527 nm respectively.  To evaluate for potential interactions between these dyes and ZnO-
NPs we first evaluated their fluorescence in the presence of ZnO-NP dispersions and H2O2 
solutions at the concentrations listed above without bacterial cells.  Stock solutions of the dyes 
were made according to manufacturer’s instructions and were added to ZnO-NP or H2O2 samples 
and incubated for 30minutes.  Samples were then pelleted and fluorescence reading of both the 
supernatants and resuspended pellets were obtained using Perkin Elmer Enspire Multimode Plate 
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Reader.  Comparing the pellets versus the supernatants provided information regarding interaction 
between the dye and the NPs which distribute to the pellet fraction.     
For bacterial experiments, mid-log cultures grown under aerobic conditions were pelleted 
and resuspended in water, ZnO-NPs dispersions, or H2O2 at the concentrations listed above. Cells 
with fluorescent ROS detection dyes were exposed to NPs or H2O2 at 37°C for 30 minutes. The 
pellets represent intracellular ROS while the supernatants represent extracellular ROS or ROS 
spilled from lysed cells.  Of note, there were no significant differences in the data trends for pellets 
or supernatants (see Figure S 2.9). For clarity only the data for the pellets are reported here. All 
samples were then serially diluted and plated on tryptic soy agar for CFU enumeration to provide 
a simultaneous measurement of bacterial cell death.  This allowed us to correlate the amount of 
ROS in a sample with the degree of bacterial killing in that same sample.  
To confirm that ZnO-NPs dispersions can indeed generate ROS via photocatalysis, APF and 
H2DCFDA fluorescence was also measured on ZnO-NP dispersions without bacteria but after UV 
excitation.  These samples were exposed to either ambient light or 2 minutes UV excitation via a 
UV light box (Figure S 2.10).   
2.3.6 Lipid Peroxidation 
Lipid peroxidation was evaluated using the thiobarbituric acid reactive substances assay (TBARS): 
OxiSelect™ TBARS Assay Kit (Cell Biolabs, San Diego, California).  Mid-log phase cultures 
grown under aerobic conditions were pelleted and resuspended in ZnO-NPs dispersions or H2O2 
at the concentrations listed above.  After 30minutes, TBARS reagents were added and incubated 
at 95°C for 50 minutes.  Samples were centrifuged and supernatant was collected for fluorescent 
spectroscopy measurements 540nm excitation and 590nm emission.  Just prior to addition of 
TBARS reagents, an aliquot of each sample was removed for serially dilution and CFU 
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enumeration to allow for simultaneous measurement of lipid peroxidation and bacterial cell death 
for each sample.  A malondialdehyde (MDA) standard curve (provided by the kit) was used to 
convert the fluorescence measurements into MDA equivalent concentrations (Figure S 2.11). 
2.3.7 Bacterial Growth Recovery by Antioxidant  
Antioxidant recovery was evaluated by adding increasing concentrations of N-acetylcysteine, 
NAC, to the culture media with H2O2 or ZnO-NPs. NAC concentrations between 10mM and 
70mM were evaluated to determine the maximum cell growth recovery in the presence of H2O2 
without toxicity.  A concentration of 50mM resulted in maximal recovery with low toxicity 
(Figure S 2.12).  Mid-log culture, 10l, was exposed to 50mM NAC (final concentration) for 15 
minutes.  Then 1ml of 8, 80, 160, or 400 g/ml final concentrations of ZnO-NP dispersions or 
0.25mM or 0.5mM H2O2 was added to the cells.  Each sample, ~100L, were then plated in a 
96well plate, and growth curves were measured turbidometrically (OD600) each hour for 10 hours 
under aerobic shaking conditions. To provide a simultaneous measurement of NP and H2O2 
mediated killing, a 10l aliquot of each sample after only 30 minutes exposure were serially diluted 
and plated on tryptic soy agar for CFU enumeration. 
2.3.8 ZnO-NP Supernatant Growth Curves 
To evaluate for ZnO dissolution or catalysis of soluble toxic substances on the ZnO-NP surface, 
we evaluated the toxicity of media conditioned with ZnO-NPs.  Briefly, ZnO-NP were sonicated 
into TSBG at concentrations of 0, 80, 160, and 400 g/ml for 3 minutes and then incubated at 37°C 
for 30min.  As a control, ZnCl2 was dissolved into TSBG at concentrations of 0, 50, 100, 200, and 
300 g/ml and treated similarly with sonication and incubation.  The ZnO and ZnCl2 samples were 
then centrifuged at 14,000g for 10 min and the supernatants were removed.  Those supernatants 
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were then inoculated with ~ 5x107 CFU/ml in a 96-well plate, and growth curves were measured 
turbidometrically (OD600) each hour for 14h under aerobic shaking conditions. 
2.3.9 Gene Expression Analysis 
To evaluate changes in gene expression by S. aureus in response to ZnO-NPs, RNA was isolated 
from S. aureus after exposure to a sub-lethal but growth inhibitory concentration (160 g/ml) of 
ZnO-NPYs (Figure S 2.13). S. aureus grown at the same time but not exposed to ZnO-NPYs were 
used as a control. A total of 3 ZnO-NP and 3 control samples were obtained and analyzed on 
independent microarray chips. Mid-log phase cells were lysed with lysostaphin followed by 
proteinase k digestion.  Total RNA was isolated using Trizol (Invitrogen, Carlsbad, CA) followed 
by RNeasy column cleanup (Qiagen, Valencia, CA).  RNA quantity and quality was confirmed on 
an Agilent 2100 Bioanalyzer before being applied to S. aureus whole genome microarray 
(GeneChipTM, Affymetrix, Santa Clara, CA).   
Microarray results were validated by performing quantitative RT-PCR on select genes 
identified to be significantly up or down regulated in the microarray analysis. Briefly, RNA was 
purified from S. aureus COL samples exposed to sub-lethal dose of ZnO-NPs, identical to 
microarray gene expression experiments. S. aureus grown in the same condition while not exposed 
to ZnO-NPs were used as controls.  RNA was isolated through a lysostaphin digestion, TRizol 
extraction (Invitrogen, Carlsbad, CA), and then elution by RNeasy mini kit (Qiagen, Valencia, 
CA). RNA quality was checked using NanoDrop 2000 (ThermoFisher Scientific, Kalamazoo, MI) 
and RT-PCR was performed using QuantiFast SYBR Green RT-PCR Kit (Qiagen, Valencia, CA), 
and StepOnePlus Real-Time PCR System (Applied Biosystems, ThermoFisher Scientific, 
Kalamazoo, MI). Primers (Supplemental Table 1) were designed using National Center for 
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Biotechnology Information database and ordered from Integrated DNA Technologies (Skokie, 
Illinois).  
2.3.10 Statistical Analysis 
All data presented in this study are displayed as mean plus or minus standard error of the mean 
unless otherwise stated.  To evaluate the role of oxidative stress on S. aureus toxicity we performed 
simultaneous measurements of ROS generation (by fluorescence of APF and H2DCFDA) or lipid 
peroxidation (by TBARS) and quantitative culture.  Each measurement was performed in triplicate 
and at least 5 independent experiments were run on different days. We compared ROS content or 
lipid peroxidation associated with a greater than two-log reduction in CFUs for the two ZnO-NP 
preparations and H2O2.  Hypothesis testing was performed via ANOVA with repeated measures.  
Post-hoc pairwise testing was performed using the Tukey test with p < 0.05 indicating significance.   
To evaluate the capacity of NAC to mitigate bacterial killing we compared the resulting CFUs 
after exposure to ZnO-NPs or H2O2 with and without the presence of NAC. Again, ANOVA with 
repeated measures was used for hypothesis testing.  To evaluate growth recovery by NAC, 
individual growth curves were summarized by calculating a growth rate constant using linear 
regression of the log-transformed optical density data. We then performed linear regression on the 
growth rate constants as a function of ZnO-NP dose with and without NAC.  Hypothesis testing 
was performed using ANOVA of the resulting regression models. 
For the microarray gene expression analysis, weighted linear models specific for microarray 
analysis 210 were fit to the data to compare ZnO-NP treated samples to control. Specifically, we 
increased the power to detect differences by pooling information from all probesets to stabilize the 
variance estimate and samples were weighted on a gene-by-gene update algorithm 211.  We selected 
probesets with a fold change of 1.5 or greater and an adjusted p-value of 0.05 or less. The p-values 
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were adjusted for multiple comparisons using false discovery rate of 5% 212.  Genes were then 
grouped by biological function. Finally, gene set enrichment analysis (GSEA) was used to organize 
genes by function, transcriptional regulation, and pathway associations (Biocyc Pathway/Genome 
database for S. aureus, www.biocyc.org) and identify significant biological functions or pathways 
altered in response to ZnO-NPs. Pathways with enrichment p-value of 0.05 or less were identified.  
The p-values were adjusted for multiple comparisons using a Bonferroni correction. 
Fold change in gene expression between control and ZnO-NP treated bacteria was 
determined by quantitative RT-PCR using the delta-delta Ct method.  Five separate pairs of control 
and test samples were performed for each gene of interest with triplicate reactions for each 
replicate.  Student’s t-test was used to evaluate each gene for significant change in gene expression 
with the null hypothesis equal to zero change.  Again p-values were adjusted for multiple 
comparisons.   
2.4 Results 
2.4.1 ZnO-NP Characterization 
Although the two NPs are different in size and shape, their electron diffraction patterns were 
identical and matched the hexagonal crystalline phase of bulk ZnO (Figure 2.1 a and b). Their 
average particle aggregation sizes, under the aqueous conditions used in this study, were also very 
similar (Figure S 2.14). The NPYs and NSPs also had similar FTIR patterns indicating little 
difference in surface chemistry (Figure 2.1c).  The photoluminescence spectrum of both NP 
dispersions shows only one emission peak, located at 390nm (Figure 2.1d). There are no other 
peaks observed, particularly around 520nm, which would indicate the presence of singly ionized 
oxygen vacancies. The NPY’s narrow luminescence peak is consistent with their small size and 
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high crystallinity.  Contrarily, the NSPs had a broader peak, corresponding to their larger size and 
broader spectrum of light-emitting states. 
 
Figure 2.1 Transmission electron micrographs of (a) ZnO-NPYs and (b) ZnO-NSPs. Insets show selected area electron 
diffraction. (c) Fourier transform infrared spectra and (d) photoluminescence spectra of corresponding ZnO-NPs.  The 
spectra in (c & d) were shifted with respect to the ordinate for clarity 
2.4.2 Antimicrobial Properties of ZnO-NPs 
Bactericidal activities of both types of NPs and H2O2 against S. aureus demonstrate dose dependent 
killing in all cases (Figure 2.2).  Exposure to ZnO-NP dispersions and H2O2 solutions resulted in 
greater than 1000x reduction in colony forming units (CFU) from control (5x107 CFUs of S. aureus 
without ZnO-NPs or H2O2 grown for 18h) for both shapes at 800μg/ml and H2O2 at 0.75mM.  CFU 
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reduction due to increasing H2O2 concentrations was similar to the potency of the ZnO-NPs. These 
concentrations of H2O2 were used as a positive control in the subsequent experiments.  
 
Figure 2.2 Reduction in colony counts (from 5x107) observed after exposure to increasing concentrations of ZnO-
NPYs and NSPs as well as H2O2.  Note the different scales of abscissa for ZnO-NPs and H2O2.  Error bars represent 
standard error of five independent experiments run on different days 
2.4.3 ROS Production in Presence of ZnO-NPs 
Understanding the potential for NPs to interact with a variety of fluorescent probes, we first 
evaluated the fluorescence of APF and H2DCFDA in NP dispersions and H2O2 solutions without 
bacterial cells (Figure S 2.15). As expected, there is a dose dependent increase in fluorescence of 
both APF and H2DCFDA in the presence of H2O2. Likewise, we observed dose dependent 
fluorescence of both ROS indicators in the NP dispersions. However, the absolute fluorescence of 
APF for low dose ZnO-NPs (80g/ml) was slightly less than pure water. In addition, a large 
fraction of APF became bound to the ZnO-NPs as seen by the high fluorescence noted in the pellet 
fraction. Higher doses of ZnO-NPs (800g/ml) resulted in only modest elevations in pellet 
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fluorescence but significant increases in the supernatant. This indicates potential saturation of APF 
on the NPs. On the other hand, H2DCFDA appeared to have less affinity for the NPs with 
significantly less fluorescence in the pellet fraction.  There were no significant differences between 
the NSPs and the NPYs.  Although H2DCFDA appears to be a more reliable ROS indicator with 
respect to ZnO-NPs, we utilized both indicators in the subsequent studies. 
To determine the baseline production of ROS by bacterial cells due to aerobic metabolism 
we obtained the fluorescence of APF and H2DCFDA generated by 5x107 S. aureus CFUs (the 
initial inoculum in all future experiments). There is a substantial increase in ROS production as 
indicated by the increase in APF and H2DCFDA fluorescence with the addition of bacteria (Figure 
S 2.16). It should be noted that the cells were resuspended in water (not growth media) to remove 
variation due to rapidly dividing cells. Given the high background ROS production by bacterial 
cells alone, as well as the significant sample to sample variation (note error bars), all subsequent 
measurements of ROS fluorescence were expressed as a percent change from a control (bacteria 
without H2O2 or ZnO-NPs) prepared from the same bacterial colony. 
S. aureus exposure to H2O2 resulted in steady, dose-dependent increase in APF 
fluorescence (Figure 2.3a). For both ZnO-NP preparations, there was also a dose-dependent 
increase. However, the absolute quantity was always smaller than that of H2O2 as well as smaller 
than the paired controls (i.e., <100%). The difference between the two NP shapes was statistically 
insignificant. This decrease in APF below controls may indicate that ZnO-NPs reduce cellular 
metabolism and resulting metabolic ROS, although interaction with APF as seen in Figure S 2.16 
is also possible. As such, the fluorescence of H2DCFDA was also used to detect small molecule 
ROS (Figure 2.3c). As expected, the presence of H2O2 resulted in a large dose-dependent increase 
in H2DCFDA fluorescence. Similarly, both ZnO-NPs had a dose-dependent increase in H2DCFDA 
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fluorescence above control, with the effect from NPYs being modestly greater than NSPs. These 
findings alone might appear to confirm the initial ROS hypothesis. Indeed, ZnO-NSPs used in this 
study were previously shown to produce intracellular ROS194. However, these ROS can be 
produced in a dose-dependent manner as a side product. To be the cause of cell death, ROS from 
the NPs need to be produced in amounts comparable to a known ROS-based antibacterial agent, 
for instance H2O2, the gold standard in this field. Here, the absolute amount of ROS generated by 
bacteria exposed to ZnO-NPs was significantly smaller than those exposed to H2O2. To quantify 
the relationship between cell death and ROS production, we correlated the resulting CFU counts 
with the ROS fluorescence measurements. We then compared the APF and H2DCFDA 
fluorescence required for a 2-log or greater reduction in CFUs for H2O2 and the two ZnO-NP 
preparations (Figure 2.3b and d). H2O2 generated significantly greater amounts of ROS to kill the 
same amount of S. aureus as the ZnO-NPs (p ˂ 0.001). This finding leads to different conclusions 




Figure 2.3 Dose and shape-dependent ROS production by (a) APF and (c) H2DCFDA fluorescence after exposure to 
ZnO-NPYs and -NSPs as well as H2O2.  Note the different scales of abscissa for ZnO-NPs.  Error bars represent 
standard error of five independent experiments run on different days. (b) Dot plots of APF and (d) H2DCFDA 
fluorescence associated with a two-log reduction in CFUs for each treatment.  Black horizontal lines represent the 
mean value.  p-values represent significant difference determine by ANOVA with repeated measures and post-hoc 
Tukey testing. 
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2.4.4 Lipid Peroxidation in The Presence of ZnO-NPs 
Although APF and H2DCFDA detect a wide range of small molecule ROS, many ROS are so 
reactive that their presence is transient and could be difficult to detect. A downstream result of 
intracellular oxidative stress is lipid peroxidation. To confirm ZnO-NPs were not producing a toxic 
but undetected ROS, we evaluated downstream lipid peroxidation. There was minimal to no 
increase in lipid peroxidation for all doses and shapes of ZnO-NPs tested (Figure 2.4a).  On the 
other hand, the addition of H2O2 resulted in robust dose-dependent lipid peroxidation.  Using a 
similar analysis as for small molecule ROS, we compared the degree of lipid peroxidation required 
for a greater than 2-log reduction in colonies. As before, we observed that H2O2 generated 
significantly more oxidative stress - lipid peroxidation in this case - for the same degree of bacterial 
eradication as ZnO-NPs (p˂0.001, Figure 2.4b). NPYs generated higher levels of lipid 
peroxidation than NSPs although the absolute difference was small (p<0.001, Figure 2.4b).   
 
Figure 2.4 (a) Dose-dependent lipid peroxidation by ZnO-NPs and H2O2.  Error bars represent standard error of five 
independent experiments run on different days. (b) Dot plots of lipid peroxidation associated with a two-log reduction 
in CFUs for each treatment.  Black horizontal lines represent the mean.  p-values denote significant differences 
determined by ANOVA with repeated measures and post-hoc Tukey testing.   
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2.4.5 Antioxidant Recovery from Oxidative Stress 
As a complementary test, we attempted to mitigate the oxidative stress to bacteria by adding the 
well-known antioxidant NAC to the culture media prior to the addition of ZnO-NPs or H2O2. The 
addition of NAC resulted in near complete recovery of bacterial colonies whose counts were 
dramatically reduced by H2O2 (Figure 2.5a). On the other hand, the addition of NAC did not 
mitigate the antibacterial activity of either ZnO-NP (Figure 2.5b and c).  On the contrary, NAC 
improved the antibacterial effect of ZnO-NPs at 400g/ml. This could be due to better stability of 
NPs at high concentrations in the presence of NAC, therefore being more effective. Alternatively, 
NAC can be toxic at high concentrations (See Figure S 2.12) and this particular concentration was 
synergistic with the ZnO-NPs. However, the key finding was that the presence of NAC did not 
recover any bacterial growth, as opposed to H2O2. The effect of NAC was similar for bacterial 
growth curves obtained in the presence of H2O2 and ZnO-NPs. For H2O2 almost 50% recovery 
was seen in the presence of NAC (Figure S 2.17). However, in the case of ZnO-NPs, growth 
curves and the resulting dose-dependent growth rates were unchanged by NAC (Figure 2.5 d-i). 
The addition of NAC to NP treated cultures did not recover the S. aureus growth rate.    
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Figure 2.5 Reduction in colony counts (from 5x107) observed after exposure to increasing concentrations of (a) H2O2, 
(b) ZnO-NSPs, or (c) ZnO-NPYs with and without 50 mM NAC. Growth curves of S. aureus in ZnO-NPYs dispersions 
of increasing concentration (d) without and (e) with NAC.  Growth curves for S. aureus in ZnO-NSP dispersions (g) 
without and (h) with NAC.  Growth rate constants as a function of (f) ZnO-NPY or (i) ZnO-NSP concentration. Error 
bars represent standard error of five independent experiments run on different days.  
2.4.6 Toxicity of ZnO-NP Conditioned Media 
The bacterial growth media (i.e., TSBG) was conditioned with ZnO-NPs as well as ZnCl2 to 
evaluate for any potential toxicity of dissolved Zn2+ ions or other undetermined soluble species 
catalyzed by the ZnO-NP surface. ZnO-NP conditioned media had minimal to no toxicity 
compared to ZnCl2 dissolved in media at concentrations consistent with maximum expected 
dissolution of ZnO (Figure 2.6). Although ZnCl2 has a different Zn2+ ion release profile at the 
selected concentrations, we demonstrate that the total amount of Zn ions incorporated into our NPs 
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at highest concentration of 400ug/ml (which is relative to 300ug/ml ZnCl2) are less toxic to 
bacteria, thereby challenging the Zn ion toxicity mechanisms of ZnO-NPs against bacteria.  
 
Figure 2.6 Growth curves of S. aureus in the media condition with ZnO (a) NPY and (b) NSP dispersions as well as 
(c) ZnCl2.  Error bars represent standard error of three independent experiments run on different days 
2.4.7 Gene Expression Changes in Response to ZnO-NPs  
Over 800 different gene transcripts were identified as significantly changed in S. aureus exposed 
to ZnO-NPYs compared to controls. Of those, 556 had previously identified function. Of these, 
181 genes were up-regulated and 375 were down-regulated (Appendix 1). Functional classification 
of the genes with a significant change in expression is shown in Figure 2.7a. GSEA was performed 
to identify specific pathways or biological functions whose genes are significantly enriched in the 
ZnO-NP treated group (Table 3).  Specifically, ZnO-NPY treated S. aureus has up-regulation of 
pyrimidine biosynthesis and sugar degradation and down-regulation of amino acid synthesis. Most 
notably, 5 of the 10 most up-regulated genes belong to the uridine monophosphate (UMP) 
biosynthesis pathway (Figure 2.7b), a subpathway of the pyrimidine biosynthesis superpathway. 
Interestingly 10 of the 13 oxidative stress genes significantly altered in the microarray were down 
regulated upon ZnO-NPs exposure, and only 3 were upregulated (Figure 2.7c;Table 3). The 
upregulated ROS genes experienced an average fold change of 1.91, which is not as strong as the 
UMP pathway, which experienced average fold changes above 10.  To validate the results of the 
microarray experiments we selected two genes from the UMP biosynthesis pathway (carB and 
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pyrE), two amino acid biosynthesis genes (lysC and leuD), and one oxidative stress gene (katA) 
for quantitative RT-PCR (Figure 2.7d). The results indeed confirm the upregulation of the UMP 
pathway and downregulation of amino acid synthesis and oxidative stress genes.   
 
Figure 2.7 (a) Functional classification of genes with significant change in transcription upon exposure to ZnO-NPs 
(b) UMP biosynthesis pathway with associated enzymes and their fold-change in expression after exposure to ZnO-
NPs (c) Oxidative stress genes response to ZnO-NPs exposure (d) Quantitative RT-PCR of selected genes to validate 
microarray results.  Error bars represent standard error for n=5 independent samples with triplicate reactions for each.  




The work here not only addresses fundamental questions regarding the mechanism of action for 
ZnO-NP, but it also gives a new rationale for the clinical translation of ZnO-NPs. We demonstrate 
here that primary antibacterial mode of actions remains undiscovered between ZnO-NPs and 
bacteria. Literature suggests that the presence of ROS may lead to only sporadic cell death in 
bacterial biofilms, induce genetic variability, and possibly increase biofilm development213. 
Multiple studies emphasize bacteria’s ability to combat excessive ROS and how they incorporate 
excess ROS into many metabolic and respiratory pathways for survival 193,199,200. Interestingly, 
moderate excess ROS may have unexpected consequences and increase the production of 
extracellular polymeric substances, accelerating the growth of biofilm. For instance, this behavior 
is noticed in Acinetobacter oleivorans 214.  Evolutionary biologists have speculated that microbial 
biofilm’s response to ROS may have evolved in response to increasing oxygen concentration on 
Earth, resulting in the integration of ROS into several different signaling pathways, including the 
switch between planktonic and biofilm forms 199.  Therefore, substances causing excessive ROS 
may not be the best choice to prevent biofilm growth and in particular for combating antibiotic 
resistant infections of indwelling medical devices. Since ZnO-NPs kill bacteria without inducing 
high level of oxidative stress, they can obviate ROS-inactivating pathways evolved in bacteria.    
Furthermore, the presence of ROS extensively damages mammalian cells, where ROS react with 
polyunsaturated fatty acids in the lipid bilayer and promoting lipid peroxidation, and inactivate 
cellular surface proteins leading to loss of cell integrity 215. NPs that have an ROS mediated 
bactericidal effect promote mammalian cell death as well. ZnO-NPs present a distinct advantage 
of broad spectrum antibacterial activity 128,141 similar to H2O2 without oxidative stress to 
mammalian tissues or its rapid decay related to short life time of radicals in biological media. 
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The data presented here indicates that oxidative stress does not play the central role in 
antibacterial activity of ZnO-NPs with respect to MRSA. Particularly, taking into account the gene 
expression results of the oxidative stress genes in response to ZnO-NPs exposure, the down 
regulation of majority of ROS responsive genes indicates that ROS could not be the primary mode 
of action for an antibacterial effect. Indeed, comparison of our results with microarray experiments 
with S. aureus exposed to H2O2 from the literature showed less than 10% concordance in 
significantly up- or down- regulated genes between the two studies 216,217.  Other work with ZnO-
NPs has also shown down-regulation of oxidative stress genes 218,219. Some have interpreted that 
finding as evidence against an oxidative stress mechanism while others have interpreted it as 
making the cells more susceptible to ROS. These disparate interpretations have continued to fuel 
the ZnO-NP mechanism controversy. However, the multiple lines of evidence provided here, 
including gene expression, comparison with H2O2 and lack of recovery with an antioxidant, 
confirm that ROS mediated toxicity is not the mechanism of action for ZnO-NPs. The persistent 
controversy and multiple experiments required here to investigate it, highlight the complexity in 
evaluating the mechanism of action of any antimicrobial NP. Specifically, confirmation or 
rejection of any hypothesized mechanism typically requires multiple lines of evidence including 
both observed cellular response as well as molecular and ‘omics’ data. 
A consideration of other possible mechanisms with interesting possibilities for molecular 
and nanoscale engineering is required to further increase and/or tune NP potency 112,220. Other 
mechanisms of antibacterial activity of NPs to be considered include toxic ions complexes, 
bacterial membrane disruption, and enzyme inhibition. In addition, the ability of NPs to suppress 
amyloid peptide fibrillation essential for biofilm formation may also need to be considered 221.  
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The ROS production hypothesis for antimicrobial activity is predicated on catalysis of ROS 
on the ZnO surface. We acknowledge that the techniques described here are certainly not an 
exhaustive evaluation of toxic species dissolved from or catalyzed by ZnO-NPs.  That being said, 
to evaluate for the production of undetected, soluble, ZnO-NP catalyzed, toxic species, we used 
the supernatant of ZnO-NP dispersions in growth media to generate growth curves of S. aureus.  
If ZnO-NPs dissolve into toxic Zn2+ ions or they catalyze the production of soluble toxic species 
in media then we would expect S. aureus growth to be inhibited by the supernatant of ZnO-NP 
dispersions, similar to ZnCl2 curves.  However, almost no growth inhibition is observed with the 
supernatants of ZnO-NPs dispersions (Recall Figure 2.6).  This suggests that the ZnO-NPs must 
remain dispersed with the cells to have their effect and the experimental conditions of the assays 
did not contribute to ion dissolution of the NPs. Furthermore, our gene expression data do not 
identify significant changes in expression of gene pathways related to metal ion transport. 
With respect to membrane disruption, although lipid peroxidation results were negative in 
our study, it is possible that there are other membrane disruption mechanisms present between 
ZnO-NPs and Gram-positive cells. Previous studies show that NPs with different surface chemistry 
can differentially attach to various parts of the bacteria’s surface123,150,222,223. Notably, 
lipopolysaccharides are attracted to NPs via variety of intermolecular forces including electrostatic 
interactions, hydrogen bonding, and van der Waals forces, that may cause lipid bilayer rupture, 
loss of membrane potential and cell death 224. However, it should be noted that cell membrane 
compromise and lysis is a common event for most antibacterial agents, including those whose 
mechanism does not involve the cell membrane (e.g., streptomycin). Therefore, documenting cell 
membrane damage in the presence of a particular NP is not sufficient. Rather the timing of loss of 
cell membrane integrity, proton motive force, and lysis in relation to other processes is critical. 
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Again, we highlight the need for multiple lines of evidence with well-defined controls to test any 
specific hypothesis. Of note, our gene expression studies do not show significant changes in 
expression of genes related to cell membrane synthesis/repair. 
Considering enzyme inhibition, it was shown recently that ZnO-NPs can enter cells through 
membrane disruption 114,123 and cause enzyme inhibition 23 exemplified by strongly suppressed 
activity of β-galactosidase, an essential enzyme in bacterial metabolism. Enzymatic inhibition is 
not unique to β-galactosidase and may represent a family of biomolecular processes leading to 
suppression of bacterial growth or cellular death 143. Ultimately, it is more than likely that several 
of these mechanisms together impact viability of bacteria. While the exact enzymatic targets for 
ZnO-NPs remain a question, our gene expression microarray data revealed a metabolic pathway, 
(i.e., UMP biosynthesis) not previously considered for ZnO-NP mediated bacterial toxicity. 
Upregulation of the UMP and other pyrimidine biosynthesis pathways have been shown to be 
critical for continued growth in anaerobic environment 225. The combined up-regulation of this 
pathway with sugar catabolism suggests that ZnO-NPs may have a profound effect on 
carbohydrate metabolism and bioenergetics. This is a fundamentally new mechanism of action for 
consideration (Figure 2.8). Furthermore, when compared to other analyses of staphylococcal 
transcriptome response to various stressors, we did not find any significant concordance with heat 
shock, cold shock, stringent response, SOS response, anaerobic response, or oxidative stress 
216,217,226,227.  Future work on the antimicrobial effects of ZnO-NPs can now be directed at these 
pathways and the phenotypic manifestations of altered metabolic state. 
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Figure 2.8 H2O2 readily diffuses through the cell membrane. High concentrations overwhelm catalase and peroxidase 
enzymes leading to hydroxyl radical formation via Fenton reaction.  In addition, high concentration of H2O2 can inhibit 
superoxide dismutase (SOD) driving Haber-Weiss reaction and additional production of hydroxyl radical.  These ROS 
(hydroxyl radical and superoxide radical) cause toxicity through lipid peroxidation, nucleic acid damage and protein 
oxidation.  Zn2+ ions require cell membrane transporters to enter the cell. In high concentrations that exceed normal 
homeostatic mechanism these ions displace other metal ions cofactors on proteins, causing mis-metalation and 
resulting protein dysfunction.  Evidence here suggests an alternative mechanism for ZnO-NPs. ZnO-NPs result in 
dramatic increases in pyrimidine biosynthesis, sugar metabolism and decreases in amino acid synthesis. This 
combination or cellular processes suggests that ZnO-NPs alter energy metabolism within the cell. The precise 
mechanism by which ZnO-NPs enter the cell and the specific intracellular molecular targets remain unclear. 
It is important to note that this work is limited to S. aureus. However, the ZnO-NPs used in this 
study were shown to also be toxic to Staphylococcus epidermidis at these concentrations 141.  
Others have shown broad antimicrobial spectrum for ZnO-NPs 219,228. However, the 
generalizability of this novel potential bioenergetics mechanism involving pyrimidine and amino 
acid biosynthesis as well as sugar catabolism remains a question. That being said, the UMP 
biosynthesis pathway is quite similar for S. aureus and E. coli 225. Furthermore, enzymes in amino 
acid synthesis are also quite highly conserved within bacteria 229. This indicates that the mechanism 
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may be applicable to both Gram-negative and Gram-positive organisms. Although it does not 
appear that the UMP pathway is necessary for anaerobic metabolism in E. coli as it is in S. aureus 
225.  This may explain why a higher dose of ZnO-NPs is typically required for E. coli. Ultimately, 
the surface chemistry and crystalline structure of a particular ZnO-NP preparation may have a 
profound effect on its interaction with the surface of a Gram-positive versus Gram-negative 
organism and therefore may dictate species selectivity regardless of the final mechanism 230. 
Likewise, the three-dimensional shape may be important in accessibility of ZnO-NPs to specific 
molecular targets 23,231.  
2.6 Conclusions 
Here we have demonstrated that oxidative stress and toxic ion dissolution are inadequate to cause 
ZnO-NP mediated killing of methicillin resistant S. aureus. By means of gene expression analysis 
we demonstrate that ZnO-NPs may have a profound effect on anaerobic carbohydrate metabolism 
and energetics with upregulation of the UMP biosynthesis pathway being a key response. 
Altogether, the findings about the unexpectedly small role of ROS production and large role of 
alterations in carbohydrate metabolism and bioenergetics give strong indication of biomimetic 
mode of action of NPs 96.  
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2.7 Supplemental Information 
 
 
Figure S 2.9 ROS detection in bacterial pellets and supernatants by APF and H2DCFDA fluorescence after 30-
minute exposure to increasing concentrations of (a) H2O2 or (b) ZnO-NSPs and -NPYs. Error bars represent standard 





Figure S 2.10 Two minutes of UV light exposure resulted in significant increase in ROS production by ZnO-NPs 
as measured by H2DCFDA fluorescence. However, the general dose dependence trend is unchanged. 
 
 




Figure S 2.12 Dose response of bacterial recovery after exposure to 0.25 and 0.5mM H2O2 in the presence of 
increasing doses of N-acetylcysteine (NAC). The initial inoculum was 5x107 CFU. 50mM NAC leads to complete 
recovery from a >2 log reduction in colonies caused by 0.5mM H2O2. Increased doses of NAC beyond 50mM however, 
lead to toxicity and cell death. 
 
Figure S 2.13 Growth curves of S. aureus with and without 160μg/ml ZnO-NPs used for the gene expression 




Figure S 2.14 Size distribution of nanoparticle aggregates in aqueous dispersion. Error bars represent standard 





Figure S 2.15 Fluorescence of (a) APF and (b) H2DCFDA in water, H2O2, and ZnO NPs. Each measurement was 




Figure S 2.16 Fluorescence of (a) APF and (b) H2DCFDA due to baseline cellular respiration. Each measurement 
was made in triplicate. Error bars represent standard error of three independent experiments run on different days. 
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Figure S 2.17 Growth curves of S. aureus with H2O2, NAC and H2O2 plus NAC. Each measurement was made in 
triplicate. Error bars represent standard error of five independent experiments run on different days. 
 
 
Table 2 Primer Pairs for RT-PCR Gene Expression Quantification 
Orientation Gene Primer Sequence (5'--3') 
+ 16s rRNA TCGTGTCGTGAGATGTTGGG 
- 16s rRNA GTTTGTCACCGGCAGTCAAC 
+ leuD GTCGTGAACATGCTGCTTGG 
- leuD TGGAAACGCTTGTCTGGTGA 
+ lycC ATCCGCCACGTGGAAATGTA 
- lycC CTGACGTCCCACAAGAAGCA 
+ katA GGAGCGTGACATTCGAGGAT 
- katA GACCCGTCCAGAAATCCCAG 
+ pyrE GCTGGTATTCCACATGCAGC 







Table 3 Pathways with Genes Significantly Enriched (Up or Downregulated) by ZnO-NPs 
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Gene ID Fold Change 
Downrelgulated 
Nitrate reductase gamma chain (narL) SACOL2392 -2.56 
Thioredoxin SACOL2550 -2.16 
NAD dehydrogenase SACOL0941 -2.11 
Acyl carrier protein phosphodiesterase (acpD) SACOL0190 -1.80 
Succinate dehydrogenase (sdhA) SACOL1159 -1.74 
Catalase (katA) SACOL1368 -1.72 
NADP flavin oxidoreductase (frpP) SACOL2534 -1.69 
Luciferase SACOL0394 -1.62 
Thioredoxin reductase SACOL2369 -1.59 
Upregulated 
Oxidoreductase SACOL0763 1.60 
Cytochrome d ubiquinol oxidase subunit I (cydA) SACOL1094 2.00 
Cytochrome d ubiquinol oxidase subunit II (cydB) SACOL1095 2.13 
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Membrane Dynamics of ZnO Nanoparticles in Methicillin-Resistant 
Staphylococcus aureus and Subsequent Effects on Cell Respiration 
3.1 Abstract 
Zinc oxide NPs are noted to be an attractive broad-spectrum alternative to traditional small 
molecule antibiotics. The most commonly reported mechanism of actions are oxidative stress, Zn2+ 
ion dissolution and membrane damage.  Previously we showed that ZnO-NPs induce cell death in 
methicillin resistant Staphylococcus aureus by means beyond the commonly reported mechanisms 
of oxidative stress and the generation of toxic ions. We identified that ZnO-NPs strongly affect 
specific pathways: particularly pyrimidine biosynthesis, carbohydrate degradation and amino acid 
synthesis. Therefore, in this chapter, we further explore how ZnO-NPs affect pathways and study 
their interaction with cell membrane. We show that within 60 minutes of exposure, ZnO-NPs 
reduce bacterial growth with minimal disruption to the cell membrane. More thorough 
investigation utilizing scanning transmission electron microscopy (STEM) shows that ZnO-NPs 
penetrate bacterial cells as early as 5 minutes post-exposure without causing observable cell 
damage. Immediately after exposure, ZnO-NPs exhibit a dose dependent reduction of cellular 
respiration, as measured through oxygen consumption rate. With prolonged NPs exposure, cells 
switch from aerobic to anaerobic respiration, and eventually to cell death. Our data suggest that a 
time sensitive antimicrobial mechanism of action exists for ZnO-NPs, whereby cell metabolism is 
immediately affected upon NPs exposure and membrane damage is a downstream response to 
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bacterial cell death. The ZnO-NPs’ interaction with metabolic pathways within S.aureus indicates 
a unique mechanism that has previously not been identified. 
3.2 Introduction 
Among other metal oxide NPs, ZnO appears to be one of the most promising for clinical translation 
due to its high potency against antibiotic resistant bacterial strains 232, low toxicity to mammalian 
cells 122,201,233, and low cost.  Apart from antimicrobial activity induced by dispersions, surfaces 
coated with ZnO-NPs, 128,150 for instance layer-by-layer assembled (LbL) coatings, 234,235  suppress 
biofilm formation of common bacterial pathogens141 as well.  Staphylococcal adhesion and biofilm 
growth can be reduced by as much as 95% for NPs of specific shapes 141.  These findings motivate 
an in-depth look into the fundamental mechanism of action for ZnO-NPs.   
In Chapter 2 we have shown that Zn2+ ion release cannot be the only mechanism of action 
via comparison of growth curves of ZnO-NP conditioned media and ZnCl2 dissolution. 
Furthermore, there is no change in gene expression for metal ion transport 144. We also disproved 
the notion that ZnO-NPs antimicrobial activity is due to ROS generation by comparing its potency 
to Hydrogen Peroxide (H2O2)121,101. The amount of ROS required was much greater than what was 
generated by ZnO-NPs compared to H2O2 and was not mitigated by the administration of 
antioxidant N-acetylcysteine. Additionally, gene expression data indicated the downregulation of 
oxidative stress genes, and thus ROS could not be the primary mode of action141. We showed 
evidence pointing to multiple metabolic pathways being involved in the antimicrobial activity of 
ZnO NPs. 
The final commonly reported mechanism of action of ZnO-NP’s antibacterial activity suggests 
that ZnO-NPs damage the bacterial cell membrane153–157. Since most ZnO-NPs are positively 
charged, it is expected that they can interact with the negatively charged bacterial membrane. 
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However, membrane interaction is complex and may provide the opportunity for many 
downstream and consequential effects of ZnO-NPs on bacterial cells. This interaction can cause 
lysis and loss of structural integrity which can be identified through changes in metabolism and 
cell entry. The order and causality of the NPs and membrane interaction are unknown. 
In this chapter, we explore the antibacterial mechanism of ZnO-NYPs by focusing on the 
membrane and metabolism of Methicillin-resistant Staphylococcus aureus. We present a time 
course of bacterial response to ZnO-NPYs exposure and the cellular location of ZnO-NPYs 
through multiple microscopy methods.  
3.3 Materials and Methods 
3.3.1 Bacterial Strain, Media and Growth Conditions 
Methicillin-resistant Staphylococcus aureus strain USA300 was used in all experiments since it is 
a well characterized strain of S. aureus. A glycerol stock of the strain was maintained at −80°C 
and was plated on tryptic soy agar. Single colony inoculates were grown in synthetic nasal medium 
(SNM)146 under shaking conditions at 37°C. SNM is reported to mimic human nasal conditions146. 
Krismer, B. et al. analyzed human nasal secretions by metabolomics and found potential nutrients 
in low concentrations. We chose to study S. aureus and ZnO-NPYs interactions in this media as it 
represents a suitable in vivo surrogate environment for in vitro studies. The simplicity and complete 
understanding of each component of SNM allowed us to control for our NP surface chemistry and 
stability within the media. Bacterial growth for experiments first required the growth of an 
overnight culture, which was then diluted 1:10 into SNM for mid-log culture-optical density of 
0.55-0.64 at 600nm (OD600). Mid-log reached after 18 hr of incubation (slow growth due to the 
minimal nutrient content of the media), and this culture was used for all experiments. 
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3.3.2 ZnO NPYs Synthesis and Characterization 
ZnO nanopyramids with hexagonal base (ZnO-NPYs) were synthesized and characterized in our 
laboratory206. These ZnO-NPYs were synthesized without capping agents or surfactants and have 
previously shown strong antibacterial activity towards S. aureus101,141. Briefly, ZnO-NPYs were 
synthesized by mixing 0.2 g potassium hydroxide with 5.5 g Zn(Ac)2 ∙ 2H2O and adding anhydrous 
methanol and refluxing for 48h.  After synthesis, the white precipitate was purified by washing 
three times with methanol (centrifuging at 8,000g) and then frozen in Milli-Q® water (-80°C) to 
be lyophilized for 24 hours. The dry powder was extensively characterized as reported in Chapter 
2.   
3.3.3 ZnO-NPYs Solution Preparation and Dose-Response  
Dry ZnO-NPYs powder was measured and reconstituted into SNM and sonicated for 5 minutes 
for bacterial experiments. Minimum inhibitory concentration (MIC) for 1.0 x106 bacterial cells 
was optimized using various concentrations of ZnO-NPYs. The MIC for the ZnO-NPYs was 
determined to be 10µg/ml. Which is drastically lower from MIC of ZnO-NPYs (660µg/ml) in a 
tryptic soy broth as demonstrated before141 and Chapter 2. Concentrations of ZnO-NPYs include 
2.5, 5.0, and 10.0µg/ml. All antibiotics and enzymes were purchased from Sigma. Growth curves 
were generated by adding 1.0x106 bacterial cells (10µL of SNM mid-log culture, 0.55-0.64 at 
OD600) to various ZnO-NPYs concentrations and controls. Each sample, 100µL, was then plated 
in a 96well plate, and growth curves were measured turbidometrically (OD600) each hour for 15 
hours under aerobic shaking conditions (BioTEK Synergy 2 Plate Reader, Vermont, USA).  
3.3.4 Lactate Dehydrogenase Detection  
Lactate dehydrogenase (LDH) was quantified by using Cell Biolabs’ CytoSelect™ LDH 
Cytotoxicity Assay Kit. Sonicated ZnO-NPYs solutions and antibiotics were mixed with 1.0 
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x106/ml mid-log USA300 culture in SNM and exposed to the LDH cytotoxicity assay reagent. 
Antibiotics, chloramphenicol, and streptomycin were used as controls, and lysostaphin used as 
positive control. Their MIC was identified to be 4µg/ml, 2µg/ml, and 1 unit, respectively. Cells 
were exposed to the NPYs and controls for 10, 20, 30, 60, 120, and 180 minutes. OD was collected 
at 490nm. SNM with cells was used as the negative control. The relative cytotoxicity percentage 
was calculated by equation 
Equation 1 OD experimental – OD negative control)/ (OD positive control – OD negative control)*100 
in where negative control is cells in SNM and positive control is lysostaphin. 
3.3.5 Membrane Depolarization   
BacLight™ Bacterial Membrane Potential Kit (ThermoFisher) was used to quantify bacterial 
membrane depolarization. The fluorescent membrane potential indicator -3,3'-
Diethyloxacarbocyanine Iodide (DiOC2(3)) was used to detect membrane depolarization. 
DiOC2(3) is a fluorescence dye which exhibits red fluorescence in cell with intact membrane 
potential and shifts toward green emission in compromised cells. The red to green fluorescence 
shift in the bacterial populations were distinguished using a flow cytometer (Bio-Rad ZE5 Cell 
Analyzer). Samples were prepared by exposing 1.0 x 106 mid-log-cultured cells to 2.5, 5, 10, 
15µg/ml ZnO-NYPs for 15, 30, 60, 120, and 180 minutes at 37°C in shaking conditions (200rpm). 
Samples were stained with DiOC2(3) prior to inject into the instrument, the final concentration of 
30uM for 10 minutes at room temperature. Carbonyl cyanide m-chlorophenyl hydrazine (CCCP)  
is a proton ionophore and causes membrane depolarization as it reduces ATP production by efflux 
pump inhibition and increases membrane permeability in bacteria236,237. CCCP was used as a 
positive control for membrane depolarization, and cells were exposed to this ionophore for 20 
minutes before measurement.  
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Excitation/emission used for DiOC2(3) was 482/497, with a flow cytometer laser line of 488. 
Fluorescein and Texas Red dye filters were used. The forward scatter, side scatter, and 
fluorescence was collected with logarithmic signal amplification. An unstained control sample was 
used to locate bacterial populations in the forward and side scatter channels. Side scatter was used 
as the parameter for setting acquisition triggers. The threshold level was set to minimize electronic 
noise appearing on the instrument. Forward versus side scatter was used to gate bacteria, and 
fluorescence photomultiplier tube voltages were adjusted such that the green and red MFI values 
were approximately equal without compensation. The acquisition was performed with washing 
between each sample and thresholding on FSC at a value of 1,000. Using the ratiometric parameter, 
calculated as follows 
Equation 2 (RC mean) – (GC mean) + 1.5(# of channels per decade).  
The 1.5-decade offset assures that the ratiometric values are positive. The number of channels per 
decade*1.5 in our system was 384. Therefore, our ratiometric parameter was calculated as 
Equation 3 [(red value) – (green value) +384]. 
Data analysis was compiled using DenovoFCS software. On a ratiometric histogram, markers were 
set around positive control peak (+CCCP) and negative control (-CCCP), cell in SNM) peaks to 
record the mean ratio values. Membrane depolarization was determined as the percentage for ZnO-
NPYs exposed cells and controls that fell within the +CCCP marker.   
3.3.6 Oxygen Consumption  
The Seahorse XFe96 Analyzer (Agilent) was used to quantitate live-cell oxygen consumption rates 
(OCR). Mid-log S. aureus cells, grown to an OD600 of ∼0.5, were plated into the XF Cell Culture 
Microplates at a cell density of 1.0 x 106/well and were centrifuged for 10 min at 1,400 × g in a 
Heraeus Multifuge ×1R (M-20 rotor) to attach them to the plates. After centrifugation, fresh SNM 
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media was added to each well for a final volume of 180µL. To assure uniform cellular seeding, 
initial OCR was calibrated for ten cycles (30 min) before the injection of ZnO-NPYs (2.5, 5, 10 
µg/ml). Measurement was taken for 100 minutes. Maximal OCR read on the SeaHorse is ∼700–
800 pmol/min, after which point the consumption rate exceeds the replenishment of the system 
and curves show a false declination in OCR; we did not notice this in our system.  
3.3.7 Electron Microscopy  
Mid-log-cultured S. aureus cells were exposed to 10µg/ml ZnO-NPYs in MilliQ water for certain 
minutes (1, 5, 10, 15 and 30 min) and fixed in 2.5% glutaraldehyde (microscopy grade) for 24h at 
4C. Samples were placed onto cupper-based carbon TEM grids (TedPella), washed twice with 
MilliQ water, and serially dehydrated with ethanol (30-100%) within the incubation period of 10 
minutes at room temperature between each concentration switch. 
Transmission electron microscopy (TEM) images of ZnO-NPYs were obtained with JEOL 
3011 high-resolution electron microscope equipped with a CCD camera and a field emission gun 
(FEG) operating at 300 kV. Scanning electron microscopy (SEM-TLD) imaging, high-angle 
annular dark-field scanning transmission electron microscopy (HAADF-STEM) imaging, and 
focused ion beam slicing (FIB) were done with FEI Helios 650 Nanolab SEM/FIB. SEM images 
of cells were obtained with a through-the-lens detector (TLD) at 30kV and 0.16nA; only vesicles 
were imaged at 24kV with 0.20nA current. HAADF-STEM images were obtained with the STEM 
detector under 30 kV with a current of 0.40nA. FIB was done with deposition of platinum (first) 
and carbon (second), and then sliced with ion beam and imaged at 10kV and 0.20nA. Elemental 
mapping and energy-dispersive X-ray (EDX) along with HAADF-STEM images were obtained 
with Thermo Fisher Talos F200X G2, a 200 kV FEG scanning transmission electron microscope 
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(S/TEM) equipped with Super-X window-less detector consists of four equal crystals with an 
active area of 4 × 30 mm2 and a solid angle of 0.9 srad. 
3.3.8 Nanolive Microscopy 
Mid-log cultures S. aureus cells were again exposed to 10µg/ml ZnO-NPYs in a flow channel slide 
with a #1.5H glass bottom (Ibidi) and channel height of 450µm. After exposing cells to ZnO-NPY 
solution, the cells were filled to the channel and let them settle at the bottom of the slide for 10 
minutes. Samples were imaged under a 10x objective on a Nanolive 3D Cell Explorer-fluo label-
free imaging of live cells.  
3.3.9 Statistical Analysis  
All data presented in this study are displayed as mean plus or minus standard error of the mean 
unless otherwise stated. To evaluate the role of ZnO-NPYs on S. aureus membrane and cellular 
respiration, simultaneous measurements are made for membrane depolarization (fluorescence of 
DiOC2(3)), membrane damage (LDH release assay), and cell respiration inhibition (OCR) 
measurements. Each measurement was performed in triplicates, and at least 5 independent 
experiments were run on different days. 
3.4 Results  
3.4.1 ZnO-NPYs Effect on S. aureus Aerobic Metabolism 
3.4.1.1 LDH Release Assay 
Lactate dehydrogenase (LDH) release assay was used to indicate membrane damage or 
cytotoxicity in response to ZnO-NPYs and antibiotics. No immediate membrane damage was 
noticed until 60 min expose time (Figure 3.1). LDH release (% Lysis) increases after 60 min of 
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exposure to ZnO-NPYs. During the first 30-minute of ZnO-NPYs exposure, cells release little to 
no LDH from the cells comparing to control, indicating no significant membrane damage. 
However, with an increased incubation period of 60-180 minutes, membrane damage is evident 
(% lysis increases up to 50 %) in a NP dose dependent manner. Streptomycin, a bactericidal, and 
chloramphenicol, a bacteriostatic, antibiotics were used as controls for this assay as they are known 
for having membrane damage as a downstream effect of their mechanism of action. Both 
antibiotics’ mechanism of action is the inhibition of protein synthesis through binding to ribosomal 
subunits238–240. Streptomycin inhibits polypeptide synthesis and forces misreads240. It has been 
proposed that these polypeptides can still incorporate with the membrane causing them to be leaky 
to small molecules which is important for our work because we are expecting membrane damage 
as a downstream effect of the mechanism241. Chloramphenicol  stops mRNA translation as well 
and causes jamming of translocation complexes on the cell membrane, which results in unfolded 
proteins accumulation in cytoplasm.242,243. As a downstream of effect of this action, cell membrane 
loses its integrity and LDH release increases.  As expected, both antibiotic samples demonstrate 
strong membrane damage within 30 min exposure to cells. Lysostaphin, on the other hand, directly 
targets crosslinking in the peptidoglycan of Staphylococci. Therefore, it has a strong immediate 
membrane damage action, and LDH releases immediately after exposure to cells. For this reason, 
lysostaphin is used to set 100% lysis point and the percentage calculations of other samples are 
made based on lysostaphin’s LDH release at each time point (Figure S 3.8).  
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Figure 3.1 LDH release assay for cells exposed to ZnO-NPYs and antibiotics. % Lysis of cells (a) exposed to ZnO-
NPYs in concentration of 2.5, 5 and 10 µg/ml, (b) treated with chloramphenicol and streptomycin antibiotics. Control 
for each experiment is cells in SNM media. Lysostaphin results in Figure S1 are used for percentage calculations. 
Error bars represent standard error of five independent experiments run on different days. 
3.4.1.2 Oxygen Consumption  
Extracellular measurement of oxygen consumption is a simple and powerful way to monitor 
respiration rates and a good assessment for total energy metabolism244. Oxygen consumption rate 
as the result of cellular respiration is determined by a measurement of the amount of dissolved 
oxygen in the medium. There is an observed dose-dependent decrease in oxygen consumption rate 
with increased concentrations of ZnO-NPY (Figure 3.2a), whereas no significant change is 
observed for antibiotics (Figure 3.2b). The system is calibrated with 10 cycles for 30 minutes 
before adding ZnO-NPYs or antibiotics at time 0. Data collected over the calibration (30 min) are 
averaged to yield the basal OCR (Figure 3.2b). OCR change over time (∆OCR/∆Time) is 
calculated by subtracting the basal values from the values at maximum incubation time (100 min). 
∆OCR/∆Time clearly decreases as ZnO-NPYs concentration increases. 
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Figure 3.2 Oxygen consumption rate (OCR) of the cells exposed to (a) different concentration of ZnO-NPYs. ZnO-
NPYs are added to cells at time 0, after 10 calibration cycles (30min) (c) OCR change over time for ZnO-NPYs 
exposed cells; and is calculated based on basal data calculated the average OCR during calibration time. Control is 
cells in SNM media. Error bars represent standard error of five independent experiments run on different days. 
3.4.1.3 Membrane Depolarization 
CCCP is a proton ionophore and causes membrane depolarization as it reduces ATP production 
by efflux pump inhibition and increases membrane permeability in bacteria236,237. CCCP, positive 
control for membrane depolarization, was used to calculate % membrane depolarization of ZnO-
NPYs exposed cells and controls (Figure 3.3a). The ratio of red to green fluorescence intensity 
was plotted and used as a size-independent indicator of membrane potential (Figure 3.3b). Based 
on the % depolarization data, ZnO-NPYs do not cause any significant membrane depolarization 
up until 180 min compared to control (Figure 3.3c).  
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Figure 3.3 Membrane depolarization of cells exposed to ZnO-NPYs and antibiotics. (a) % depolarization of cells 
exposed to different concentration of ZnO-NPYs (b) Flow cytometer results for positive (CCCP) and negative 
controls. (c) The ratio of red to green fluorescence intensity was used as a size-independent indicator of membrane 
potential. Control in graph is cells in SNM media. Error bars represent standard error of five independent experiments 
run on different days. 
 
3.4.2 Microscopy Analysis 
ZnO NPYs are positively charged NP, therefore their interaction with cell membrane is expected. 
However, this electrostatic interaction cannot simply explain the mechanism of action or cell entry. 
Here, we will further investigate the NP- membrane interaction via different imaging method. Each 
method has limitations and disadvantages, for example, in FIB imaging NP on the surface can be 
dragged into cytoplasm and cause misleading results. Therefore, we utilized several imaging 
techniques and analysis method to confirm ZnO-NPYs membrane interaction and cell entry. 
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3.4.2.1 ZnO-NPYs  
ZnO-NPYs are characterized under TEM microscopy (Figure 3.4). TEM images confirm ZnO-
NPYs are within 15 nm range and are crystalline hexagonal based-pyramid NPs.  
 
Figure 3.4 (a-b) TEM images of ZnO-NPYs. (b) High-resolution TEM (HR-TEM) image at high magnification (c) 
SAED pattern of ZnO-NPYs. Scale bar: (a) 20nm, (b) 5nm 
3.4.2.2 ZnO-NPYs Entry to Cells  
There is an observed time-dependent ZnO-NPYs accumulation on the cell surface, cell entry, and 
aggregation inside the cells (Figure 3.5). In TEM images, we started to see ZnO-NPYs accumulate 
on the cell surface within 1 minute after exposure (Figure 3.5 a-b). ZnO-NPYs, dark spots, 
accumulate inside the cells after 5 min of exposure (Figure 3.5c), and after 30 min of exposure, 
the cell lysis (Figure 3.5 f-red circle). This data led us to hypothesize that ZnO are entering cells.  
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Figure 3.5 TEM images ZnO-NPYs exposed cells in time dependent experiment. Cells are exposed to ZnO-NPYs for 
(a) 1 minute without wash (b) 1 minute (c) 5 min (d) 10 min (e) 15 min (f) 30 min. All samples are washed before 
fixation unless otherwise differently stated. ZnO-NPYs or their accumulations in cells are marked with arrow in each 
image. Dotted red circle in (f) shows cell lysis after 30min exposure. Scale bar: 200nm 
We also performed HAADF-STEM and SEM-TLD imaging to confirm these dark spots are inside 
the cells but not on the surface (Figure S 3.9). SEM-TLD images show secondary electrons 
coming from the just the cell surface. HAADF-STEM images, on the other hand, show an annular 
dark field image formed by very high angle, incoherently scattered electrons. HAADF is highly 
sensitive to variations in the atomic number of atoms in the sample and the detector senses a greater 
signal from elements with a higher atomic number (heavier elements). This cause the ZnO-NPYs 
to appear brighter in the resulting image as opposed to TEM images (See Chapter 3.7.2). We 
further performed elemental mapping to confirm whether the spots contains ZnO-NPYs (Figure 
3.6). Co-localization of Zn and O on the bright spots confirms ZnO-NPYs entry (Figure 3.6a). 
The intensity of Zn and O increase within these spots (Figure 3.6b). On the other hand, we do not 
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observe any Zn signal in cell only samples (See Chapter 3.7.3). We therefore believe that ZnO-
NPYs enter and start aggregating inside the cells. As the number of NPs increase in the cells, the 
number of bright spots increase in the HAADF-STEM images (See Chapter 3.7.4). We visualized 
ZnO containing spots localizing inside cells via Focused ion beam (FIB) slicing on ZnO-NPYs 
exposed cells. The sliced images show that the Zn containing spots are located inside the NP 





Figure 3.6 (a) Elemental analysis of ZnO-NPYs exposed cells after 10 min of exposure along with HAADF-STEM 
image (b) Intensity profile of ZnO-NPY accumulation in cells. (Zn-zinc, O-oxygen, P-phosphorus, N-nitrogen, and 
C-carbon). Bright spots (one of them is marked with an arrow) in HAADF are an accumulation of ZnO-NPYs in cells. 
(b) An overlay image of HAADF, Zn and O. White box in this image specifies an area for intensity profile. The graph 
shows intensity profile for each image HAADF (black line), Zn (red line) and O (blue line). Yellow, orange and purple 
boxes show 3 different ZnO-NPYs accumulated spots. Zn and O signal to background (cell) ratio is higher in these 
spots. These spots are measured ~50nm in diameter based on this graph’s x-axes. Scale bar: 200nm 
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3.4.2.3 Nanolive Imaging 
Further alternative confirmation of ZnO-NPYs entry was obtained by the Nanolive 3D Cell 
Explorer in which different cell components and NPs can be distinguished based on the distinctive 
refractive index (See Chapter 3.7.6). ZnO-NPYs in media and cell only samples were used as a 
control to determine the digital stain of each component (membrane, cytoplasm and NPs) based 
on their distinguished refractive index for analysis. We used red digital stain for cell membrane, 
green digital stain for cytoplasm and blue digital stain for ZnO-NPYs. The blue color in ZnO-
NPYs exposed cells can be clearly seen in Figure 3.7. We also confirmed the digital stain of NPs 
with FITC-labeled ZnO-NPYs (Figure S 3.19).   
ZnCl2 is also used as a control for eliminating the possibility of Zn2+ ions release from ZnO-NPYs 
and aggregate in cells. We did not observe any spots in cells or Zn signal in elemental mapping or 
in Nanolive imaging. Data not shown but similar data obtain with cell only sample (Figure 3.7 
and Chapter 3.7.3) 
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Figure 3.7 Nanolive images of ZnO-NPYs exposed cells and cell in media. 3D images with digital staining on the 
right panel. Here we digitally labeled cell membrane with red color, cytoplasm with green (anything inside of the cell 
surface), and ZnO-NPYs with blue color. In top panel we can observe blue color within the cell. 
We observe three different features in EM imaging of ZnO-NPYs exposed cells (Figure S 3.9): 
ZnO-NPYs aggregation (See Chapter 3.4.2.2), polyphosphate granule formulation (See Chapter 
3.4.3) and vesicle formulation ( See Chapter 3.4.4) 
3.4.3 Polyphosphate Granule Formation 
As a downstream effect of ZnO-NPY entry, we observed polyphosphate granules in ZnO-NPYs 
exposed cells. It is well known that polyphosphate is a primordial energy source and an active 
metabolic regulator245. Polyphosphate granule formation started to form within 10 min of exposure 
the ZnO-NPYs. It can be seen with (Figure S 3.23) or without ZnO-NPYs aggregations (Figure 
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S 3.20 and Figure S 3.21) and the size of the granule is about 250nm. As time progresses, we 
observe more ZnO-NPYs aggregations along with polyphosphate granules (Figure S 3.22). 
3.4.4 Extracellular Membrane Vesicle formation  
S. aureus develops extracellular membrane vesicles (EV) when the cells are placed under stress. 
Disrupting the cytoplasmic membrane or altering the peptidoglycan crosslinking can modulate EV 
production by altering the permeability of the cell wall246. S. aureus exposed to ZnO-NPYs 
exhibited the release of membrane vesicles the size of 0.1 µm in diameter within 30min (See 
Chapter 3.7.8) which would indicate some damage to or disruption of the cell membrane. 
3.5 Discussion 
It is known that positively charged NPs interact and are stuck on the negatively charged cell 
membrane153–157. In this study, we observed ZnO-NPYs accumulate on the cell surface within a 
minute (Figure 3.5 a-b). This shows the bacterial membrane is a likely target of these NPs. Our 
results indicate ZnO-NPYs cause delayed membrane damage without interfering with the proton 
motive force for the first 60 min (Figure 3.1a) and is confirmed by a lack of membrane 
depolarization via DiOC2(3) (Figure 3.3).  This data suggests that ZnO-NPYs cause significant 
membrane damage occurs as a downstream effect similar to streptomycin and chloramphenicol 
(Figure 3.1b). One of the foremost functions of the cell membrane is in the respiratory activity of 
bacteria. Studies have reported that NPs disrupt the respiratory activity of the bacterial cell 
membrane, which can be analyzed by detecting the uptake of O2247. Immediate decrease in OCR 
(Figure 3.2) without significant change in membrane depolarization confirms t ZnO-NPYs - cell 
membrane interaction. However, a dose-dependent decrease in O2 consumption rate cannot be 
explained with this interaction itself. This can be the direct or downstream effect of ZnO-NPYs 
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entry to the cell. ZnO-NPYs interact with biomolecules inside the cell upon entry and cause change 
of metabolism to anaerobic which can be confirmed by gene expression data as we previously 
uncovered in chapter 2.4.7 for the up-regulation of pyrimidine synthesis pathway of UMP that 
plays role in cell energetics, is critical for the shift from aerobic to anaerobic. Localization of NPs 
in the ZnO-NPYs exposed cells can provide further information into mechanism of action. We are 
well aware that artifacts of electron microscopy are well documented and pose a major issue for 
understanding the effect of metal oxide NPs248,249. A misrepresentation of location could indicate 
a much different mechanism. Internalization of NPs is often indicated by one method but not 
another. Artifacts due to fixation, staining, or anomalous deposits can complicate our 
understanding of NPs. Singular methods alone may give a misrepresentation of true localization. 
For example, looking at Focused Ion Beam Slicing (Figure S 3.17) alone may give the impression 
of direct NP entry without accounting for the possibility of transplantation of NP during the 
processing of the sample. To combat artifacts of electron microscopy and ensure accurate 
representation, ZnO-NPYs entry is confirmed with multiple different nondestructive methods. To 
ensure reliability of bright spots observed in FIB data we ventured to confirm localization. We 
observe consistently bright spots in HAADF-STEM (See Chapter 3.7.4). Elemental analysis 
reveals that those spots are ZnO-NPYs aggregation (Figure 3.6). Using both SEM-TLD and 
HAADF-STEM images we were able to show that the bright spots are not on the surface but inside 
the cells (Figure S 3.9). Please note, in order to simplify the EM image analysis, we prepared EM 
samples in water.  However, we further confirm the observation was not due to artifact in the 
sample preparation process for electron microscopy, so we performed NanoLive microscopy, a 
live cell imaging method that can be used to observe living cells actively being exposed to ZnO-
NPY in media (Figure 3.7). This removes any potential damage to the cell outside of ZnO-NPY 
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exposure without stains, fixation or photobleaching. Utilizing the refractive index, we digitally 
label cells and ZnO. This was further confirmed by FITC labeled ZnO to ensure our digital labeling 
of refractive index was accurate (See Chapter3.7.6). Via this multi-method approach we ensure 
that the localization of ZnO-NPY in bacterial cells. 
The shape of the ZnO-NPYs is important to note here for not causing membrane damage 
until 60 min exposure time, even though NPs entry is evident within 5min. We think that the 
pointed apex of ZnO-NPYs (Figure 3.4) allows particle entry without damaging membrane 
integrity. Similar to the studies that showed NPs with tetrahedral, cuboid, and cylindrical NPs, 
which have at least one sharp corner or a needle-like shape, they readily penetrated through the 
pulmonary surfactant (PS) layer with slight PS perturbation245. Similarly, we think sharp apex of 
ZnO-NPYs allow cell penetration without membrane damage or depolarization. 
We observed different features in EM images in between the time 0 to 60min:  
polyphosphate granule and vesicle formation (Figure S 3.9). We have previously shown that ZnO-
NPYs interact with proteins and enzymes101. Therefore, we believe that once ZnO-NPYs enters 
the cells, they start interacting with biomolecules in the cells, cause cells switch from aerobic to 
anaerobic respiration, and eventually to cell death. Within 10 min, cell starts to form polyphosphate 
granules that are synthesized for both energy and phosphate storage energy. The energy released 
from these energetic carriers used to produce all vital molecules such as amino acids, nucleobases, 
sugars, and lipids. Upon entry, NPs interact with biomolecules in different pathways to further 
interfere aerobic metabolism and start forming polyphosphate granules for later use in anerobic 
state (See Chapter 3.7.7). Another feature we observed in EM images is EV formation. Even 
though we did not observe time dependent formation for these EVs, it is known that 
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Staphylococcus aureus develops extracellular membrane vesicles (EV) when their membrane is 
placed under some sort of stress246 . 
We propose that the direct mechanism of action of ZnO NPY is still complex and unknown. 
However, it was recently shown that ZnO-NPs can cause enzyme inhibition exemplified by 
strongly suppressed activity of β-galactosidase23, an essential enzyme in bacterial metabolism, 
therefore the complexity of the mechanism can be explained with ZnO NPs inhibits proteins 
involved in metabolic pathways, by formation of NP-protein adduct. Moreover, the selection of 
cell membrane transporter mutants from a mutant library indicates different responses to NP 
exposure (work that has been completed but not submitted for publication). This could indicate 
multiple mechanisms may be in play simultaneously in the antimicrobial properties of ZnO NPYs. 
A combination of many factors including sequestering of nutrients, membrane damage, and NP 
entry are responsible for the bacterial killing observed.  
3.6 Conclusions 
In this chapter, we studied ZnO-NPs interaction with cell membrane and explored how this affect 
metabolomics. The mechanism of action employed by ZnO-NPYs much more complex than 
previously understood. Immediately after exposure, ZnO-NPs exhibit a dose dependent reduction 
of cellular respiration as measured through OCR without showing any cell membrane damage. 
With prolonged NPs exposure, cells switch from aerobic to anaerobic respiration, and eventually 
to cell death. Our work highlights the importance of studying the dynamics of NPs and bacterial 
cell interactions to better understand the underlying antibacterial mechanism of action. The results 
of this study point to the importance of specific experimental controls in the interpretation of 
antimicrobial mechanistic studies and the need for targeted molecular mechanism studies. 
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3.7 Supplemental Information 
3.7.1 LDH Assay for Lysostaphin  
LDH release of lysostaphin treated cells used to set 100% lysis point for the percentage lysis 
calculation of the samples in Figure 3.1. 
 
 
Figure S 3.8 LDH release assay for chloramphenicol, streptomycin, lysostaphin and control (cell in SNM media). 
Lysostaphin has a strong membrane damage effect on cells and immediate LDH released is observed. For percentage 
lysis calculations in Figure 1, lysostaphin data is used to set 100% lysis point. Error bars represent standard error of 
five independent experiments run on different days. 
3.7.2 Cell Only Sample vs. Features Observed in ZnO-NPYs Exposed Cells 
We use SEM-TLD images to observe the surface features and HAADF-STEM images to observe 
the internal features. In Figure S 3.9, we observed different features in ZnO-NPYs exposed cells: 
ZnO-NPYs accumulation in cells, polyphosphate granule formation and vesicle formation. 
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Whereas we do not observe any internal feature or vesicle formation in cell only samples (Figure 
S 3.9). 
 
Figure S 3.9 SEM-TLD and HAADF-STEM images of (a) cell only and (b) ZnO-NPYs exposed cells. These two 
imaging is compared to show that features are inside of the not the surface features. (a) in cell only images no features 
are observed at all. (b) Arrow in each panel in ZnO-NPYs exposed cells showing a feature in cells. (c) ZnO-NPYs 
accumulation, (d) polyphosphate granule formation and (e) vesicle formation. Scale bar: 200nm 
3.7.3 Cell Only Sample 
We wanted to look more into cell only samples and performed qualitative and quantitative 
elemental analysis. As expected, we did not observe any Zn signal within cell only samples. 
Because of the background signal in elemental mapping we observe very weak signal in Zn panel 
in Figure S 3.10, however once we investigate the image intensity profile (Figure S 3.11) and 
EDX analysis (Figure S 3.12), no significant signal (noise background ratio is almost zero) 
observed as opposed to ZnO-NPYs exposed cells. In addition, the quantified elemental analysis 
Table 5 shows only 0.04 % Zn in cell only sample that confirms no significant Zn signal detected 
in cell only samples or any other special feature similar to ZnO-NPYs exposed cells. 
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Figure S 3.10  Elemental mapping of ell only sample (Zn-zinc, O-oxygen, P-phosphorus, N-nitrogen and C-carbon). 
Scale bar: 200nm   
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Figure S 3.11 An overlay image of HAADF, Zn and O of cell only sample. White box in this image specifies an area 
for intensity profile. The graph shows intensity profile for each image HAADF, Zn and O on top. Zoomed area of the 
graph at the bottom shows Zn signal intensity. Scale bar: 200nm  
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Figure S 3.12 EDX analysis of cell only sample within area 1(white box). Zoomed area (top panel) of EDX analysis 





Table 5 Quantitative EDX Analysis of Cell Only Sample 
Element Atomic Fraction (%) Mass Fraction (%) 
C 73.92 67.99 
N 13.75 3.04 
O 10.59 12.97 
Na 0.0 0.0 
P 1.48 3.50 
S 0.12 0.30 
Cl 0.10 0.28 





3.7.4 ZnO-NPYs Aggregation in Exposed Cells 
Once ZnO-NPYs started to enter cells, they start aggregating in cells and create bright spots in 
HAADF-STEM images due to the heavier atoms ( Figure S 3.13). Even though we do not observe 
aggregated spots in every cell, we can still observe Zn signals (Figure S 3.14). These data suggest 
that smaller or non-aggregated NPs in cells cannot be detectable in EM at this magnification. But 
not necessarily means they do not enter each cell. To see the individual ZnO-NPYs we need to 
utilize microtome to prepare EM samples. On the other hand, Zn signal in cells without bright 
spots is a confirmation of their presence in the cells (Figure S 3.14 and Table 6). However, 
intensity of Zn signal still much higher than Zn signal within the cells in bright spots (Figure S 
3.15), confirming ZnO-NPYs aggregation in those spots. As time progress we see more and more 
cells have bright spots and they start to lyse (Figure S 3.16).  
 
 
Figure S 3.13 HAADF-STEM image of ZnO-NPYs accumulation in cells after 10min (bright spots) and EDX analysis 
of a spot in cells. Small window on top-right is the zoom area of black box. As this spot is inside of the cell, signals 




Figure S 3.14 HAADF-STEM image of ZnO-NPYs exposed cells without bright spots and EDX analysis of a cell. 
Small window on top-right is the zoom area of black box 
 
 
Table 6 Quantitative EDX Analysis of ZnO-NPYs Exposed Cells in Figure S 3.14Error! Reference source not 
found. 
Element Atomic Fraction (%) Mass Fraction (%) 
C 67.68 56.81 
N 10.85 10.62 
O 16.86 18.86 
P 2.73 5.91 
S 0.14 0.31 
Cl 0.21 0.52 







Figure S 3.15 Overlay of HAADF-STEM image and Zn elemental mapping, and Intensity profile on bright spots 
(white box) in ZnO-NPYs exposed cells. 
 
 
Figure S 3.16 EM images of ZnO-NPYs exposed cells at 30min. (a) SEM-TLD image (b) HAADF-STEM image 
Arrow indicates ZnO NP aggregation and death cell residue mixture. Scale bar: 200nm 
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3.7.5 ZnO Accumulated Spots in FIB Sliced Image 
 
Figure S 3.17 SEM-TLD image of FIB sliced ZnO-NPYs exposed cells. This image clearly shows ZnO-NPYs 
aggregation are in the cells and size is around 50nm. 
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3.7.6 Nanolive Imaging 
3.7.6.1 Nanolive image of ZnO samples 
We utilized Nanolive for ZnO-NPYs sample only to find out NPYs digital staining. We used 
digital blue color for ZnO-NPYs make it visible in cells. 
 
Figure S 3.18 Nanolive image of ZnO-NPYs for deciding the refractive index digital stain. Left panel holographic 
image after digital processing. Right panel 3D image with blue digital stain.  
 
3.7.6.2 Fluorescent image of labeled ZnO-NPYs exposed cells. 
To confirm the digital stain of ZnO-NPYs we labeled the particles with FITC utilizing Thermo 
Scientific™ Pierce™ FITC Antibody Labeling Kit. This data confirms digital staining is coming 





Figure S 3.19 Nanolive image of FITC-Labeled ZnO-NYPs exposed cells. (a) Holography image (b)FITC image 
(c)3D image with digital staining. We can see both cells (marked with arrow) and cell-ZnO aggregation (circled). (d) 
Cell-ZnO-NPYs aggregation. (e)Side of 3D image with digital staining in (c). (f)Zoom area of side image (f), here we 
can see fluorescence coming from ZnO-NPYs inside the cell, rest of the cells around marked cell do not show any 
blue color (no ZnO-NPYs inside them). (g) digital stain of marked cell in (f). Arrow shows the same cell along the 




3.7.7 Polyphosphate Granules in ZnO-NPYs Exposed Cells 
 
Figure S 3.20 HAADF-STEM image and elemental mapping of ZnO-NPYs exposed cells. Zn-zinc, O-oxygen, P-
phosphorus, N-nitrogen, and C-carbon). Scale bar: 200nm   
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Figure S 3.21 Overlay image and HAADF-STEM image and phosphorus elemental mapping. White box in overlay 
image indicates the area on the right graph signal intensity analysis. The size of the measured polyphosphate granule 




Figure S 3.22 Time course of ZnO-NPYs exposed cell for polyphosphate granule formation (marked with white big 
arrows) and ZnO-NPYs aggregation (marked with red small arrows). As time progress we observe bigger and higher 
number of ZnO-NPYs aggregated bright spots, each cell shows some degree of polyphosphate granule formation 






Figure S 3.23 Polyphosphate granule (marked with arrow) and ZnO-NPYs accumulation together. Phosphorus signal 





Figure S 3.24 Zn signal differences between in polyphosphate granule formations (Area #1- green on the EDX 
graph) and ZnO-NPYs aggregations (Area #2- red on the EDX graph) 
 
3.7.8 Vesicle Formation in ZnO-NPYs Exposed Cells 
The feature we observed in ZnO-NPYs exposed cells is vesicle formation. Even though it is not 
clear why cells form these vesicles when they exposed to ZnO-NPYs, they excrete these vesicles 
and they require further investigation. 
 
Figure S 3.25 EM images of vesicle formations in ZnO-NPYs exposed cells after 10min. (a) SEM-TLD image, (b) 


















Self-organization of Iron Sulfide Nanoparticles into Multi-compartment Supraparticles as 
Artificial Viruses for DNA Delivery                                                                                                                           
 
4.1 Abstract 
Compartments are essential for any life.  Besides fundamental importance, their realization from 
technologically friendly inorganic nanomaterials is essential for multiplicity of biomedical and 
biochemical technologies. The practical engineering of such biomimetic structures is, however, 
complex multistep process and often involves biologically unfriendly components. Here we show 
that that amino acid-stabilized iron sulfide NPs can spontaneously self-assemble into multi-
compartment supraparticles (SPs). The transmission electron microscopy showed that NPs initially 
produce ~55nm cup-like structures and mature into ~75nm SPs with ca.190 interconnected 
compartments. The results of selected area electron diffraction and energy dispersive X-ray 
spectroscopy confirm SPs are formed from FeS2 and Fe2O3 NPs. Elemental mapping showed that 
Fe2O3 NPs are located on the surface of the SP and protecting FeS2 and compartments from the 
surroundings.  These compartmentalized particles can be used for the successful encapsulation of 




Compartmentalization is one of the key architectural components in nature. 250–253 Examples of 
shell-like biological structures of nanoscale dimensions include viruses, cellular vesicles254, 
bacterial micro-compartments,255–257 carboxysomes,258 and some organelles of various sizes 
ranging from 10 nm to 500 nm such as endosomes and lysosomes.253,259 While these shell-like 
particles are essential to provide selective transport, increase the reaction rate by keeping the 
volume small, and protect the molecules from the surroundings; they are serving only one specific 
function at a time. Interconnected compartmentalization, on the other hand, allows communication 
between its multiple compartments260 for multifunctionality and providing a large surface area 
within a particular volume for further increased reaction rate. Some of the biological particles 
having multiple interconnected compartments can be exemplified by the endoplasmic reticulum, 
Golgi apparatus, mitochondria, and chloroplast.  
Endoplasmic reticulum (ER), for example, is one of the biggest organelles in eukaryotic 
cells and responsible for multifunctionality such as protein synthesis, folding and modification as 
well as lipid, carbohydrate metabolism and calcium storage. These different functions take place 
in distinct structural domains of ER in close proximity and a parallel manner without the 
endangering of degradation and interfering261. This multifunctionality is achieved by 
interconnected multi-compartments. 
Synthetic particles with single or multi- compartments made from organic amphiphilic 
compounds253,262,263, such as nucleic acids 264,265, lipids266–268, polymers269 that form 
liposomes270,271, polymersomes250,272,273, capsosomes274–276, and protocells250,266,277 have been 
extensively utilized for multiple research and technological purposes. In contrast to other 
structures, compartmentalized biomimetic particles made from inorganic components bring novel 
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optical,278,279 mechanical280, and catalytic characteristics,281,282 but are less common and more 
challenging to make. They are typically synthesized using the organic structures as templates.283–
288  
Compartmentalized self-assembled particles from inorganic components are a much less 
investigated research area. The use of inorganic NPs is favorable also because some aspects of 
their self-organization behavior replicate those of nanoscale biological components,96,289–292 while 
possessing robustness of inorganic materials, for example, metals, semiconductors, or ceramics. 
From the fundamental perspective, it will also be essential to trace the pathway to increase the 
complexity of self-assembled structures from nanoscale components. There are diverse examples 
of self-organization of NPs that forms a new, high order nanostructure including, but not limited 
to nanoshells,183,252 helices,293–295 ribbons,296 nanostars,297 chains,290,298 rings299, sheets,187 
superlattices,300 hybrid supraparticles (SPs),301 and SPs 189,301–304. In this paper, we show self-
organization of iron sulfide NPs into multi-compartment SPs, which has ability to encapsulate 
more than one biological cargo. However, for this paper we utilized SPs for encapsulating and 
delivering one cargo, plasmid deoxyribonucleic acid (pDNA), similar to viruses.  
4.3 Materials and Methods 
All materials except plasmids were purchased from commercial sources: Iron III Chloride (FeCl3),  
sodium sulfide nonahydrate (NaS2.9H2O) and L/D-cysteine and N-Acetyl cysteine were purchased 
from Sigma-Aldrich (St. Louis, MO, USA); absolute ethanol from Fisher-Scientific (Hampton, 
NH, USA); grids with ultra-thin carbon film on holey carbon film support for transmission electron 
microscope (TEM) and carbon film only for scanning transmission electron microscope (STEM) 
analysis purchased from Ted Pella (Redding, CA, USA); disposable folded capillary cells for 
dynamic light scattering measurements were purchased from Malvern Instrument (Worcestershire, 
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UK). Hellma fluorescence cuvettes were purchased from Sigma Aldrich for UV-Vis, 
Fluorescence, and CD measurements. All cell culture materials were purchased from Gibco-BRL 
Inc. (Gaithersburg, MD, USA) unless otherwise stated differently. The pEBB-mchery plasmid is 
used to transform Escherichia coli and amplified plasmid extracted with plasmid isolation kit 
(Invitrogen™ PureLink™ HiPure Plasmid Filter Maxiprep Kit).  
4.3.1 Constituent NPs Synthesis 
0.5 x 10-3 M L-cysteine and 10-2M iron III chloride in 100 ml DI water under magnetic stirring at 
3 oC temperature under air. 10 ml of 5 x 10-1 M sodium sulfate nano-hydrate was then dropwise 
added to the solution under constant magnetic stirring. Once color changed to black, reaction 
stopped, and NPs were collected by centrifugation at 14K for 1h, washed three times with absolute 
ethanol. We dried the particles entirely at room temperature to make sure no trace of ethanol. 
Particles then dissolved in Milli Q water for further experiments. 
4.3.2 Compartmentalized SPs Synthesis 
SPs obtained by increasing the reaction temperature to room temperature. After 30 min, the color 
changed from black to yellow and the reaction is stopped. SPs are collected by centrifugation 10k 
for 15min, and subsequently washed three times with absolute ethanol. For the time-dependent 
experiment, the reaction stopped at specific time points. We dried the particles entirely at room 
temperature to make sure no trace of ethanol. Particles then dissolved in Milli Q water for further 
experiments. 
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4.3.3 Cup-like Intermediate Structure Synthesis 
The time-dependent experiment showed that intermediate structures form between time 0 (right 
after the sulfur source added to reaction) and 15min when the reaction is at room temperature. For 
collecting cup-like intermediates, the SP reaction stopped at 15min and washed three times as SPs.  
4.3.4 SP-pDNA Synthesis 
The system was slowed down by stopping the SP reaction at 15 min to utilize the compartments 
of the SPs. At this point, 150 g plasmid (pEEB cherry – 6073bp) is added dropwise to the system, 
and the reaction was allowed to complete the SP formation under magnetic stirring. After 30 min, 
SPs containing DNA (SP-pDNA) were collected and washed as usual. 
4.3.5 Calculating Amount of DNA Molecule in SP 
This calculation is based on the assumption that the average weight of a base pair (bp) is 650 
Daltons.  
Equation 4: number of DNA copies = (amount in g* 6.022x1023) / (length* 650) 
150g pDNA = 2.29*1013 pDNA molecule per sytem 
4.3.6 Particle Characterization 
UV-Vis measurements are acquired by an 8453 UV-vis Chem Station spectrophotometer produced 
by Agilent Technologies. Zeta potential of SPs was measured at 25°C using a Zetasizer Nano ZSP 
(Dynamic Light Scattering (DLS)) instrument (Malvern Instruments Ltd, Malvern, 
Worcestershire, UK). Circular Dichroism (CD) spectra were obtained by a JASCO J-815. TEM 
images obtained by utilizing JEOL 3011 high-resolution electron microscope equipped with a 
CCD camera and a field emission gun (FEG) operating at 300 kV. SEM images were obtained 
with FEI Helios 650 Nanolab SEM/FIB. STEM images obtained with JEOL 2100 Probe-Corrected 
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Analytical electron microscope equipped with a Gatan Ultrascan 1000 CCD TV camera and a field 
emission gun (FEG) operating at 200kV. The Fourier transform infrared spectroscopy (FTIR, 
Thermo-Nicolet IS-50); energy dispersive X-ray spectrometry (EDX, FEI Helios 650 Nanolab 
SEM/FIB and JEOL 2100F) and X-ray photoelectron spectrometry (XPS, Kratos Analytical AXIS 
Ultra) and X-Ray diffractometer (XRD, Rigaku Rotating Anode with Cu Kα radiation generated 
at 40 kV and 100 mA) were used to exam the composition of particles. Fluorescence data is 
obtained by a Jobin Yvon Horiba FluoroMax-3 instrument. 
4.3.7 Particle Size 
Particle size is calculated with image J analysis with number of TEM images. The total number of 
particle (n) is measured for calculatios. n for SP is 1276, n for  300 cup-like structures and  n for 
150 NP. NP Tracking Analysis (NTA) was also conducted for confirming size of SP in aqueous 
environment. NTA data were obtained by Malvern NanoSight NS300 on aqueous dispersions.  
4.3.8 Phase Identification 
Multiple diffraction rings of SPs are obtained, and d-spacing of each diffraction rings calculated 
with image-J. All results are recorded and sorted with decreasing d-spacing, here ± 0.1 Å is 
considered as a measurement error. The list of d-spacing of SPs is compared with known samples 
containing iron, sulfur, and any combination of these three elements. 
4.3.9 Excitation-Emission Matrix  
Excitation-emission matrix (EEM) is a 3D landscape with a z-axis measuring the intensity where 
red color shows the highest intensity, and purple color displays the lowest intensity. If the material 
is fluorescent, emission peaks of different excitation wavelengths should be stable in the scanning. 
Likewise, we excited SP suspension from 200 nm to 600 nm with 10 nm increments. 
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4.3.10 Electron Tomography  
The electron tomography studies at room temperature were carried out on two different systems:  
1) JEOL 2100 Probe-Corrected Analytical electron microscope equipped with a Gatan Ultrascan 
1000 CCD TV camera and a field emission gun (FEG) operating at 200kV and  
2) FEI Helios 650 Nanolab SEM/FIB with slice and view software. 
For JEOL 2100, a series of 2D projection images were recorded by tilting the specimen from -65º 
to 70º for increments of 1º. A tomography reconstruction software package Etomo was used to 
align the tilt series manually. The surface and volume rendering were generated also using the 
Avizo software. 
For Helios, slice, and view software employed. The particle cluster on a silicon wafer was 
coated with first carbon and then platinum to protect the particles from ion beam damage. The area 
is milled with an ion beam every 3 nm, and images are saved. As the specimen was not tilted with 
this method, there is no need to create the tomogram with Etomo. The images taken with Helios 
were aligned within Avizo software. The surface and volume rendering was generated also using 
the Avizo software. 
4.3.11 Surface Area and Volume Calculation 
The surface of the grid searched for SP aggregations that include different size of particles. 17 
polydisperse SPs were grouped based on location in the cluster and color-coded. Number of SP, 
each SP size in diameter, average volume, and surface area of each color-coded area were 
calculated within Avizo software. 
4.3.12 Calculation of the Number of Compartments in a SP 
If we consider the shape of the individual compartments and whole compartments unit structure 
are sphere, we can calculate the number of compartments in SP in a way that a volume of a sphere 
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is highly packed with smaller spheres. Based on our tomography analysis, the volume of 
compartments is 0.15 ± 0.048 *106 nm3, and Kepler conjecture the highest packing density of 
same-sized spheres in the three-dimensional space is
𝜋
3√2






Using the diameter of compartments (r=5.2nm- tomography analysis) number of compartments 
per SP can be calculated to be ~190. 
Equation 6: VSC * 0.74048 / VIC  190 
In where VSC is 0.15 *106 nm3, and VIC is 0.58*103 nm3, VSC: Volume of compartments in SP, VIC: 
Volume of individual compartments (Fig. S22) 
4.3.13 The Number of NPs in a SP 




90.689%. We consider the packing density of  NP in an SP is  90% and we know the volume of 
a cylinder is 𝜋𝑟2ℎ, where r=4.5nm and h=1.5nm. Therefore, number of ind NPs per SP can be 
calculated to be ~6100. 
VIN = 0.127 𝜋𝑟3.*103 nm3  
Equation 7: (VSP-VSC)/VIC = ~6100NPs 
Where VSP-VSC = 0.86 *106 nm3 
0.86 *106 nm3 * 0.9 = 0.774*106 nm3 
The top two layers (~8.9nm) of SPs are Fe2O3 NPs, therefore number of Fe2O3 NPs in SP can be 
calculated ~2975. ~48% of ind NPs are Fe2O3 NPs. 
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4.3.14 Lambda Scanning in Confocal Microscopy 
Super-resolution Leica SP8 MP Confocal STED microscope is utilized for lambda scanning. A 
lambda scan is an acquisition of an emission spectrum using spectral detectors, and it records a 
series of individual images of the sample within a defined wavelength range. Lambda scan is 
performed between 470-570 nm excitation range with a white light laser to find the best excitation 
wavelength. The size of the emission window is kept 50 nm long, and it is shifted 20 nm further 
along with excitation wavelength for the sake of the detector. The intensity of each image is 
quantified and graphed with Las X software. As the white light laser range is 470-670 nm, we 
performed the lambda scanning starting from 470 nm and ending at 570 nm (no emission after 
570nm). 
4.3.15 Cell Culture 
HEK293T cells were purchased from ATCC (#CRL-11268). Cells were maintained at 37°C with 
5% CO2 in Dulbecco's Modified Eagle's Medium (DMEM) media supplemented with 10% fetal 
bovine serum and 1% penicillin/streptomycin (Thermo Fisher Scientific, Waltham, MA) and 
passaged every 3-4 days at 80% confluency. 
4.3.16 Cell Viability Assay 
100μl HEK 293T cells were seeded on cell culture treated 96 well-plate (in the concentration of 
from 100.000 cells/ml serial dilution to 82 cells/ml and incubated at 37Co for 24 hours Then, 
medium discarded and cells were washed with PBS 2 times to remove non-attached cells. 90μl 
fresh media added along with 10μl SPs in the concentration of 10x and 1000x, and incubated for 
24h or 48h. Promega™ CellTiter 96™ Nonradioactive Cell Proliferation Assay (MTT) was 
conducted as described in the protocol.  Shortly, 15μl dye solution added to cells and incubated 
for 4 h, then 100μl stop/solubilization solution is added, and then sealed and incubated at 37Co 
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overnight to allow complete formazan product solubilization. Tetrazolium salt in the dye solution 
converted into the formazan by living cells, and the solubilization solution solubilizes the formazan 
product. The next day, plate reader (BioTek Synergy 2 Plate Reader, BioTek Instruments, Inc., 
Winooski, Vermont, USA) utilized to record absorbance at 570nm. As a blank absorbance of SP 
solutions in media used and subtracted from all samples. All experiments were repeated three 
times. The results were expressed as mean ± SD (n = 5). 
4.3.17 Cellular Uptake and Transfection 
The Hek293T cells were seeded in a Lab-Tek® chambered coverglass system at 4.8 × 104 cells 
per well (8 wells per chamber) and cultured for 24 h to achieve 70% confluence. The media is 
discarded, and cells washed two times to remove unattached cells. 20 μL of SP and SP-pDNA 
dissolved in media were added for cellular uptake and transfection, respectively. Wells are 
completed to 200 μL with media. Treated cells were incubated for 30min to 48h. The cells were 
washed two times with PBS and fixed by 4% paraformaldehyde for 1h, and fixative was aspirated, 
and the cells washed with PBS three times. Nuclei were labeled by Prolong® Gold Antifade 
Reagent with DAPI and store in the dark until imaging. Cells were imaged using Leica SP8 MP 
Confocal STED microscope. Fifteen different confocal images were taken from different locations 
of a plate in a matrix of 3 by 5 at 475 and 500 nm excitation wavelength for cellular uptake 
experiment and texas red filter for transfection experiments. Mean fluorescence intensity 
quantified by using FIJI software. Instead of threshold apply, we subtracted an empty area of an 
image of cells without particles taken by exact same conditions. The results were graphed based 
on each time point in origin, and data were normalized. This imaging was repeated on three 
different experiment sets for each time slot.   
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4.3.18 Mobility Shift Assay 
1% agarose gel was prepared with gel red, and 10 μL samples (SP, SP-pDNA, pDNA) mixed with 
10x loading dye (Thermo Scientific™ 6X TriTrack DNA Loading Dye). Samples were then loaded 
to wells along with 2 μL 1K ladder (Thermo Scientific™ GeneRuler 1 kb DNA Ladder) . Gel run 
in gel apparatus (Bio-Rad) at 35V for 2h. Gel imaged with a gel imaging instrument (Bio-Rad). 
4.3.19 DNA Release Assay 
SP-pDNA incubated in two different pH (5.5 and 7.4) in two different solvents (water and PBS 
buffer) for 0-48h every 20 min for the first 2 hours and for 6, 12, 24 and 48h, each time intervals 
absorbance was taken with nanodrop. SP in water or PBS used as a reference, and relative 
absorbances recorded for percentage calculation. 
4.3.20 Statistical Analysis 
The data were summarized as means ± standard deviation based on experimental values obtained 
in multiple measurements. Where necessary, the statistical variations (p values) between the 
group means were evaluated by one-way ANOVA.   
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4.4 Results and Discussion 
Iron sulfide (FeS2) is the most abundant mineral on the Earth and includes sulfur, an essential 
element to life. While there is little research on iron sulfide NPs, potential advantages include low 
price, non-toxicity, biocompatibility, high availability and potential biodegradability. 
Biodegradability is anticipated since it has been reported that FeS2 can be oxidized to form soluble 
iron sulfide under biologically relevant conditions involving redox enzymes305. Therefore, we aim 
to synthesized iron sulfide-based SPs as an artificial virus for packing and delivery of DNA. 
Synthesis of iron sulfide NP in the literature involves toxic reagents such as dimethyl sulfoxide 
(DMSO), thioglycolic acid (TGA), and ethylenediamine (EDA) 306,307 and include only high 
boiling point organic solvents as a function of long-chain surfactants.306 In this study, we 
investigate the possibility of a simple method that produces iron sulfide NPs, in aqueous media, 
with amino acid surface ligands in ambient conditions. Aqueous media is used to mimic nature to 
perceive the self-assembly; as aqueous media can provide a variety of forces to initiate NP self-
assembly, and a greater variety of superstructures expected to form with water-soluble NPs.292 A 
short stabilizer, amino acid, is chosen to increase the anisotropy of the NP interactions for self-
assembly. The choice of an aqueous media and amino acid stabilizer (cysteine, Cys) is also made 
to reduce the toxicity of the solvent and surfactant.  
Careful selection and optimization of the reaction conditions such as precursor 
concentrations, temperature, pH level, reaction time and temperature allowed us to find a condition 




Figure 4.1 Graphical Abstract: Nanoparticles can form compartmentalized supraparticles with cup-like structure 
intermediates 
4.4.1 Constituent Nanoparticles 
Constituent NPs are synthesized at low temperature (in ice), and they are plate-like particles with 
a diameter of 4.51.6 nm and a height of ~1.5nm.  (Figure 4.2 a, b, i and Figure S 4.7). Zeta 
potential measured for NPs is  20.51.5mV (Figure S 4.8, NP). X-Ray diffraction (XRD) gives 
a weak broad peak (Figure S 4.9a). This broad peak may suggest short-range order of NPs.308 
Therefore, we utilized selected area electron diffraction (SAED) analysis (Figure S 4.9b) for 
particle phase identification. SAED analysis reveals that NPs are not just with FeS2 (Pnnm and Pa-
3 space groups, PDF 37-475 and PDF 06-710, respectively) and but also Fe2O3 (Aba-2 space group 
ICSD 430557) NPs (Table 7). Energy dispersion X-Ray spectrometry (EDX) also confirms the 
presence of oxygen (O) along with iron (Fe), sulfur (S) in NPs (Figure S 4.9c). During the reaction, 
some of the NPs oxidized and partially transform to iron oxide NPs. Even though we aimed for 
iron sulfide NPs, iron oxide NPs incorporation will not change the value of the formed SPs and 
will actually provide even higher complexity to SPs.   
After obtaining constituent NPs, we increased the reaction temperature (room temperature) and 
conducted a time-dependent experiment. The samples are collected at time 0, after 5, 10, 15, 30, 
45, 60, 90, 120, 180, 360 minutes. TEM images show the particle formation during 0-30 min 
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(Figure 4.2 a-f), and 0-360 min (Figure S 4.10). Based on TEM images, we obtained terminal SPs 
at 30min (Figure 4.2f). UV-Vis spectroscopy gives peaks at 225nm, 270nm, and 365nm for SPs 
(Figure 4.2l -blue line). As can be seen, there is a red-shift in the spectrum from  NP (Figure 4.2l 
-black line) to SP at 30 min. For semiconductors, this is a common phenomenon that absorption 
has a red shift as particle size grows. The color change of black (iron sulfide NPs) to yellow during 
the reaction also suggests the SP formation (Figure 4.2l insert). 
4.4.2 Intermediate Structure Between NP and SPs 
At the time within 15min an intermediate (cup-like structure) formation is observed in between 
individual NP and SP. The terminal SP ( Figure 4.2g) has a solid surface with spherical structures, 
whereas the intermediate (Figure 4.2 c-d). has a translucent and more formless structure.  
Intermediate structures and terminal SPs can be seen together during synthesis ( Figure 4.2e), and 
broken SP pieces reveals similar translucent structures in TEM images (Figure 4.2d and Figure 
S 4.11). These indicate that intermediate structures have a role in SP formation. Based on the image 
analysis of TEM images, the size of the intermediate structure is measured as 55.2±23.1 nm 
(Figure 4.2j).  
4.4.3 Supraparticles 
Under high-resolution transmission electron microscopy (HR-TEM) at higher magnification, 
different direction of crystal lattices in the SPs (Figure 4.2g and h) indicates SPs formed from 
individual NPs (ca. 6100 ind NPs per SP). Based on the image analysis of TEM images, the 
diameter of SPs is 72.4±27.3 nm at 30min (Figure 4.2k) and it does not change much after this 
time point (Figure S 4.10). Even though the larger aggregations present after 6 hours, structure 
and the size of the SPs remain the same (Figure 4.2f insert). NTA data of SPs at 360 min also 
shows aggregation formation as the optimal reaction time (30-minute) passes (Figure S 4.12, 
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360min). This data suggests that SPs are self-limiting terminals when optimal time is reached. A 
system composed of finite sizes and shapes is defined by self-limiting self-assemblies. 
 
Figure 4.2 Representative high-resolution TEM images (a-h) and image J analysis (i-k) of the SP assembly. (a-b) 
TEM images of individual NPs. (c-d) Cup-like intermediate structures at 0-15 min. (e) Cup like intermediate structures 
and mature SPs together at 15min.  (f-g) Mature polydisperse SPs (30 min). (f-insert) SP after 6 hours reaction. (h) 
Individual NP in the SP (g). Based on image J analysis of EM images (i) NP are 4.5± 1.6 nm in diameter, (j) Cup-like 
intermediate structures are 55.2 ± 23.1 nm in diameter and (k) Mature SPs are 72.4 ±27.3 nm in diameter. (l) UV-Vis 
spectrum of  NP, cup-like structures (15min), and SP (30min). (l-insert) Reaction color of NP and SP at 30 min. Scale 
bars: (a, c and g) 20nm,  (b and h)5nm,  (d and insert in d)50nm, (e, f and insert in f) 200nm. 
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4.4.4 Topological Analysis of Intermediate Structure and SPs 
SEM was utilized to understand the surface topography of the intermediate structures and SPs 
(Figure 4.3 a-f). SEM-TLD images show that the intermediate structure is cup-like with open rim 
area and closed bottom ( Figure 4.3a, 3D model). Additional images acquired with high angle 
annular dark-field (HAADF) in scanning transmission electron microscopy (STEM) mode. 
HAADF images revel the organization of individual NPs in the cup-like intermediate structure 
(Figure 4.3b-arrow). 
SEM images show SPs are closed spheres are polydisperse in terms of size (Figure 4.3e), similar 
to image analysis of TEM images and NP tracking analysis measurements SPs (Figure 4.2k and 
Figure S 4.12, 30min). HAADF images reveal some internal structures, as HAADF provides high 
contrast between heavy atoms and light atoms or empty (void) areas. Therefore, HAADF images 
show the void area (compartments) in terminal SPs (Figure 4.3f-arrow).  
4.4.5 Multicompartment in Supraparticle 
For further analysis of the 3D structure of the SP and its compartmental organization, STEM 
tomography (Figure 4.3 g-i), and SEM-FIB ion milling (Figure 4.3 j-l) was utilized. Two different 
instrumentations (SEM and TEM) utilized to confirm void area (compartment) formation is not an 
artifact of the electron beam of the instrument, and both methods show similar continuous 
compartmentation. Transparent tomographic volume and computational slices reveal that SP has 
multiple continuous compartments within the shell-like structure (Figure 4.3h-k). The measured 
size of SP is 78.04 ± 37.2 nm (See 4.6.3) which is consistent with the TEM image analysis (Fig. 
1k). The measured volume of SP is 1.01*106 ± 0.832 *106 nm3, and the size of the compartments 
is 5.2 ± 1.9nm (Table 9). The total volume of the compartments in an SP is 0.15*106 ± 0.048*106 
nm3. This data indicates that approximately 17 ± 5 % of SP's volume is compartments (Table 9). 
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These analyses are especially necessary for calculating possibility as well as the number of cargos 
that can be packed in an SP.  
 
Figure 4.3 SEM and STEM images of supraparticles and cup-like intermediates (a-d) acquired with default Through 
the Lens Detector (TLD) and High-angle annular dark field (HAADF) in STEM mode. (b) HAADF shows 
compartments in supraparticles with darker color (pointed with arrow) and (d) Nanoparticle in cup-like intermediate 
with bright color (pointed with arrow). (e-f) 3D Model of cup-like structures highlighted with black circle in (c). 
Reconstructed tomography images of SPs (g-l). 3D images of supraparticles acquired by STEM tomography (g-i) and 
SEM-FIB slice and view (j-l) reconstructed with Avizo software. (g and j) Surface rendering of supraparticles. (h and 
k) transparent surface of supraparticles showing continues compartments in the supraparticles, red color in (k). (i) x-
y-z cross-section of the supraparticle with compartments (green). (l) compartments itself. Scale bars: 50nm, 3D model 
20nm. 
We conducted elemental mapping analysis to understand how these compartments are 
formed via localization the elements therefore, different type of NPs in the SPs (Figure 4.4 a-e). 
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These results indicate that Fe and S are located inside of the SP, and they are protected from the 
outside by 9.86 ± 1.85 nm thick Fe and O layer (Figure 4.4e). We can then conclude that FeS2 
NPs located inside of the SP are surrounding the continuous internal compartments and forming 
the compartments under layers of Fe2O3 NPs (Figure 4.4 f-i). Based on the calculations, 
approximately 48% of NPs are Fe2O3 and located on the surface of the SPs. 
To investigate surface composition, we performed X-ray photoelectron spectroscopy (XPS), and 
Fourier transform infrared spectroscopy (FTIR) analyses (See 4.6.4), and found out cysteine binds 
to iron in NPs on the surface from its thiol group, and the positive charge is explained by the NH3+ 
groups of the surface ligand (Figure 4.4 j).  
FeS2 has an indirect bandgap energy of 0.95 eV 309,310, and Fe2O3 has a bandgap energy of 
2.1 eV.311 These two factors combined with the different morphology, various bandgap due to 
nanoconfinement, crystal size and different intercalation chemistry make SPs almost ideal 
semiconductor for absorbing broad spectrum of light with wavelengths as long as 700 nm.312–314 
Such energy level structures of FeS2 and Fe2O3 are the main reason of broad absorption (refer back 
to Figure 4.2l). A possibility for photoluminescence from energy states higher than the band edge 
should also be considered. Based on emission scanning and 3D fluorescence spectroscopy (EEM), 
we confirmed photoluminescence of SPs (See Chapter 4.6.5). Having fluorescence property is an 
advantage for SPs tracking and localization in cell cultures.  
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Figure 4.4 Elemental analysis and cross section of SPs (a) An SEM image of SPs (b-d) Elemental analysis of the SPs 
and location of iron, sulfur and oxygen elements in SPs. (e) overlay image of three element. This image shows that 
iron oxide NPs are at the surface of the supraparticle and create a shell on the supraparticle. Supraparticles contain 
internal continuous compartments protected from the outside by Fe2O3  NP membrane 9.86  ± 1.85 nm thick. Scale 
bar in (e) 100nm. Cross-section of reconstructed supraparticle (f) surface and (g) volume acquired by STEM 
tomography. (h) Scheme of cross section where GREEN spheres show 2 layers of Fe2O3 and RED spheres show FeS2 
NPs. (i) orthogonal slice of STEM tomography. Black arrows in each image (f-i) shows compartments. 
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4.4.6 Assembly Mechanism  
Let us now describe the formation mechanisms. The self-assembly of NP into terminal SPs relies 
on attractive short-range forces: van der Waals, hydrophobic, dipolar interactions, hydrogen bonds 
and entropic forces, coordination and long-range repulsive interactions; primarily intermolecular 
electrostatic interactions. 183,187,302,315–317 Anisotropy is also quite critical for SP formation. 
Anisotropy of the force fields can result from both disk-like shaped NPs and the "patchy" 
distribution of electron density. 292 Also, type and amount of stabilizer play a critical role in SP 
formation. Short stabilizer, cysteine, provides a thinner shell on the surface and allows attraction 
forces to play their roles for SP assembly since short stabilizers increase electronic interactions 
between the NP core.292 Plus that, similar to CdS nanoshell formation, the amount of stabilizer is 
very little252 that may cause the patchy distribution of electron to increase the anisotropy and also 
may increase repulsions inside of the nanoshell to form compartments.  
NP with thin shells starts to assemble first into cup-like structures and then SPs. The cup-like 
formation is a very unusual structure for self-assembly. We saw chains,290,298 rings299, and sheets187 
assembly, but what causing concave structure. So, we think that once oxidation starts on NPs, it 
increases the anisotropy for self-assembly. The repulsion electrostatic forces   on the big lateral 
surface of the nanodisk must help them to assemble side by side instead of vertical stackings. Once 
intermediate cup-like structure are formed, couple of them come together and form SPs. Size 
distribution and anisotropy on these intermediates may cause compartment formation during the 
reactions. 
It is worthwhile to say that these SPs are very similar to virus capsids. Typical structural 
capsid protein, having a mean diameter of 5 nm and a mean thickness of couple  nm318 similar to 
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NP size and thickness. The way of SPs formation helped us to utilize the compartments for cargo 
packing.  
4.4.7 Compartment Utilization - DNA Encapsulation 
To utilize the compartments within SPs, we captured cup-like structures before they matured into 
SPs with decreasing the temperature at 15min; and add condensed pEEB cherry plasmid DNA 
(pDNA) as a reporter gene to the system dropwise. SP maturation is then allowed for another 
15min. SPs containing plasmid DNA (SP-pDNA) are analyzed for DNA presence. UV-Vis and 
circular dichroism data do not show any differences in the spectra between SP and SP-pDNA 
(Figure 4.5a-b). DLS data of SP-pDNA also provides the same zeta potential with SP (Figure 
4.5c). STEM and TEM (Figure S 4.22) do not show any significant differences. Only in HAADF 
STEM images show some difference (Figure S 4.22 d vs. h), and it looks like the compartments 
are filled in SP-pDNA (Figure S 4.22, arrow). This could be due to the organization of 
compartments are different with DNA or DNA is filling the compartments. All these data suggest 
that there is no evidence of DNA is on the surface of the SPs. The supernatant of SP-pDNA is also 
measured to make sure DNA does not remain in the solution after centrifugation (Figure 4.5a SPN 
SP-pDNA). However, these data also do not prove any DNA present in the system. Therefore, we 
utilized electrophoresis mobility shift assay (EMSA) in where naked DNA moves freely in the gel, 
but if it attached to anything becoming heavier and stays behind.  
EMSA proves the DNA present in the system by first showing a band in the gel (Figure 
4.5d-SP only, SP does not show any band in); second, it stays behind in well. (Figure 4.5d) Also, 
the DNase assay indicates that DNA is protected in SPs (Figure 4.5d SP-pDNA-DNase I). The 
absence of a free pDNA band in the SP-pDNA line, along with no DNA in the supernatant of the 
reaction, may also suggest that SPs show approximately 100% encapsulation and protection of 
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pDNA. Final prove of the DNA encapsulation is elemental mapping in where phosphate signal 
specific to DNA stays inside of the iron oxide layer of SP (Figure 4.5e). All these data confirm 
DNA is successfully encapsulated in the SP.  
 
 
Figure 4.5 DNA encapsulation: (a) UV-Vis spectra  (b) Circular dichroism and (c) Zeta potential comparison of SP, 
DNA encapsulated SP (SP-DNA) and pDNA. (d) Electromobility shift assay (EMSA). SP bounded DNA stays behind 
of naked pDNA. SP can protect DNA from DNase I degradation. (e)Elemental analysis of SP-DNA (i) An SEM image 
of SP-DNA (ii-v) Elemental analysis of the SPs and location of iron, sulfur, oxygen and phosphorus (DNA specific 
signal) elements in SP-DNA. (vi) overlay image of four element. This image shows that DNA stays under the iron 
oxide NPs shell in the supraparticle. Abbreviations: SP: Supraparticle, SPN: Supernatant, pDNA: Plasmid DNA 
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4.4.8 Cellular Uptake, Cytotoxicity, and Transfection 
For cellular experiments the number of particles per cell must be controlled. We want to provide 
as much particle as possible to overcome the drawbacks and increase the transfection but also do 
not want to cause any cytotoxicity. Based on cytotoxicity assay, we calculated particle 
concentration of SP that is ~1000 SPs per cell (10X) gives the high enough particles without 
creating cytotoxicity (See 4.6.9). For cellular uptake analysis we use the advantage of auto 
fluorescent of SPs and calculate mean fluorescent intensity of SPs under confocal images. SPs 
gave the highest emission intensity when they excited at 475 nm and 500 nm in the window of 
520-700nm emission wavelengths (See 4.6.5). Thus, confocal images of SP treated cells are 
observed at 475 nm (Figure 4.6 a) and 500 nm (Figure 4.6b). We are using two different excitation 
wavelengths to confirm the signal is coming from SPs, and it is not an artifact of the other cell 
compound. With increasing incubation time, the mean fluorescence intensity per area of an image 
is increased gradually, representing cellular uptake increases. For the first 2 hours, the cellular 
uptake was much faster; after 2 h, the cellular uptake started to slow down, and in 6 h, the cellular 
uptake gradually reached saturation where is the percentage of fluorescence positive cells no 
longer increased (Figure 4.6e). SPs are started to attach to cells in 1h; even after 3x washing, we 
can see particle attachment on the cell surface (Figure S 4.25). Fluorescence intensity of particle 
in cells does not change between 4h-12h (Figure S 4.26 a-b), and untreated cells do not show any 
fluorescence at the same laser intensity (Figure S 4.26 c).  
For transfection experiments, we imaged HEK293T cells treated with SP-pDNA for specific time 
intervals starting from 6h to 24h. Transfection is also expressed as mean fluorescent intensity of 
confocal images of reporter protein (pEBB cherry-red color). Even though cellular uptake reaches 
saturation at 6h, releasing and transcription of pDNA takes time. Therefore, we started to see red-
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colored cells after 9 hours (Figure 4.6f- See 4.6.11 for release assay). Confocal images of SP-
pDNA transfection can be seen in Figure 4.6h-j. The results comparison between SP and 
lipofectamine is not statistically significant (Figure 4.6g, Figure S 4.28). However, improving 
these SPs are very promising; as SPs can condense DNA, protect it against degradation, enter 
through cellular membranes, and facilitate endolysosomal escape in gene therapy. Here it worth 
the mention that there are possibilities that not all DNA will be packed and not all vectors will 
enter the cell and not all uptaken vectors will release the cargo. All these challenges lower the 
transfection efficiency. 
A fine balance between extracellular protection, intracellular release, and biodegradation 
is crucial. The presence of iron in SPs may facilitate cellular uptake due to van der Waals 
interactions of the SPs and cellular membrane. This feature may decrease the excessive membrane 
potential change occur with liposomes. The release of cargo after transmembrane transport is 
facilitated by the spontaneous disassembly of SPs in the cells. Attractive-repulsive forces between 
constituent NPs control SPs stability. The low dielectric constant of cytosol will result in increased 
inter-NP repulsion and, thus, SP disassembly. Therefore, the development of these particles can 
be used as an effective delivery tool for gene therapy. These SPs can be used for imaging too since 
they can be observed under confocal microscopy such as cadmium and selenium based quantum 





Figure 4.6 Cellular uptake and transfection data.  (a-d) A confocal image of cellular uptake of SP after 12h.  SP in 
cell in (b) is excited at 475 nm and in (c) is excited at 500 nm emission for both excitation is 520-570nm.  (d) SP 
aggregations can be seen in a cell. (e) Average fluorescence intensity of confocal images of SP treated cells.  (f) 
Average fluorescence intensity of confocal images of SP-DNA treated cells post-transfection 6-24h. At 24 h it reaches 
the highest transfections efficiency. (g) Transfection capability comparison of SP and lipofectamine. ***p value: (h-
j) Confocal images of cells post-transfection 24h. Cheery protein gives the red color to the cells. Scale bars: (b-e) 
0.5µm, (h-j)25µm  
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4.5 Conclusions 
In this paper, we showed that inorganic NPs could self-assemble to SPs with compartments within 
a stable shell. Self-organization of these SPs origins from very unusual shape, cup-like, 
intermediate structures. Couple of cup-like structures assembles in a way that arranges into a multi-
compartment within a shell. These self-organized compartments can be used for multiple functions 
such as biomacromolecules packing and delivery. Hence, the development of these particles can 
be used as an effective delivery tool for DNA or mRNA as artificial viruses for next generation 
theranostic applications.  
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4.6 Supplemental Information 
4.6.1 Constituent Nanoparticles 
 
Figure S 4.7 STEM images of nanoparticles that are seen from various angles. (a) Dark Field (b) Bright Field (c) 
Scheme of ind NP - represents 45 different images and shows plate-like particles. (d) AFM data of NP.  Scale bar (a,b) 









Figure S 4.9 (a) XRD data of constituent NPs. (b) SAED of constituent NPs and corresponding d-spacing of each 




Table 7 Comparison of d-spacing of NPs vs. FeS2 and Fe2O3 
NP  FeS2 (Pnnm)  FeS2 (Pa-3)  Fe2O3 (Aba2) 
d-spacing  d(hkl)  hkl  d(hkl)  hkl  d(hkl)  hkl 
3.476  3.4313  110         
3.159      3.1339  111  3.262  200 
2.854  2.8677  011      2.9371  111 
2.774  2.689  101  2.7141  200     
2.481  2.4083  111  2.4275  210  2.351  020 
2.243  2.218  200  2.216  211  2.2118  120 
2.076  2.0524  210  1.9191  220  1.9073  220 
1.887  1.7545  211  1.8094  221  1.8805  202 
1.683  1.5921  031  1.6366  311  1.6446  022 
1.47  1.3998  230  1.4507  321  1.4685  222 
1.297  1.2977  320  1.2794  411  1.2256  331 
Components of this table is chosen based on selected area electron diffraction (SAED) analysis  
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4.6.2 Time Dependent Experiment During SP Formation 
 
Figure S 4.10 TEM images of ind NPs and synthesis reaction time points at, 0, 5, 15, 30, 60, 90, 120, 180 and 360min. 
Scale bars: (a) 5nm, (b-k) 100nm 
 
 




Figure S 4.12 Nanoparticle tracking analysis of SP at 30 min and 360min. 
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4.6.3 Statistical Analysis of SP and Compartments Volume 
For the statistical analysis of the compartments, SEM-FIB ion milling (slice and view) was utilized 
since STEM tomography is not quite feasible for a cluster imaging and requires excess tomography 
data. SEM-FIB uses only the sliced particle images instead of tilted imaging; it is quite useful for 
multiple particle analyses at once. We, therefore, chose an area that has a cluster with polydisperse 
SPs for further investigation under SEM. Polydispersity is crucial to represent the entire SP 
population (Figure S 4.13). Seventeen SPs in this cluster are first grouped based on location in the 
cluster and color-coded.  Number of SPs, each SP size in diameter, average volume, and surface 
area of each color-coded area (blue, green, red, yellow, gray, and light blue) are measured (Table 
8). We used  
Figure S 4.14 for calculation of the volume. As SPs are not perfect spheres, volume measurements 
(1.01*106 ± 0.832 *106  nm3) are slightly different than the calculation based on the average radius 
of a sphere with R=72.4 (1.59 ± 0.0853*106 nm3) (Table 9).  
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Figure S 4.13 3D reconstruction images of supraparticles acquired by SEM-FIB slice and view.  Scale bars: 50nm.  
 
Table 8 Summary of Volume and Surface Area of SPs in Figure (a) Based on 3D Reconstruction Analysis 
Color area 
of SPs 
Number of SP 
in each color 
area 
Diameter of each SP 
in each color (nm) 
Total Volume 
(106 nm3) 












40.74, 68.97, 97.52 
1.3 0.83 
Yellow 1 124.29 1.15 0.67 
Gray 1 60.29 0.10 0.12 





Table 9 Measured Average Diameter and Volume of SPs and Compartments  
 Diameter (nm) Volume (*106 nm3) 
Calculated volume 
(*106 nm3) (R=72.4nm) 
Supraparticle 78.05± 37.22 1.01 ± 0.0832 1.59 ± 0.0853 
Compartment 5.2± 1.9 0.15± 0.048 
* Volume is calculated 
based on average sized SP 
from image J. 






Figure S 4.14 Geometrical model for ind NP calculation in a SP.  SP with radius RSP, ind NP with radius rIN, 
compartments of SP with radius RSC, individual compartments with radius rIC. 
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4.6.4 Surface Composition of SPs 
We performed X-ray photoelectron spectroscopy (XPS), and Fourier transform infrared 
spectroscopy (FTIR) analyses to investigate surface composition ( 
Figure S 4.15 a-b). High-resolution XPS data (Figure S 4.16) suggests that cysteine binds to iron 
from the thiol group with the presence of Fe-S bond on FeS2 surface and O-Fe-S bond on the Fe2O3 
surface.  S2p spectra were fitted with several doublets corresponding to the S2p 3/2 − 1/2 components 
with a 1.2 eV spin-orbit splitting and area ratio of 0.5.320 The S2p binding energy at 162.30 eV and 
163.50 eV should be assigned to FeS2 S2p3/2 and S2p1/2 respectively. On the other hand, the S2p 
binding energy at 167.20 eV and 168.40 eV should be assigned the sulfur from cysteine binds to 
Fe2O3 (S-Fe-O) S2p3/2 and S2p1/2 respectively. The peak at 167.20eV (5 eV shift of typical S-H 
peak 162.20eV) is indicating the chemisorption of cysteine via a sulfur group on Fe2O3 321,322 
(Figure S 4.16 a). Fe2p spectra of high-spin compounds exhibit multiple complex splitting and 
have satellite features. Therefore, five peaks are observed under Fe2p.  Two peaks for Fe2O3 2p3/2 
and 2p1/2, and two peaks for their satellite peaks. The fifth peak is 2p3/2 for FeS2.  Fe2p in FeS2 has 
low spin compounds; therefore, no split or satellite features observed (Figure S 4.16 b). O1s 
binding energy at 529.80 eV should be assigned to Fe2O3, and 531.5 eV should be assigned to O-
C=O from L-cysteine (Figure S 4.16 c). The cysteine binding on the NP confirmed with FT-IR ( 
Figure S 4.15 a).  Amino acids generally show IR spectra specific to both carboxylate and primary 
amine salts since they exist as zwitterions52. Therefore, L-cysteine showed very broad peak for 
NH3+ stretch ((NH3+)) at 3000-3500 cm-1 and COO- stretch ((COO-)) at 1350-1700 cm-1 all are 
very typical amino acid IR spectra.323  The weak S–H bend at 2550 cm-1 specifies a cysteine 
molecule ( 
Figure S 4.15 a). Asymmetric COO- and NH3+ stretching can cause a shift in the position in the 
IR spectra due to dipole moment change as when cysteine binds on the metal surface with high 
electron density. Weak S-H peak disappears in SPs' IR spectra, and this verifies the covalent 
interaction of sulfur and iron ( 
Figure S 4.15 a). Therefore, cysteine binding to iron from the thiol group is confirmed, and the 
positive charge is explained by the NH3+ groups of the surface ligand (Fig. 3j and  




Figure S 4.15 (a) FT-IR spectra of L-cysteine (a-blue) and SP (b-green). (b) XPS survey spectrum of SPs.   
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Figure S 4.17 An atomic representative of iron sulfide NP (c) and iron oxide NP with L-cysteine on the surface. L-
cysteine bind s to iron from thiol group.  
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4.6.5 Photoluminescence Analysis of SP 
We performed an emission scanning and 3D fluorescence spectroscopy (EEM) to confirm 
photoluminescence. The stable emission peaks are seen at between 320 nm - 650 nm confirms the 
autofluorescence of SPs (Figure S 4.18a and Figure S 4.19). Emission picks at 350-550nm 
(Figure S 4.19b-solid lined box) with broad range excitations (200-600nm) sources large stokes 
shift (~50nm). We also performed lambda scanning under Leica SP8 confocal microscope to find 
the best excitation and corresponding emission wavelengths for future confocal imaging. 
Fluorescence intensity data from lambda scanning is entirely consistent with our fluorescence data 
and stays in the highest excitation range (Figure S 4.18). This data also shows the highest emission 
can be obtained when SP suspension excited at 475nm and 500nm under confocal microscopy. 
Further imaging is continued with 475nm and 500 nm excitation with a 520-570 nm emission 
window. The resolution of the light microscopy is not enough to observe individual SP; however, 
around 200nm aggregations of SPs can be easily seen (Figure S 4.18b-e)  
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Figure S 4.18 (a) Fluorescence emission of the SP. The graph shows SP emission at the excitation wavelengths from 
200 to 600 every 10 nm increments. The graph in the insert shows UV-Vis spectrum of the SP. b-e) SP suspension 
under confocal microscopy. b is excited at 475 nm and c is excited at 500 nm emission for both emission is 520-
570nm. d) DIC image e) overlay image. Scale bar : 2 𝜇m f)Excitation spectrum in confocal microscopy shows 475nm 




Figure S 4.19 (a) 3D waterfall of Figure S10a fluorescence spectra and (b) contour map Excitation-emission matrix 
(EEM) spectra of the SP suspension. RS is Rayleigh scattering peak, λex = λem .  Solid lined box in (b) shows stable 
picks (350-550nm) with broad range excitations (200-600nm).  Dashed box in (b) shows the excitation range gives 
highest emission.  
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4.6.6 Chemical Composition of Cup-Like Structures 
To understand the mechanism of cup-like structure formation, we checked the composition of cup-
like structures. Cup like structures are also composed of Fe, S, and O (Figure S 4.20); the amount 
of Fe2O3 NP is higher than FeS2 NPs (Table 10). However, the amount of FeS2 NP is higher in SP. 
Not packed FeS2 NPs must be washed through washing steps while we collect cup-like structures 
from the reaction.  Color change during the reaction shows that individual NPs are self-assembled 
into first cup-like structures (15min) and then SPs (30 min) with the effect of oxidation. 
Figure S 4.20 (a) Elemental analysis of the SPs and location of iron, sulfur and oxygen elements in cup-like structures, 




Table 10 Atomic Percentage of Elements in Cup-Like Intermediate Obtained By EDX 
Element  Atomic Percentage, % 
Fe  42.8 
S  13 
O  44.2 
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4.6.7 SPs with Different Amino Acids 
Different handed or derivative of cysteine such that L-cysteine, D-cysteine, and N-Acetyl cysteine 
(NAC) are used to synthesize SPs. Nevertheless, the type of stabilizer did not change the SPs 
formation and their structures (Figure S 4.21). Only with NAC mostly cup-like intermediate 
structures are observed at the same reaction time (30min) (Figure S 4.21c); since the solubility of 
NAC is different than cysteine, and it takes a longer time to complete the reaction for forming 
terminal SPs.  
 
Figure S 4.21 Same reaction condition with different stabilizer. L-cysteine (a), D-cysteine (b) and N-Acetyl-Cysteine 
(NAC) (c) Scale bar: (a) 200nm (insert 20nm) (b) 100nm (insert 20nm) (c ) 100nm  
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4.6.8 SP vs. SP-pDNA Comparison 
 
Figure S 4.22 Comparison of SP and SP-DNA. STEM images of supraparticle (a-d) and SP-pDNA (e-h) acquired 
with default Through the Lens Detector (TLD), Bright field (BF), Dark Field (DF) and High-angle annular dark field 
(HAADF) (STEM mode) detectors. HAADF shows compartments in supraparticles with darker color (pointed with 
arrow) in (d). In SP-pDNA HAADF filled compartment.  TEM images of SP (i) and SP-pDNA (j). Scale bar: (a-h) is 
200nm, (i-J) is 50 nm, insert in (i) is 200nm, insert in (j) is 5nm. 
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4.6.9 SP Concentration and Cytotoxicity 
We calculated particle concentration before cellular experiments via nanosight what gives the 
number of particles per ml. Particles are prepared in different concentration: 1011 particles/ml 
(1000x) and 109 particles/ml (10x) (Figure S 4.23). The cellular uptake is also a critical step for 
transfection. Hence, we performed cellular uptake before transfection to make time progress data 
of the uptake of SPs. For this experiment, we used 10X concentration of SP (~1000 SPs per cell) 
and HEK293T cell, as this cell line is prominent for transfection experiments. The uptake is 
expressed as mean fluorescent intensity of SPs under confocal images. As we discovered 
previously, SPs gave the highest emission intensity when they excited at 475 nm and 500 nm 
(Figure S 4.18) in the window of 520-700nm emission wavelengths. Further analysis made based 
on these two excitation wavelengths. 
Even though toxicity is not expected with these SPs, the cytotoxicity may still originate 
from the nature of NPs. So, we tested how SP-pDNA affect the viability of human cells 
(HEK293T) for different exposure times, concentrations, and cell numbers (Figure S 4.24). The 
toxicity of SP-pDNA on cells compared to the control group is insignificant if the particle: cell 
ratio kept 4000 or low for 24h (Figure S 4.24)., dashed lines show the thresholds for both treatment 
times). It is noticeable that 1000x concentration is decreasing cell viability significantly since 
particle: cell ratio is 4*105 or higher (Figure S 4.24 blue color). One can even easily see particle 
aggregations by the naked eye in cell culture plates for these concentrations. After 48h of 
incubation in the presence of 10x SP-pDNA, cell viability decreased by ca.22% if particle: cell 
ratio is higher than 2000 (Figure S 4.24 b, dashed lines show the threshold).  
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For transfection experiments, HEK293T cells treated with SP-pDNA with 1000 particle: cell ratio 
for specific time intervals starting from 6h to 24h.  
 
Figure S 4.23 (a) Nanosight data for SP (10x) and (b) cup-like structures (1x) concentration.  
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Figure S 4.24 Cell viability assay for SP-DNA 10 times concentrated (10X) and 1000 times concentrated (1000X) 
along with cell only.  (a) 24h treatment (b) 48h treatment. Dashed lines show threshold of cell: particle ratio for 
significant cell viability reduction 
  
 136 
4.6.10 Cellular Uptake 
Figure S 4.25 HEK cells treated with SP for 1 hour. (a) is excited at 475 nm and (b) is excited at 500 nm emission for 




Figure S 4.26 Cellular uptake confocal images. (a-b) HEK cells treated with SPs. (c) HEK cells are not treated with 
SP. (a) Cell treatment with SP after 4h, (b-c) Cell treatment with SP after 12h. All images are taken under same 
conditions, laser power, intensity and brightness are all same. (A) is excited at 475 nm and (B) is excited at 500 nm; 
emission window for both excitations are 520-570 nm. (C) DIC or DAPI images (D) Merged image. Scale bar: (a) 
4µm (b) 2 µm (c) 4 µm. 
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4.6.11 DNA Release and Degradation Assay of SP-pDNA 
DNA release assay performed to find out in what conditions and how long it takes to release the 
DNA from the SP-pDNA complex. pDNA release assay of SP-pDNA was conducted at two 
different pH (5.5 and 7.4) in two different solvents (water and PBS buffer). pH 7.4 and PBS buffer 
is used as the model of biological fluids such as blood and intracellular fluid. pH 5.5 and water are 
used to model the early/late endosome environment and to make TEM imaging easier, 
respectively. The relative pDNA release was quantified by nanodrop at 260nm (Figure S 4.27a).  
Encapsulated pDNA released at acidic conditions (pH 5.5 in water and pH 5.8 in PBS) within 
2hours (Figure S 4.27b) as SP started to degrade as seen in TEM images (Fig. S16d -shows only 
samples in water). TEM images show increasing ind NPs content as time progress after 30min 
(blue box), 1h (red box), and 2h (black box) (Figure S 4.27d). SP-pDNA stays stable even after 
50h in water and PBS at pH 7.4 (Figure S 4.27d a green and red lines).  Electrophoresis is also 
utilized as proof of intact pDNA release (Figure S 4.27d c).   
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Figure S 4.27 DNA release and degradation of SP-pDNA under biologically relevant conditions. Graph shows relative 
DNA release percentage during acid incubation time of SP-pDNA for 48h (a). Red box zoomed graph shows DNA 
release percentage for 2h (b). Gel electrophoresis  shows free DNA after 30 min acid incubation along with intact SP-
pDNA (c ).  TEM images shows number of ind NPs increase and SPs decrease over acid incubation time for 2 h. (d) 
Each image zoomed on colored boxes for high resolution images. Scale bars: top panel 50nm, bottom panel 1nm. 
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Figure S 4.28 24h Post-transfection comparison of SP-pDNA and Lipofectamine. Supraparticle with DNA and 
lipofectamine. (a) SP-pDNA (b) Lipocfectamine after 24 transfection. (A) Texas red filter for cherry red (B) DIC (C) 






5.1 Scientific Contribution 
The work in this thesis provides two main contributions to the field of engineered biomimetic NPs 
in biomedical applications. The first contribution directly impacts preclinical research on 
engineering antibacterial NPs, which is critical to advancing our understanding of the molecular 
mechanism of NPs as next-generation antibiotics (Part I: Chapter 2 and 3). The second contribution 
is indirectly impacting the next-generation vaccine development field. A vector that is 
biocompatible, stable at room temperature, and can carry any nucleic acid with high transfection 
efficiency, similar to viruses, is what the field is looking for 324 (Part II: Chapter 4).  
5.1.1 Understanding the Mechanism of Antibacterial Activity of NPs  
Understanding the molecular mechanism of the antibacterial activity of NPs will help in 
engineering next-generation antibiotics that combat emerging drug resistance. The work presented 
in part I of this thesis (chapters 2 and 3) contributes to the potential clinical translation of ZnO-
NPs since it shows that the mechanism of action is much more complex than previously reported. 
Therefore, it would be challenging for S. aureus to develop resistance against these ZnO-NPs. 
In addition, a well-defined description of the antimicrobial molecular mechanism is necessary 
to guide the engineering of NPs toward a specific mechanism of antibacterial activity. Fine-tuning 
the NP activity using biomimetic concepts 96 opens the possibilities of improving both potency 
and selectivity of NPs as antimicrobials. 
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5.1.1.1  The Effect of ROS Formation and Ion Release on Engineered ZnO-NPs Toxicity  
In chapter 2, as opposed to popular belief, we demonstrated that oxidative stress and ion dissolution 
from ZnO-NPYs are not sufficient to kill methicillin-resistant S. aureus. We found that ZnO-NPYs 
profoundly affect aerobic carbohydrate metabolism and energetics via upregulation of the UMP 
biosynthesis pathway in gene expression analysis. Altogether, the findings of the unexpectedly 
small role of ROS production and extensive role of alterations in carbohydrate metabolism and 
bioenergetics suggest that the mechanism of action of ZnO-NPYs are much more complex than 
previously reported and further exploration is needed.  
5.1.1.2 Engineered NP and Bacterial Cell Membrane Interaction 
In chapter 3, we have demonstrated that ZnO-NPYs interact with the bacterial cell membrane and 
enter cells without causing significant membrane damage and membrane depolarization. 
Localization of ZnO-NPYs helps to understand the kinetics of the time-sensitive antibacterial 
mechanism of action. Cell metabolism is immediately affected upon NP-membrane interaction. 
The collective analysis of the dynamics of NPs and bacterial cell interactions helped us better 
understand the underlying antibacterial mechanism of action. We think that NPs are 
simultaneously interacting with many biomolecules in different metabolic pathways that do not 
allow S.aureus to develop resistance. The downstream effect of NP entry can cause polyphosphate 
granule and vesicle formation, and response to bacterial cell death. 
5.1.2 Engineering New Iron-Based Artificial Virus for Nucleic Acid Delivery 
In part II (chapter 4), we engineered a biomimetic SP self-assembled with multi-compartments 
similar to intracellular organelles or viruses that can be utilized as a vector for nucleic acid 
delivery. Self-assembly of iron-based NPs forms an intermediate structure, nano cups before 
assembling into SPs. This progressive self-assembly generates multi-compartments within a shell 
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that can be utilized for multiple functions such as biomacromolecules packing and delivery. The 
tight structural integration of NP components in supraparticles presents the capacity to protect the 
nucleic acid from degradation and deliver it to cells. These SPs, artificial viruses, display 
similarities to viruses: they self-assemble, have relatively high uniformity, have a modular core-
shell structure with around 100 nm dimensions, and can carry biological cargo. In addition to 
biocompatibility and easy preparation, these SPs are stable at room temperature for a long time. 
Therefore, the development of these SPs can help to expand the window of the next-generation 
vaccine development strategies. 
5.2 Future Directions 
We found that the choice of media is used for the bacterial studies affects the MIC of ZnO-NPYs; 
however, we did not have a chance to investigate the specific media-NP interactions. In Chapter 
2, we investigated the antibacterial activity of ZnO-NPYs in TSBG in where MIC is ten times 
higher than the MIC in SNM used in Chapter 3. TSBG is the most commonly used, nutritionally 
rich media for bacterial studies; however, the ingredients are not well defined, and do not provide 
physiologically relevant conditions. SNM, on the other hand,  is reported to mimic human nasal 
conditions146 that represents a suitable in vivo surrogate environment for in vitro studies. We think, 
in addition of interactions of biomolecules in cells, ZnO-NPYs may interact with essential amino 
acids in media that allow much lower (10x) MIC in SNM. The simplicity and complete 
understanding of each component of SNM can allow us additional investigation on NP-media 
interactions that can further help clinical implications.  
Continued investigation and engineering of biomimetic NPs are essential for future 
biomedical applications. However, detailed exploration of every engineered NP is not practical, is 
labor-intensive, and costly in terms of time and money. Therefore, the work on a machine-learning 
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algorithm to continue to explore NP and biomacromolecule interactions would accelerate studies. 
And this algorithm may help better engineer antibacterial NPs and contribute to selecting 
appropriate cargo for engineered SPs. As Feynman mentioned decades ago, there is still plenty of 
room at the bottom to make new technologies, and ML algorithms can accelerate the development 
of these technologies. 
5.3 Translations Potential 
Next-generation antimicrobials: Metal oxide NPs can be used as an antibacterial agent since they 
have a complex mechanism of action on bacteria. It will be challenging for bacteria to develop 
resistance to these complex mechanisms. ZnO-NPs, in particular, can be used as next-generation 
antibacterial agents since it has been shown that they are selectively killing bacteria over the 
mammalian cells.325 This selectivity will allow ZnO-NPs to be translated into clinics such as 
antibacterial coatings on catheters and implants prone to biofilm formation. In the spotlight of the 
recent pandemic, the engineering of new types, probably smaller NPs, can also be translated as 
anti-viral agents into clinics. 
Supraparticles as next-generation vaccines: During the recent COVID-19 pandemic, nucleic acid 
vaccines have become popular since these vaccines are capable of scalable manufacturing within 
a short period of time. This success relies on a vector that is biocompatible, easy to prepare, and 
can carry any nucleic acid with high efficiency. Specifically, the vector that is thermostable will 
gain more importance over the next years. Accessibility was one of the most significant issues for 
COVID-vaccines. Many developing countries, just because they do not have appropriate systems 
for transferring and storing the vaccines, cannot access the vaccines, which affects the controlling 
the spread326. Thus, the vectors that are stable at room temperature are highly preferred for next-
generation vaccines. The SPs presented in this thesis are engineered from inorganic nanoparticles 
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that have stability at room temperature for a long time. Therefore, the development of these kinds 
of SPs can be translated into clinics as an accessible vector in next-generation vaccines for 





1. Feynman, R. P. There’s plenty of room at the bottom. Micromechanics MEMS Class. Semin. 
Pap. to 1990 XXIII, 2–9 (1997). 
2. Qu, A. et al. Quantitative zeptomolar imaging of miRNA cancer markers with nanoparticle 
assemblies. Proc. Natl. Acad. Sci. 116, 3391–3400 (2019). 
3. Andres, C. M., Zhu, J., Shyu, T., Flynn, C. & Kotov, N. A. Shape-Morphing Nanocomposite 
Origami. Langmuir 30, 5378–5385 (2014). 
4. Wang, Y. et al. Anti-Biofilm Activity of Graphene Quantum Dots via Self-Assembly with 
Bacterial Amyloid Proteins. ACS Nano 13, 4278–4289 (2019). 
5. Zhao, S. et al. The Future of Layer-by-Layer Assembly: A Tribute to ACS Nano Associate 
Editor Helmuth Möhwald. ACS Nano 13, 6151–6169 (2019). 
6. Huang, T. et al. Enhanced Antibacterial Activity of Se Nanoparticles Upon Coating with 
Recombinant Spider Silk Protein eADF4(kappa16). Int. J. Nanomedicine 15, 4275–4288 
(2020). 
7. Ahmed, F. et al. Novel Biomimatic Synthesis of ZnO Nanorods Using Egg White 
(Albumen) and Their Antibacterial Studies. J. Nanosci. Nanotechnol. 16, 5959–5965 
(2016). 
8. Nie, C. et al. Bioinspired and biocompatible carbon nanotube-Ag nanohybrid coatings for 
robust antibacterial applications. Acta Biomater. 51, 479–494 (2017). 
9. Mainwaring, D. E. et al. The nature of inherent bactericidal activity: insights from the 
nanotopology of three species of dragonfly. Nanoscale 8, 6527–6534 (2016). 
10. Xu, L., Zhao, X., Xu, C. & Kotov, N. A. Water-Rich Biomimetic Composites with Abiotic 
Self-Organizing Nanofiber Network. Adv. Mater. 30, (2018). 
11. Zhang, Z., Zhang, J., Zhang, B. & Tang, J. Mussel-inspired functionalization of graphene 
for synthesizing Ag-polydopamine-graphene nanosheets as antibacterial materials. 
Nanoscale 5, 118–123 (2013). 
12. Liu, M., Wang, S. & Jiang, L. Nature-inspired superwettability systems. Nat. Rev. Mater. 
2017 27 2, 1–17 (2017). 




14. Wang, M. et al. Biomimetic Solid-State Zn2+ Electrolyte for Corrugated Structural 
Batteries. ACS Nano 13, 1107–1115 (2019). 
15. Fang, R. H., Jiang, Y., Fang, J. C. & Zhang, L. Cell membrane-derived nanomaterials for 
biomedical applications. Biomaterials 128, 69–83 (2017). 
16. Turlybekuly, A. et al. Synthesis, characterization, in vitro biocompatibility and antibacterial 
properties study of nanocomposite materials based on hydroxyapatite-biphasic ZnO micro- 
and nanoparticles embedded in Alginate matrix. Mater. Sci. Eng. C. Mater. Biol. Appl. 104, 
109965 (2019). 
17. Mahmoudi, M., Sant, S., Wang, B., Laurent, S. & Sen, T. Superparamagnetic iron oxide 
nanoparticles (SPIONs): Development, surface modification and applications in 
chemotherapy. Adv. Drug Deliv. Rev. 63, 24–46 (2011). 
18. Wei, G., Bhushan, B. & Torgerson, P. M. Nanomechanical characterization of human hair 
using nanoindentation and SEM. Ultramicroscopy 105, 248–266 (2005). 
19. Parodi, A. et al. Synthetic nanoparticles functionalized with biomimetic leukocyte 
membranes possess cell-like functions. Nat. Nanotechnol. 2012 81 8, 61–68 (2012). 
20. Jin, K., Luo, Z., Zhang, B. & Pang, Z. Biomimetic nanoparticles for inflammation targeting. 
Acta Pharm. Sin. B 8, 23–33 (2018). 
21. Wang, W. et al. Bioinspired Pollen-Like Hierarchical Surface for Efficient Recognition of 
Target Cancer Cells. Adv. Healthc. Mater. 6, 1700003 (2017). 
22. Li, W. & Szoka, F. C. Lipid-based nanoparticles for nucleic acid delivery. Pharm. Res. 24, 
438–449 (2007). 
23. Cha, S. H. et al. Shape-Dependent Biomimetic Inhibition of Enzyme by Nanoparticles and 
Their Antibacterial Activity. ACS Nano 9, 9097–9105 (2015). 
24. Nitta, S. K. & Numata, K. Biopolymer-based nanoparticles for drug/gene delivery and 
tissue engineering. International Journal of Molecular Sciences 14, 1629–1654 
(Multidisciplinary Digital Publishing Institute, 2013). 
25. W. Hamley, I. Self-assembly of amphiphilic peptides. Soft Matter 7, 4122–4138 (2011). 
26. A, Z. Construction and characterization of virus-like particles: a review. Mol. Biotechnol. 
53, 92–107 (2013). 
27. Moeinzadeh, S. & Jabbari, E. Nanoparticles and Their Applications. Springer Handbooks 
11, 335–361 (2017). 
28. B, D., Z, L., GF, W., SL, Y. & VK, W. Virus-like particle vaccines: immunology and 
formulation for clinical translation. Expert Rev. Vaccines 17, 833–849 (2018). 
 
 148 
29. Komla, E. et al. Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of 
Tetanus Toxoid-Conjugated Heroin Vaccine in Mice. Vaccines 9, (2021). 
30. Akbarzadeh, A. et al. Liposome: classification, preparation, and applications. Nanoscale 
Res. Lett. 2013 81 8, 1–9 (2013). 
31. A, P. et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to 
clinic. Crit. Rev. Ther. Drug Carrier Syst. 26, 523–580 (2009). 
32. Fan, Y. & Moon, J. J. Nanoparticle Drug Delivery Systems Designed to Improve Cancer 
Vaccines and Immunotherapy. Vaccines 3, 662–85 (2015). 
33. Kuai, R., Ochyl, L. J., Schwendeman, A. & Moon, J. J. Lipid-Based Nanoparticles for 
Vaccine Applications. Biomed. Eng. Front. Res. Converging Technol. 9, 177–197 (2016). 
34. Sharma, V. K. & Agrawal, M. K. A historical perspective of liposomes-a bio nanomaterial. 
Mater. Today Proc. 45, 2963–2966 (2021). 
35. Cowen, T., Karim, K. & Piletsky, S. A. Solubility and size of polymer nanoparticles. Polym. 
Chem. 9, 4566–4573 (2018). 
36. Kotov, N. A. Inorganic Nanoparticles as Protein Mimics as Protein Mimics. 
37. Tiwari, J. N., Tiwari, R. N. & Kim, K. S. Zero-dimensional, one-dimensional, two-
dimensional and three-dimensional nanostructured materials for advanced electrochemical 
energy devices. Prog. Mater. Sci. 57, 724–803 (2012). 
38. Huang, C., Chen, X., Xue, Z. & Wang, T. Effect of structure: A new insight into 
nanoparticle assemblies from inanimate to animate. Sci. Adv. 6, eaba1321 (2020). 
39. Khan, I., Saeed, K. & Khan, I. Nanoparticles: Properties, applications and toxicities. Arab. 
J. Chem. 12, 908–931 (2019). 
40. Saha, K., Agasti, S. S., Kim, C., Li, X. & Rotello, V. M. Gold Nanoparticles in Chemical 
and Biological Sensing. (2012). doi:10.1021/cr2001178 
41. Geethalakshmi, R. & Sarada, D. Gold and silver nanoparticles from Trianthema decandra: 
synthesis, characterization, and antimicrobial properties. Int. J. Nanomedicine 7, 5375 
(2012). 
42. Kavaz, D., Umar, H. & Shehu, S. Synthesis, characterization, antimicrobial and 
antimetastatic activity of silver nanoparticles synthesized from Ficus ingens leaf. Artif. cells, 
nanomedicine, Biotechnol. 46, S1193–S1203 (2018). 
43. Munchow, E. A. et al. Synthesis and characterization of CaO-loaded electrospun matrices 
for bone tissue engineering. Clin. Oral Investig. 20, 1921–1933 (2016). 
44. Rajeshkumar, S. & Naik, P. Synthesis and biomedical applications of Cerium oxide 
 
 149 
nanoparticles – A Review. Biotechnol. Reports 17, 1–5 (2018). 
45. Gao, Y. et al. Size-tunable Au@Ag nanoparticles for colorimetric and SERS dual-mode 
sensing of palmatine in traditional Chinese medicine. J. Pharm. Biomed. Anal. 174, 123–
133 (2019). 
46. Velmurugan, P. et al. Antibacterial activity of silver nanoparticle-coated fabric and leather 
against odor and skin infection causing bacteria. Appl. Microbiol. Biotechnol. 98, 8179–
8189 (2014). 
47. Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J. & El-Sayed, M. A. The golden 
age: gold nanoparticles for biomedicine. Chem. Soc. Rev. 41, 2740–2779 (2012). 
48. Unser, S., Bruzas, I., He, J. & Sagle, L. Localized Surface Plasmon Resonance Biosensing:  
Current Challenges and Approaches. Sensors 2015, Vol. 15, Pages 15684-15716 15, 15684–
15716 (2015). 
49. Mohan, S. et al. Completely green synthesis of dextrose reduced silver nanoparticles, its 
antimicrobial and sensing properties. Carbohydr. Polym. 106, 469–474 (2014). 
50. Makwana, B. A., Vyas, D. J., Bhatt, K. D., Jain, V. K. & Agrawal, Y. K. Highly stable 
antibacterial silver nanoparticles as selective fluorescent sensor for Fe3+ ions. Spectrochim. 
Acta. A. Mol. Biomol. Spectrosc. 134, 73–80 (2015). 
51. Yu, M. et al. Antibiotics mediated facile one-pot synthesis of gold nanoclusters as 
fluorescent sensor for ferric ions. Biosens. Bioelectron. 91, 143–148 (2017). 
52. Soomro, R. A. et al. L-cysteine protected copper nanoparticles as colorimetric sensor for 
mercuric ions. Talanta 130, 415–422 (2014). 
53. Ronavari, A. et al. Biological activity of green-synthesized silver nanoparticles depends on 
the applied natural extracts: a comprehensive study. Int. J. Nanomedicine 12, 871–883 
(2017). 
54. Alkilany, A. M. & Murphy, C. J. Toxicity and cellular uptake of gold nanoparticles: what 
we have learned so far? J. Nanoparticle Res. 2010 127 12, 2313–2333 (2010). 
55. Sigmund, W. et al. Processing and Structure Relationships in Electrospinning of Ceramic 
Fiber Systems. J. Am. Ceram. Soc. 89, 395–407 (2006). 
56. Liong, M. et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug 
delivery. ACS Nano 2, 889–96 (2008). 
57. Chang, C., Wang, X., Bai, Y. & Liu, H. Applications of nanomaterials in enantioseparation 
and related techniques. TrAC - Trends Anal. Chem. 39, 195–206 (2012). 
58. Gounani, Z. et al. Mesoporous silica nanoparticles carrying multiple antibiotics provide 
enhanced synergistic effect and improved biocompatibility. Colloids Surf. B. Biointerfaces 
 
 150 
175, 498–508 (2019). 
59. Qi, G., Li, L., Yu, F. & Wang, H. Vancomycin-modified mesoporous silica nanoparticles 
for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-
like cells. ACS Appl. Mater. Interfaces 5, 10874–10881 (2013). 
60. Sattary, M., Amini, J. & Hallaj, R. Antifungal activity of the lemongrass and clove oil 
encapsulated in mesoporous silica nanoparticles against wheat’s take-all disease. Pestic. 
Biochem. Physiol. 170, 104696 (2020). 
61. Xu, G. et al. Reduced bacteria adhesion on octenidine loaded mesoporous silica 
nanoparticles coating on titanium substrates. Mater. Sci. Eng. C. Mater. Biol. Appl. 70, 386–
395 (2017). 
62. Safi, S., Karimzadeh, F. & Labbaf, S. Mesoporous and hollow hydroxyapatite 
nanostructured particles as a drug delivery vehicle for the local release of ibuprofen. Mater. 
Sci. Eng. C. Mater. Biol. Appl. 92, 712–719 (2018). 
63. Thomas, S., Harshita, B. S. P., Mishra, P. & Talegaonkar, S. Ceramic Nanoparticles: 
Fabrication Methods and Applications in Drug Delivery. Curr. Pharm. Des. 21, 6165–6188 
(2015). 
64. Narayan, R., Nayak, U. Y., Raichur, A. M. & Garg, S. Mesoporous Silica Nanoparticles: A 
Comprehensive Review on Synthesis and Recent Advances. Pharm. 2018, Vol. 10, Page 
118 10, 118 (2018). 
65. Lin, Y.-S. & Haynes, C. L. Impacts of Mesoporous Silica Nanoparticle Size, Pore Ordering, 
and Pore Integrity on Hemolytic Activity. J. Am. Chem. Soc. 132, 4834–4842 (2010). 
66. Patel, K. D., Singh, R. K. & Kim, H.-W. Carbon-based nanomaterials as an emerging 
platform for theranostics. Mater. Horizons 6, 434–469 (2019). 
67. Zhang, M. (Assistant professor of biomedical engineering), Naik, R. (Rajesh) & Dai, L. 
Carbon nanomaterials for biomedical applications. 
68. Astefanei, A., Núñez, O. & Galceran, M. T. Characterisation and determination of 
fullerenes: A critical review. Anal. Chim. Acta 882, 1–21 (2015). 
69. Pandiyan, R., Mahalingam, S. & Ahn, Y.-H. Antibacterial and photocatalytic activity of 
hydrothermally synthesized SnO2 doped GO and CNT under visible light irradiation. J. 
Photochem. Photobiol. B. 191, 18–25 (2019). 
70. Brahmachari, S., Mandal, S. K. & Das, P. K. Fabrication of SWCNT-Ag nanoparticle 
hybrid included self-assemblies for antibacterial applications. PLoS One 9, e106775 (2014). 
71. Maiti, D., Tong, X., Mou, X. & Yang, K. Carbon-Based Nanomaterials for Biomedical 
Applications: A Recent Study. Front. Pharmacol. 0, 1401 (2019). 
 
 151 
72. Fan, X., Liu, Y., Wang, X., Quan, X. & Chen, S. Improvement of Antifouling and 
Antimicrobial Abilities on Silver-Carbon Nanotube Based Membranes under 
Electrochemical Assistance. Environ. Sci. Technol. 53, 5292–5300 (2019). 
73. Chan, T. S. Y. et al. Carbon nanotube compared with carbon black: effects on bacterial 
survival against grazing by ciliates and antimicrobial treatments. Nanotoxicology 7, 251–
258 (2013). 
74. Yang, S.-T., Luo, J., Zhou, Q. & Wang, H. Pharmacokinetics, Metabolism and Toxicity of 
Carbon Nanotubes for Biomedical Purposes. Theranostics 2, 271 (2012). 
75. Du, J., Wang, S., You, H. & Zhao, X. Understanding the toxicity of carbon nanotubes in the 
environment is crucial to the control of nanomaterials in producing and processing and the 
assessment of health risk for human: A review. Environ. Toxicol. Pharmacol. 36, 451–462 
(2013). 
76. Girigoswami, K. Toxicity of Metal Oxide Nanoparticles. Adv. Exp. Med. Biol. 1048, 99–
122 (2018). 
77. Esfandiari, N., Simchi, A. & Bagheri, R. Size tuning of Ag-decorated TiO2 nanotube arrays 
for improved bactericidal capacity of orthopedic implants. J. Biomed. Mater. Res. A 102, 
2625–2635 (2014). 
78. Geng, S. et al. Anisotropic Magnetite Nanorods for Enhanced Magnetic Hyperthermia. 
Chem. – An Asian J. 11, 2996–3000 (2016). 
79. Roca, A. G. et al. Design strategies for shape-controlled magnetic iron oxide nanoparticles. 
Adv. Drug Deliv. Rev. 138, 68–104 (2019). 
80. Ittrich, H., Peldschus, K., Raabe, N., Kaul, M. & Adam, G. Superparamagnetic Iron Oxide 
Nanoparticles in Biomedicine: Applications and Developments in Diagnostics and Therapy. 
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der Bildgeb. Verfahren 185, 
1149–1166 (2013). 
81. Miller, M. M., Prinz, G. A., Cheng, S.-F. & Bounnak, S. Detection of a micron-sized 
magnetic sphere using a ring-shaped anisotropic magnetoresistance-based sensor: A model 
for a magnetoresistance-based biosensor. Appl. Phys. Lett. 81, 2211 (2002). 
82. Laurent, S. et al. Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, 
Vectorization, Physicochemical Characterizations, and Biological Applications. Chem. Rev. 
108, 2064–2110 (2008). 
83. Margarethe Hofmann-Amtenbrink1, B. von R. & Hofmann,  and H. New forms of 
superparamagnetic nanoparticles for biomedical applications. Superparamagnetic 
nanoparticles Biomed. Appl. Margarethe 65, 119–147 (2009). 
84. Ling, D., Lee, N. & Hyeon, T. Chemical Synthesis and Assembly of Uniformly Sized Iron 
Oxide Nanoparticles for Medical Applications. Acc. Chem. Res. 48, 1276–1285 (2015). 
 
 152 
85. Arularasu, M. V., Devakumar, J. & Rajendran, T. V. An innovative approach for green 
synthesis of iron oxide nanoparticles: Characterization and its photocatalytic activity. 
Polyhedron 156, 279–290 (2018). 
86. Ismail, R. A., Sulaiman, G. M., Abdulrahman, S. A. & Marzoog, T. R. Antibacterial activity 
of magnetic iron oxide nanoparticles synthesized by laser ablation in liquid. Mater. Sci. Eng. 
C. Mater. Biol. Appl. 53, 286–297 (2015). 
87. Nehra, P., Chauhan, R. P., Garg, N. & Verma, K. Antibacterial and antifungal activity of 
chitosan coated iron oxide nanoparticles. Br. J. Biomed. Sci. 75, 13–18 (2018). 
88. de Rancourt, Y., Couturaud, B., Mas, A. & Robin, J. J. Synthesis of antibacterial surfaces 
by plasma grafting of zinc oxide based nanocomposites onto polypropylene. J. Colloid 
Interface Sci. 402, 320–326 (2013). 
89. Ke, Y. et al. Polypseudorotaxane functionalized magnetic nanoparticles as a dual responsive 
carrier for roxithromycin delivery. Mater. Sci. Eng. C. Mater. Biol. Appl. 99, 159–170 
(2019). 
90. Liu, Z. et al. Synthesis of polyethylenimine (PEI) functionalized silver nanoparticles by a 
hydrothermal method and their antibacterial activity study. Mater. Sci. Eng. C. Mater. Biol. 
Appl. 42, 31–37 (2014). 
91. Gu, Y. et al. Vitamin B2 functionalized iron oxide nanozymes for mouth ulcer healing. Sci. 
China. Life Sci. 63, 68–79 (2020). 
92. Cheng, Z., Zaki, A. Al, Hui, J. Z., Muzykantov, V. R. & Tsourkas, A. Multifunctional 
Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities. Science 
(80-. ). 338, 903–910 (2012). 
93. Hong, S. et al. The Binding Avidity of a Nanoparticle-Based Multivalent Targeted Drug 
Delivery Platform. Chem. Biol. 14, 107–115 (2007). 
94. Wagner, C. S., Shehata, S., Henzler, K., Yuan, J. & Wittemann, A. Towards nanoscale 
composite particles of dual complexity. J. Colloid Interface Sci. 355, 115–123 (2011). 
95. Dizaj, S. M., Jafari, S. & Khosroushahi, A. Y. A sight on the current nanoparticle-based 
gene delivery vectors. Nanoscale Res. Lett. 9, 252 (2014). 
96. Kotov, N. A. Inorganic Nanoparticles as Protein Mimics. Science 330, 188–189 (2010). 
97. Tian, H., Chen, J. & Chen, X. Nanoparticles for gene delivery. Small 9, 2034–2044 (2013). 
98. Xu, Z. P., Zeng, Q. H., Lu, G. Q. & Yu, A. B. Inorganic nanoparticles as carriers for efficient 
cellular delivery. Chem. Eng. Sci. 61, 1027–1040 (2006). 
99. Loureiro, A., G. Azoia, N., C. Gomes, A. & Cavaco-Paulo, A. Albumin-Based Nanodevices 
as Drug Carriers. Curr. Pharm. Des. 22, 1371–1390 (2016). 
 
 153 
100. Martis, E., Badve, R. & Degwekar, M. Nanotechnology based devices and applications in 
medicine: An overview. Chronicles Young Sci. 3, 68 (2012). 
101. Kadiyala, U. et al. Unexpected insights into antibacterial activity of zinc oxide nanoparticles 
against methicillin resistant Staphylococcus aureus (MRSA). Nanoscale 10, 4927–4939 
(2018). 
102. Conly, J. M. Antimicrobial resistance - Judicious use is the key. Canadian Journal of 
Infectious Diseases 15, 249–251 (2004). 
103. Alqahtani, F. et al. Antibacterial Activity of Chitosan Nanoparticles Against Pathogenic N. 
gonorrhoea. Int. J. Nanomedicine 15, 7877–7887 (2020). 
104. Dadgostar, P. Antimicrobial Resistance: Implications and Costs. Infect. Drug Resist. 12, 
3903 (2019). 
105. Wat, D. & Doull, I. Respiratory virus infections in cystic fibrosis. Paediatric Respiratory 
Reviews 4, 172–177 (2003). 
106. Smyth, R. L., Smyth, A. R., Tong, C. Y. W., Hart, C. A. & Heaf, D. P. Effect of respiratory 
virus infections including rhinovirus on clinical status in cystic fibrosis. Arch. Dis. Child. 
73, 117–120 (1995). 
107. Hiatt, P. W. et al. Effects of viral lower respiratory tract infection on lung function in infants 
with cystic fibrosis. Pediatrics 103, 619–626 (1999). 
108. Collinson, J. et al. Effects of upper respiratory tract infections in patients with cystic 
fibrosis. Thorax 51, 1115–1122 (1996). 
109. Villeret, B. et al. Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-
Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin 
Production and Tissue Resilience. Front. Immunol. 11, 117 (2020). 
110. Morens, D. M., Taubenberger, J. K. & Fauci, A. S. Predominant Role of Bacterial 
Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic 
Influenza Preparedness. J. Infect. Dis. 198, 962–970 (2008). 
111. Shafran, N. et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor 
for death compared to influenza patients. Sci. Reports 2021 111 11, 1–8 (2021). 
112. Djurisic, A. B. et al. Toxicity of metal oxide nanoparticles: mechanisms, characterization, 
and avoiding experimental artefacts. Small 11, 26–44 (2015). 
113. Jiang, W., Mashayekhi, H. & Xing, B. Bacterial toxicity comparison between nano- and 
micro-scaled oxide particles. Environ. Pollut. 157, 1619–1625 (2009). 
114. Kumar, A., Pandey, A. K., Singh, S. S., Shanker, R. & Dhawan, A. Engineered ZnO and 
TiO(2) nanoparticles induce oxidative stress and DNA damage leading to reduced viability 
 
 154 
of Escherichia coli. Free Radic Biol Med 51, 1872–1881 (2011). 
115. Liu, J. L., Luo, Z. & Bashir, S. A progressive approach on inactivation of bacteria using 
silver-titania nanoparticles. Biomater. Sci. 1, 194–201 (2013). 
116. Romero-Urbina, D. G. et al. Ultrastructural changes in methicillin-resistant Staphylococcus 
aureus induced by positively charged silver nanoparticles. Beilstein J. Nanotechnol. 6, 
2396–2405 (2015). 
117. Setyawati, M. I., Fang, W., Chia, S. L. & Leong, D. T. Nanotoxicology of common metal 
oxide based nanomaterials: their ROS-y and non-ROS-y consequences. Asia-Pacific J. 
Chem. Eng. 8, 205–217 (2013). 
118. Zhang, L., Ding, Y., Povey, M. & York, D. ZnO nanofluids – A potential antibacterial agent. 
Prog. Nat. Sci. 18, 939–944 (2008). 
119. Zhang, L., Wu, L., Mi, Y. & Si, Y. Silver Nanoparticles Induced Cell Apoptosis, Membrane 
Damage of Azotobacter vinelandii and Nitrosomonas europaea via Generation of Reactive 
Oxygen Species. Bull. Environ. Contam. Toxicol. 103, 181–186 (2019). 
120. Nabraska Transposon Mutant Library. 
121. Jin, S. E. & Jin, H. E. Antimicrobial activity of zinc oxide nano/microparticles and their 
combinations against pathogenic microorganisms for biomedical applications: From 
physicochemical characteristics to pharmacological aspects. Nanomaterials 11, 1–35 
(2021). 
122. Premanathan, M., Karthikeyan, K., Jeyasubramanian, K. & Manivannan, G. Selective 
toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis 
through lipid peroxidation. Nanomedicine 7, 184–192 (2011). 
123. Xie, Y., He, Y., Irwin, P. L., Jin, T. & Shi, X. Antibacterial activity and mechanism of action 
of zinc oxide nanoparticles against Campylobacter jejuni. Appl Env. Microbiol 77, 2325–
2331 (2011). 
124. Zhang, L. et al. Mechanistic investigation into antibacterial behaviour of suspensions of 
ZnO nanoparticles against E. coli. J. Nanoparticle Res. 12, 1625–1636 (2009). 
125. Du, J. et al. Antibacterial activity of a novel Forsythia suspensa fruit mediated green silver 
nanoparticles against food-borne pathogens and mechanisms investigation. Mater. Sci. Eng. 
C. Mater. Biol. Appl. 102, 247–253 (2019). 
126. Padmavathi, A. R. et al. Copper oxide nanoparticles as an effective anti-biofilm agent 
against a copper tolerant marine bacterium, Staphylococcus lentus. Biofouling 35, 1007–
1025 (2019). 
127. Garza-Cervantes, J. A. et al. Antimicrobial and antibiofilm activity of biopolymer-Ni, Zn 
nanoparticle biocomposites synthesized using R. mucilaginosa UANL-001L 
 
 155 
exopolysaccharide as a capping agent. Int. J. Nanomedicine 14, 2557–2571 (2019). 
128. Applerot, G. et al. ZnO nanoparticle-coated surfaces inhibit bacterial biofilm formation and 
increase antibiotic susceptibility. RSC Adv. 2, 2314–2321 (2012). 
129. Krishnamoorthy, K., Manivannan, G., Kim, S. J., Jeyasubramanian, K. & Premanathan, M. 
Antibacterial activity of MgO nanoparticles based on lipid peroxidation by oxygen vacancy. 
J. Nanoparticle Res. 14, 1–10 (2012). 
130. Yazhini, K. B. & Prabu, H. G. Antibacterial activity of cotton coated with ZnO and ZnO-
CNT composites. Appl. Biochem. Biotechnol. 175, 85–92 (2015). 
131. Lallo da Silva, B., Caetano, B. L., Chiari-Andreo, B. G., Pietro, R. C. L. R. & Chiavacci, L. 
A. Increased antibacterial activity of ZnO nanoparticles: Influence of size and surface 
modification. Colloids Surf. B. Biointerfaces 177, 440–447 (2019). 
132. Shao, F. et al. Bio-synthesis of Barleria gibsoni leaf extract mediated zinc oxide 
nanoparticles and their formulation gel for wound therapy in nursing care of infants and 
children. J. Photochem. Photobiol. B. 189, 267–273 (2018). 
133. Balaure, P. C. et al. In vitro and in vivo studies of novel fabricated bioactive dressings based 
on collagen and zinc oxide 3D scaffolds. Int. J. Pharm. 557, 199–207 (2019). 
134. Venkatasubbu, G. D., Baskar, R., Anusuya, T., Seshan, C. A. & Chelliah, R. Toxicity 
mechanism of titanium dioxide and zinc oxide nanoparticles against food pathogens. 
Colloids Surf. B. Biointerfaces 148, 600–606 (2016). 
135. Kalpana, V. N. et al. Biosynthesis of zinc oxide nanoparticles using culture filtrates of 
Aspergillus niger: Antimicrobial textiles and dye degradation studies. OpenNano 3, 48–55 
(2018). 
136. Fouda, A., El-Din Hassan, S., Salem, S. S. & Shaheen, T. I. In-Vitro cytotoxicity, 
antibacterial, and UV protection properties of the biosynthesized Zinc oxide nanoparticles 
for medical textile applications. Microb. Pathog. 125, 252–261 (2018). 
137. Pandimurugan, R. & Thambidurai, S. UV protection and antibacterial properties of seaweed 
capped ZnO nanoparticles coated cotton fabrics. Int. J. Biol. Macromol. 105, 788–795 
(2017). 
138. Sasani Ghamsari, M., Alamdari, S., Han, W. & Park, H.-H. Impact of nanostructured thin 
ZnO film in ultraviolet protection. Int. J. Nanomedicine 12, 207–216 (2017). 
139. Mohseni, S., Aghayan, M., Ghorani-Azam, A., Behdani, M. & Asoodeh, A. Evaluation of 
antibacterial properties of Barium Zirconate Titanate (BZT) nanoparticle. Braz. J. 
Microbiol. 45, 1393–1399 (2014). 
140. Kujda, M. et al. Charge Stabilized Silver Nanoparticles Applied as Antibacterial Agents. J. 
Nanosci. Nanotechnol. 15, 3574–3583 (2015). 
 
 156 
141. McGuffie, M. J. et al. Zinc oxide nanoparticle suspensions and layer-by-layer coatings 
inhibit staphylococcal growth. Nanomedicine Nanotechnology, Biol. Med. 12, 33–42 
(2016). 
142. M, A. et al. Antimicrobial activity of iron oxide nanoparticle upon modulation of 
nanoparticle-bacteria interface. Sci. Rep. 5, 14813 (2015). 
143. Saptarshi, S. R., Duschl, A. & Lopata, A. L. Interaction of nanoparticles with proteins: 
relation to bio-reactivity of the nanoparticle. J Nanobiotechnology 11, 26 (2013). 
144. Kadiyala, U., Kotov, N. A. & VanEpps, J. S. Antibacterial Metal Oxide Nanoparticles: 
Challenges in Interpreting the Literature. Curr. Pharm. Des. 24, 896–903 (2018). 
145. Sushnitha, M., Evangelopoulos, M., Tasciotti, E. & Taraballi, F. Cell Membrane-Based 
Biomimetic Nanoparticles and the Immune System: Immunomodulatory Interactions to 
Therapeutic Applications. Front. Bioeng. Biotechnol. 0, 627 (2020). 
146. Krismer, B. et al. Nutrient Limitation Governs Staphylococcus aureus Metabolism and 
Niche Adaptation in the Human Nose. PLoS Pathog. 10, (2014). 
147. Padmavathy, N. & Vijayaraghavan, R. Enhanced bioactivity of ZnO nanoparticles - An 
antimicrobial study. Sci. Technol. Adv. Mater. 9, (2008). 
148. Lemire, J. A. et al. Antimicrobial activity of metals: mechanisms, molecular targets and 
applications. Nat Rev Microbiol 11, 371–384 (2013). 
149. Pasquet, J. et al. The contribution of zinc ions to the antimicrobial activity of zinc oxide. 
Colloids Surfaces A Physicochem. Eng. Asp. 457, 263–274 (2014). 
150. Dutta, R. K., Nenavathu, B. P., Gangishetty, M. K. & Reddy, A. V. Studies on antibacterial 
activity of ZnO nanoparticles by ROS induced lipid peroxidation. Colloids Surf B 
Biointerfaces 94, 143–150 (2012). 
151. Horie, M. et al. Association of the physical and chemical properties and the cytotoxicity of 
metal oxide nanoparticles: metal ion release, adsorption ability and specific surface area. 
Metallomics 4, 350–360 (2012). 
152. Soni, D. et al. Oxidative Stress and Genotoxicity of Zinc Oxide Nanoparticles to 
Pseudomonas Species, Human Promyelocytic Leukemic (HL-60), and Blood Cells. Biol. 
Trace Elem. Res. 178, 218–227 (2017). 
153. Gutiérrez, C., Plessing, C. Von & García, A. Metal nanostructures as antibacterial agents. 
Sci. against Microb. Pathog. Commun. Curr. Res. Technol. Adv. 210–218 (2011). 
154. Zhang, L., Ding, Y., Povey, M. & York, D. ZnO nanofluids-A potential antibacterial agent. 
Prog. Nat. Sci. 18, 939–944 (2008). 
155. Zhang, L., Jiang, Y., Ding, Y., Povey, M. & York, D. Investigation into the antibacterial 
 
 157 
behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). J. Nanoparticle Res. 9, 
479–489 (2007). 
156. Stanković, A. et al. Influence of size scale and morphology on antibacterial properties of 
ZnO powders hydrothemally synthesized using different surface stabilizing agents. Colloids 
Surf. B. Biointerfaces 102, 21–28 (2013). 
157. Stoimenov, P. K., Klinger, R. L., Marchin, G. L. & Klabunde, K. J. Metal oxide 
nanoparticles as bactericidal agents. Langmuir 18, 6679–6686 (2002). 
158. Zhang, J. & Saltzman, M. Engineering biodegradable nanoparticles for drug and gene 
delivery. Chem. Eng. Prog. 109, 25 (2013). 
159. Ding, Y. et al. Gold nanoparticles for nucleic acid delivery. Mol. Ther. 22, 1075–83 (2014). 
160. Sokolova, V. & Epple, M. Inorganic nanoparticles as carriers of nucleic acids into cells. 
Angew. Chemie - Int. Ed. 47, 1382–1395 (2008). 
161. Li, S. & Huang, L. Nonviral gene therapy: promises and challenges. Gene Ther. 7, 31–34 
(2000). 
162. Cross, D. & Burmester, J. K. Gene Therapy for Cancer Treatment : Past , Present and Future. 
4, 218–227 (2006). 
163. Pranatharthiharan, S., Patel, M. D., D’Souza, A. A. & Devarajan, P. V. Inorganic 
nanovectors for nucleic acid delivery. Drug Deliv. Transl. Res. 3, 446–470 (2013). 
164. Wolff, J. A. & Budker, V. The Mechanism of Naked DNA Uptake and Expression. 
Advances in Genetics 54, 1–20 (2005). 
165. Kay, M. A., Glorioso, J. C. & Naldini, L. Viral vectors for gene therapy: the art of turning 
infectious agents into vehicles of therapeutics. Nat. Med. 7, 33–40 (2001). 
166. Gao, K. & Huang, L. Nonviral methods for siRNA delivery. Molecular Pharmaceutics 6, 
651–658 (2009). 
167. Yamanouchi, D. et al. Biodegradable arginine-based poly(ester-amide)s as non-viral gene 
delivery reagents. Biomaterials 29, 3269–3277 (2008). 
168. Dufès, C., Uchegbu, I. F. & Schätzlein, A. G. Dendrimers in gene delivery. Advanced Drug 
Delivery Reviews 57, 2177–2202 (2005). 
169. Choi, Y. & Chang, J. Viral vectors for vaccine applications. Clin. Exp. Vaccine Res. 2, 97–
105 (2013). 
170. Semple, S. C. et al. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 
28, 172–6 (2010). 
171. Wu, J., Yamanouchi, D., Liu, B. & Chu, C.-C. Biodegradable arginine-based poly(ether 
 
 158 
ester amide)s as a non-viral DNA delivery vector and their structure–function study. J. 
Mater. Chem. 22, 18983–18991 (2012). 
172. Alhakamy, N. A., Dhar, P. & Berkland, C. J. Charge Type, Charge Spacing, and 
Hydrophobicity of Arginine-Rich Cell-Penetrating Peptides Dictate Gene Transfection. al, 
(2016). 
173. Piccinini, E., Pallarola, D., Battaglini, F. & Azzaroni, O. Recognition-driven assembly of 
self-limiting supramolecular protein nanoparticles displaying enzymatic activity. Chem. 
Commun. (Camb). 51, 14754–7 (2015). 
174. Lee, J.-M., Yoon, T.-J. & Cho, Y.-S. Recent developments in nanoparticle-based siRNA 
delivery for cancer therapy. Biomed Res. Int. 2013, 782041 (2013). 
175. Ramos-Perez, V., Cifuentes, A., Coronas, N., de Pablo, A. & Borrós, S. Modification of 
carbon nanotubes for gene delivery vectors. Methods Mol. Biol. 1025, 261–8 (2013). 
176. Lu, A. H., Salabas, E. L. & Sch??th, F. Magnetic nanoparticles: Synthesis, protection, 
functionalization, and application. Angewandte Chemie - International Edition 46, 1222–
1244 (2007). 
177. Fishbein, I., Chorny, M. & Levy, R. J. Site-specific gene therapy for cardiovascular disease. 
Curr. Opin. Drug Discov. Devel. 13, 203–13 (2010). 
178. Karimi, M., Avci, P., Mobasseri, R., Hamblin, M. R. & Naderi-Manesh, H. The novel 
albumin-chitosan core-shell nanoparticles for gene delivery: Preparation, optimization and 
cell uptake investigation. J. Nanoparticle Res. 15, (2013). 
179. Liu, C. & Zhang, N. Nanoparticles in gene therapy: Principles, prospects, and challenges. 
Progress in Molecular Biology and Translational Science 104, 509–562 (Academic Press, 
2011). 
180. Guevara, M. L., Persano, F. & Persano, S. Advances in Lipid Nanoparticles for mRNA-
Based Cancer Immunotherapy. Front. Chem. 0, 963 (2020). 
181. B. Devika  Chithrani, †,‡, Arezou A.  Ghazani, †,‡ and & Warren C. W.  Chan*, †,‡,§. 
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian 
Cells. Nano Lett. 6, 662–668 (2006). 
182. Read, M. L., Logan, A. & Seymour, L. W. Barriers to Gene Delivery Using Synthetic 
Vectors. Adv. Genet. 53, 19–46 (2005). 
183. Xia, Y. et al. Self-assembly of self-limiting monodisperse supraparticles from polydisperse 
nanoparticles. Nat. Nanotechnol. 6, 580–587 (2011). 




185. Li, F., Josephson, D. P. & Stein, A. Colloidal assembly: The road from particles to colloidal 
molecules and crystals. Angewandte Chemie - International Edition 50, 360–388 (2011). 
186. Tang, Z. Spontaneous Organization of Single CdTe Nanoparticles into Luminescent 
Nanowires. Science (80-. ). 297, 237–240 (2002). 
187. Tang, Z., Zhang, Z., Wang, Y., Glotzer, S. C. & Kotov, N. A. Self-assembly of CdTe 
nanocrystals into free-floating sheets. Science 314, 274–8 (2006). 
188. Xia, Y. et al. supraparticles from polydisperse nanoparticles. Nat. Nanotechnol. 6, 580–587 
(2011). 
189. Xia, Y. & Tang, Z. Monodisperse inorganic supraparticles: formation mechanism, 
properties and applications. Chem. Commun. (Camb). 48, 6320–6336 (2012). 
190. Schlachter, E. K. et al. Metabolic pathway and distribution of superparamagnetic iron oxide 
nanoparticles: in vivo study. Int. J. Nanomedicine 6, 1793–1800 (2011). 
191. Applerot, G. et al. Understanding the antibacterial mechanism of CuO nanoparticles: 
revealing the route of induced oxidative stress. Small 8, 3326–3337 (2012). 
192. Cui, Y. et al. The molecular mechanism of action of bactericidal gold nanoparticles on 
Escherichia coli. Biomaterials 33, 2327–2333 (2012). 
193. von Moos, N. & Slaveykova, V. I. Oxidative stress induced by inorganic nanoparticles in 
bacteria and aquatic microalgae--state of the art and knowledge gaps. Nanotoxicology 8, 
605–630 (2014). 
194. Leung, Y. H. et al. Antibacterial activity of ZnO nanoparticles with a modified surface 
under ambient illumination. Nanotechnology 23, 475703 (2012). 
195. Thill, A. et al. Cytotoxicity of CeO2 Nanoparticles for Escherichia coli. Physico-Chemical 
Insight of the Cytotoxicity Mechanism. Environ. Sci. Technol. 40, 6151–6156 (2006). 
196. Leung, Y. H. et al. Mechanisms of antibacterial activity of MgO: non-ROS mediated 
toxicity of MgO nanoparticles towards Escherichia coli. Small 10, 1171–1183 (2014). 
197. Lyon, D. Y., Brunet, L., Hinkal, G. W., Wiesner, M. R. & Alvarez, P. J. Antibacterial 
activity of fullerene water suspensions (nC60) is not due to ROS-mediated damage. Nano 
Lett 8, 1539–1543 (2008). 
198. Gaupp, R., Ledala, N. & Somerville, G. A. Staphylococcal response to oxidative stress. 
Front. Cell. Infect. Microbiol. 2, 33 (2012). 
199. Gambino, M. & Cappitelli, F. Mini-review: Biofilm responses to oxidative stress. 
Biofouling 32, 167–178 (2016). 
200. Painter, K. L. et al. Staphylococcus aureus Adapts to Oxidative Stress by Producing 
 
 160 
H(2)O(2)-Resistant Small-Colony Variants via the SOS Response. Infect. Immun. 83, 1830–
1844 (2015). 
201. Reddy, K. M. et al. Selective toxicity of zinc oxide nanoparticles to prokaryotic and 
eukaryotic systems. Appl. Phys. Lett. 90, 213902–213903 (2007). 
202. Li, M., Zhu, L. & Lin, D. Toxicity of ZnO Nanoparticles to Escherichia coli: Mechanism 
and the Influence of Medium Components. Environ. Sci. Technol. 45, 1977–1983 (2011). 
203. McDevitt, C. A. et al. A Molecular Mechanism for Bacterial Susceptibility to Zinc. PLOS 
Pathog. 7, e1002357 (2011). 
204. Reed, R. B., Ladner, D. A., Higgins, C. P., Westerhoff, P. & Ranville, J. F. Solubility of 
nano-zinc oxide in environmentally and biologically important matrices. Environ. Toxicol. 
Chem. 31, 93–99 (2012). 
205. Wang, N., Tong, T., Xie, M. & Gaillard, J. F. Lifetime and dissolution kinetics of zinc oxide 
nanoparticles in aqueous media. Nanotechnology 27, 324001 (2016). 
206. Yang, M., Sun, K. & Kotov, N. A. Formation and assembly-disassembly processes of ZnO 
hexagonal pyramids driven by dipolar and excluded volume interactions. J. Am. Chem. Soc. 
132, 1860–1872 (2010). 
207. Repine, J. E., Fox, R. B. & Berger, E. M. Hydrogen peroxide kills Staphylococcus aureus 
by reacting with staphylococcal iron to form hydroxyl radical. J Biol Chem 256, 7094–7096 
(1981). 
208. Thomas, E. L., Milligan, T. W., Joyner, R. E. & Jefferson, M. M. Antibacterial activity of 
hydrogen peroxide and the lactoperoxidase-hydrogen peroxide-thiocyanate system against 
oral streptococci. Infect Immun 62, 529–535 (1994). 
209. Yan, W. et al. Self-assembly of chiral nanoparticle pyramids with strong R/S optical 
activity. J. Am. Chem. Soc. 134, 15114–15121 (2012). 
210. Smyth, G. K. Linear models and empirical bayes methods for assessing differential 
expression in microarray experiments. Stat Appl Genet Mol Biol 3, Article3 (2004). 
211. Ritchie, M. E. et al. Empirical array quality weights in the analysis of microarray data. BMC 
Bioinformatics 7, 261 (2006). 
212. Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and 
Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B 57, 289–300 (1995). 
213. Čáp, M., Váchová, L. & Palková, Z. Reactive Oxygen Species in the Signaling and 
Adaptation of Multicellular Microbial Communities. Oxid. Med. Cell. Longev. 2012, 13 
(2012). 
214. Jang, I.-A., Kim, J. & Park, W. Endogenous hydrogen peroxide increases biofilm formation 
 
 161 
by inducing exopolysaccharide production in Acinetobacter oleivorans DR1. Sci. Rep. 6, 
21121 (2016). 
215. Stark, G. Functional Consequences of Oxidative Membrane Damage. J. Membr. Biol. 205, 
1–16 (2005). 
216. Chang, W., Small, D. A., Toghrol, F. & Bentley, W. E. Global Transcriptome Analysis of 
Staphylococcus aureus Response to Hydrogen Peroxide. J. Bacteriol. 188, 1648–1659 
(2006). 
217. Nobre, L. S. & Saraiva, L. M. Effect of combined oxidative and nitrosative stresses on 
Staphylococcus aureus transcriptome. Appl Microbiol Biotechnol 97, 2563–2573 (2013). 
218. Pati, R. et al. Topical application of zinc oxide nanoparticles reduces bacterial skin infection 
in mice and exhibits antibacterial activity by inducing oxidative stress response and cell 
membrane disintegration in macrophages. Nanomedicine 10, 1195–1208 (2014). 
219. Raghupathi, K. R., Koodali, R. T. & Manna, A. C. Size-Dependent Bacterial Growth 
Inhibition and Mechanism of Antibacterial Activity of Zinc Oxide Nanoparticles. Langmuir 
27, 4020–4028 (2011). 
220. Amna, S. et al. Review on Zinc Oxide Nanoparticles: Antibacterial Activity and Toxicity 
Mechanism. Nano-Micro Lett. 7, 219–242 (2015). 
221. Yoo, S. Il et al. Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: 
functional similarities with proteins. Angew. Chemie 50, 5110–5 (2011). 
222. Arakha, M., Saleem, M., Mallick, B. C. & Jha, S. The effects of interfacial potential on 
antimicrobial propensity of ZnO nanoparticle. Sci. Rep. 5, 9578 (2015). 
223. de Planque, M. R. R., Aghdaei, S., Roose, T. & Morgan, H. Electrophysiological 
Characterization of Membrane Disruption by Nanoparticles. ACS Nano 5, 3599–3606 
(2011). 
224. Jacobson, K. H. et al. Lipopolysaccharide Density and Structure Govern the Extent and 
Distance of Nanoparticle Interaction with Actual and Model Bacterial Outer Membranes. 
Environ. Sci. Technol. 49, 10642–10650 (2015). 
225. McIllMurray, M. B. & Lascelles, J. Anaerobiosis and the Activity of Enzymes of 
Pyrimidine Biosynthesis in Staphylococcus aureus. Microbiology 64, 269–277 (1970). 
226. Anderson, K. L. et al. Characterization of the Staphylococcus aureus heat shock, cold shock, 
stringent, and SOS responses and their effects on log-phase mRNA turnover. J Bacteriol 
188, 6739–6756 (2006). 
227. Fuchs, S., Pané-Farré, J., Kohler, C., Hecker, M. & Engelmann, S. Anaerobic Gene 
Expression in Staphylococcus aureus. J. Bacteriol. 189, 4275–4289 (2007). 
 
 162 
228. Jones, N., Ray, B., Ranjit, K. T. & Manna, A. C. Antibacterial activity of ZnO nanoparticle 
suspensions on a broad spectrum of microorganisms. FEMS Microbiol Lett 279, 71–76 
(2008). 
229. Hernandez-Montes, G., Diaz-Mejia, J. J., Perez-Rueda, E. & Segovia, L. The hidden 
universal distribution of amino acid biosynthetic networks: a genomic perspective on their 
origins and evolution. Genome Biol 9, R95 (2008). 
230. Yu, F. et al. Zn or O? An Atomic Level Comparison on Antibacterial Activities of Zinc 
Oxides. Chemistry 22, 8053–8058 (2016). 
231. Liao, H. et al. Falling Leaves Inspired ZnO Nanorods–Nanoslices Hierarchical Structure 
for Implant Surface Modification with Two Stage Releasing Features. ACS Appl. Mater. 
Interfaces 9, 13009–13015 (2017). 
232. Zhang, Y., Nayak, T. R., Hong, H. & Cai, W. Biomedical Applications of Zinc Oxide 
Nanomaterials. Curr Mol Med 13, 1633–1645 (2013). 
233. Cory, H. et al. Preferential killing of cancer cells and activated human T cells using 
ZnO nanoparticles. Nanotechnology 19, 295103 (2008). 
234. Pastoriza-Santos, I. et al. One-Pot Synthesis of Ag@TiO2 Core−Shell Nanoparticles and 
Their Layer-by-Layer Assembly. Langmuir 16, 2731–2735 (2000). 
235. Podsiadlo, P. et al. Layer-by-Layer Assembly of Nacre-like Nanostructured Composites 
with Antimicrobial Properties. Langmuir 21, 11915–11921 (2005). 
236. Sekyere, J. O. & Amoako, D. G. Carbonyl cyanide m-chlorophenylhydrazine (CCCP) 
reverses resistance to colistin, but not to Carbapenems and tigecycline in multidrug-resistant 
Enterobacteriaceae. Front. Microbiol. 8, (2017). 
237. Park, Y. K. & Ko, K. S. Effect of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on 
killing Acinetobacter baumannii by colistin. J. Microbiol. 53, 53–59 (2015). 
238. GALE, E. F. & FOLKES, J. P. The assimilation of amino-acids by bacteria. XV. Actions 
of antibiotics on nucleic acid and protein synthesis in Staphylococcus aureus. Biochem. J. 
53, (1953). 
239. HANCOCK, R. The bactericidal action of streptomycin on Staphylococcus aureus and some 
accompanying biochemical changes. J. Gen. Microbiol. 23, (1960). 
240. Luzzatto, L., Apirion, D. & Schlessinger, D. Mechanism of action of streptomycin in E. 
coli: interruption of the ribosome cycle at the initiation of protein synthesis. Proc. Natl. 
Acad. Sci. U. S. A. 60, 873–880 (1968). 
241. Davis, B. D. Mechanism of Bactericidal Action of Aminoglycosides. (1987). 
242. Van Stelten, J., Silva, F., Belin, D. & Silhavy, T. J. Effects of antibiotics and a proto-
 
 163 
oncogene homolog on destruction of protein translocator SecY. Science (80-. ). 325, (2009). 
243. Segers, K. & Anné, J. Traffic Jam at the Bacterial Sec Translocase: Targeting the SecA 
Nanomotor by Small-Molecule Inhibitors. Chemistry & Biology 18, 685–698 (Cell Press, 
2011). 
244. Mookerjee, S. A., Gerencser, A. A., Nicholls, D. G. & Brand, M. D. Quantifying 
intracellular rates of glycolytic and oxidative ATP production and consumption using 
extracellular flux measurements. J. Biol. Chem. 292, 7189 (2017). 
245. Luo, Z. et al. The role of nanoparticle shape in translocation across the pulmonary surfactant 
layer revealed by molecular dynamics simulations. Environ. Sci. Nano 5, 1921–1932 
(2018). 
246. Wang, X., Thompson, C. D., Weidenmaier, C. & Lee, J. C. Release of Staphylococcus 
aureus extracellular vesicles and their application as a vaccine platform. Nat. Commun. 9, 
1–13 (2018). 
247. A, E., D, M., DK, C. & CP, H. The short-term toxic effects of TiO₂nanoparticles toward 
bacteria through viability, cellular respiration, and lipid peroxidation. Environ. Sci. Pollut. 
Res. Int. 22, 17917–17924 (2015). 
248. Leung, Y. H. et al. Transmission electron microscopy artifacts in characterization of the 
nanomaterial-cell interactions. Appl. Microbiol. Biotechnol. 2017 10113 101, 5469–5479 
(2017). 
249. Chen, S. et al. Avoiding artefacts during electron microscopy of silver nanomaterials 
exposed to biological environments. J. Microsc. 261, 157 (2016). 
250. Bayoumi, M., Bayley, H., Maglia, G. & Sapra, K. T. Multi-compartment encapsulation of 
communicating droplets and droplet networks in hydrogel as a model for artificial cells. Sci. 
Rep. 7, 1–11 (2017). 
251. Kushner, D. J. Self-assembly of biological structures. Bacteriol. Rev. 33, 302–45 (1969). 
252. Yang, M. et al. Self-assembly of nanoparticles into biomimetic capsid-like nanoshells. Nat 
Chem 9, 287–294 (2017). 
253. Mitragotri, S. & Lahann, J. Physical approaches to biomaterial design. Nat. Mater. 8, 15–
23 (2009). 
254. Settembre, C., Fraldi, A., Medina, D. L. & Ballabio, A. Signals from the lysosome: a control 
centre for cellular clearance and energy metabolism. Nat. Rev. Mol. Cell Biol. 14, 283–96 
(2013). 
255. Kerfeld, C. A., Heinhorst, S. & Cannon, G. C. Bacterial Microcompartments. Annu. Rev. 
Microbiol. 64, 391–408 (2010). 
 
 164 
256. Kerfeld, C. A. et al. Protein Structures Forming the Shell of Primitive Bacterial Organelles. 
Science (80-. ). 309, 936–938 (2005). 
257. Yeates, T. O., Kerfeld, C. A., Heinhorst, S., Cannon, G. C. & Shively, J. M. Protein-based 
organelles in bacteria: carboxysomes and related microcompartments. Nat. Rev. Microbiol. 
6, 681–691 (2008). 
258. Tanaka, S. et al. Atomic-level models of the bacterial carboxysome shell. Science (80-. ). 
319, 1083–1086 (2008). 
259. Martin, W. Evolutionary origins of metabolic compartmentalization in eukaryotes. Philos. 
Trans. R. Soc. B Biol. Sci. 365, 847–855 (2010). 
260. Lentini, R., Yeh Martín, N. & Mansy, S. S. Communicating artificial cells. Current Opinion 
in Chemical Biology 34, 53–61 (2016). 
261. Voeltz, G. K., Rolls, M. M. & Rapoport, T. A. Structural organization of the endoplasmic 
reticulum. EMBO Rep. 3, 944–950 (2002). 
262. Chen, A. H. & Silver, P. A. Designing biological compartmentalization. Trends Cell Biol. 
22, 662–70 (2012). 
263. Tawfik, D. S. & Griffiths, A. D. Man-made cell-like compartments for molecular evolution. 
Nat. Biotechnol. 16, 652–656 (1998). 
264. Aldaye, F. A., Palmer, A. L. & Sleiman, H. F. Assembling Materials with DNA as the 
Guide. Science (80-. ). 321, 1795–1799 (2008). 
265. Wei, B., Dai, M. & Yin, P. Complex shapes self-assembled from single-stranded DNA tiles. 
Nature 485, 623–626 (2012). 
266. Zhu, T. F. & Szostak, J. W. Coupled Growth and Division of Model Protocell Membranes. 
J. Am. Chem. Soc. 131, 5705–5713 (2009). 
267. Balakumaran, A. et al. Superparamagnetic iron oxide nanoparticles labeling of bone 
marrow stromal (mesenchymal) cells does not affect their ‘stemness’. PLoS One 5, e11462 
(2010). 
268. Channon, K., Bromley, E. H. & Woolfson, D. N. Synthetic biology through biomolecular 
design and engineering. Current Opinion in Structural Biology 18, 491–498 (2008). 
269. Belluati, A. et al. Multicompartment Polymer Vesicles with Artificial Organelles for Signal‐
Triggered Cascade Reactions Including Cytoskeleton Formation. Adv. Funct. Mater. 
2002949 (2020). doi:10.1002/adfm.202002949 
270. Paleos, C. M., Tsiourvas, D., Sideratou, Z. & Pantos, A. Formation of artificial 
multicompartment vesosome and dendrosome as prospected drug and gene delivery 
carriers. Journal of Controlled Release 170, 141–152 (2013). 
 
 165 
271. Bolinger, P.-Y., Stamou, D. & Vogel, H. An Integrated Self-Assembled Nanofluidic System 
for Controlled Biological Chemistries. Angew. Chemie 120, 5626–5631 (2008). 
272. Peters, R. J. R. W. et al. Cascade reactions in multicompartmentalized polymersomes. 
Angew. Chemie - Int. Ed. 53, 146–150 (2014). 
273. Marguet, M., Edembe, L. & Lecommandoux, S. Polymersomes in polymersomes: Multiple 
loading and permeability control. Angew. Chemie - Int. Ed. 51, 1173–1176 (2012). 
274. Godoy-Gallardo, M. et al. Multicompartment Artificial Organelles Conducting Enzymatic 
Cascade Reactions inside Cells. ACS Appl. Mater. Interfaces 9, 15907–15921 (2017). 
275. Hosta-Rigau, L., York-Duran, M. J., Zhang, Y., Goldie, K. N. & Städler, B. Confined 
multiple enzymatic (cascade) reactions within poly(dopamine)-based capsosomes. ACS 
Appl. Mater. Interfaces 6, 12771–12779 (2014). 
276. Chandrawati, R. et al. Triggered cargo release by encapsulated enzymatic catalysis in 
capsosomes. Nano Lett. 11, 4958–4963 (2011). 
277. Engelhart, A. E., Adamala, K. P. & Szostak, J. W. A simple physical mechanism enables 
homeostasis in primitive cells. Nat. Chem. 8, 448–453 (2016). 
278. Huang, Y. et al. Impact of MoS&lt;sub&gt;2&lt;/sub&gt; supporting interface on the 
photothermal-induced deformation of gold nanoshells: tracked through an optical 
microfiber. 2D Mater. (2019). doi:10.1088/2053-1583/ab2c22 
279. Khalid, M., Ciracì, C., Khalid, M. & Ciracì, C. Numerical Analysis of Nonlocal Optical 
Response of Metallic Nanoshells. Photonics 6, 39 (2019). 
280. Liu, Y. F., Wang, Y. Q., Liu, Y. F. & Wang, Y. Q. Thermo-Electro-Mechanical Vibrations 
of Porous Functionally Graded Piezoelectric Nanoshells. Nanomaterials 9, 301 (2019). 
281. Pampalakis, G. From Chemical Gardens to Quasibiological Inorganic Cells. 
ChemistrySelect 4, 2802–2805 (2019). 
282. Barge, L. M. et al. From Chemical Gardens to Chemobrionics. Chem. Rev. 115, 8652–8703 
(2015). 
283. Caruso, F., Spasova, M., Susha, A., Giersig, M. & Caruso, R. A. Magnetic nanocomposite 
particles and hollow spheres constructed by a sequential layering approach. Chem. Mater. 
13, 109–116 (2001). 
284. Iskandar, F., Mikrajuddin & Okuyama, K. In Situ Production of Spherical Silica Particles 
Containing Self-Organized Mesopores. Nano Lett. 1, 231–234 (2001). 
285. Walsh, D., Lebeau, B. & Mann, S. Morphosynthesis of Calcium Carbonate (Vaterite) 
Microsponges. Adv. Mater. 11, 324–328 (1999). 
 
 166 
286. Jung, J. H., Ono, Y. & Shinkai, S. Novel preparation method for multi-layered, tubular silica 
using an azacrown-appended cholesterol as template and metal-deposition into the 
interlayer space. J. Chem. Soc. Perkin Trans. 2 0, 1289–1291 (1999). 
287. Ono, Y. et al. Preparation of novel hollow fiber silica using collagen fibers as a template. 
Chem. Lett. 475–476 (1999). doi:10.1246/cl.1999.475 
288. Van Bommel, K. J. C., Friggeri, A. & Shinkai, S. Organic templates for the generation of 
inorganic materials. Angewandte Chemie - International Edition 42, 980–999 (2003). 
289. Glotzer, S. C. & Solomon, M. J. Anisotropy of building blocks and their assembly into 
complex structures. Nat. Mater. 6, 557–562 (2007). 
290. Tang, Z., Kotov, N. A. & Giersig, M. Spontaneous Organization of Single CdTe 
Nanoparticles into Luminescent Nanowires. Science (80-. ). 297, 237–240 (2002). 
291. Ariga, K. et al. Challenges and breakthroughs in recent research on self-assembly. Sci. 
Technol. Adv. Mater. 9, 014109 (2008). 
292. Kotov, N. A. N. A. Practical aspects of self-organization of nanoparticles: Experimental 
guide and future applications. Journal of Materials Chemistry 21, 16673–16674 (2011). 
293. Feng, W. et al. Assembly of mesoscale helices with near-unity enantiomeric excess and 
light-matter interactions for chiral semiconductors. Sci. Adv. 3, e1601159 (2017). 
294. Yang, M. & Kotov, N. A. N. A. Nanoscale helices from inorganic materials. J. Mater. Chem. 
21, 6775–6792 (2011). 
295. Yan, J. et al. Self-Assembly of Chiral Nanoparticles into Semiconductor Helices with 
Tunable near-Infrared Optical Activity. Chem. Mater. 32, 476–488 (2020). 
296. Srivastava, S. et al. Light-controlled self-assembly of semiconductor nanoparticles into 
twisted ribbons. Science (80-. ). 327, 1355–9 (2010). 
297. Zhou, H., Kim, J.-P., Bahng, J. H., Kotov, N. A. & Lee, J. Self-Assembly Mechanism of 
Spiky Magnetoplasmonic Supraparticles. Adv. Funct. Mater. 24, 1439–1448 (2014). 
298. Gao, M. R. et al. One-pot synthesis of hierarchical magnetite nanochain assemblies with 
complex building units and their application for water treatment. J. Mater. Chem. 21, 
16888–16892 (2011). 
299. Wei, A., Kasama, T. & Dunin-Borkowski, R. E. Self-assembly and flux closure studies of 
magnetic nanoparticle rings. J. Mater. Chem. 21, 16686–16693 (2011). 
300. Shevchenko, E. V et al. Structural characterization of self-assembled multifunctional binary 
nanoparticle superlattices. J. Am. Chem. Soc. 128, 3620–37 (2006). 




302. Park, J. Il et al. Terminal supraparticle assemblies from similarly charged protein molecules 
and nanoparticles. Nat. Commun. 5, 3593 (2014). 
303. Zhou, Y. et al. Biomimetic Hierarchical Assembly of Helical Supraparticles from Chiral 
Nanoparticles. ACS Nano 3248–56 (2016). doi:10.1021/acsnano.5b05983 
304. Piccinini, E., Pallarola, D., Battaglini, F. & Azzaroni, O. Self-limited self-assembly of 
nanoparticles into supraparticles: towards supramolecular colloidal materials by design. 
Mol. Syst. Des. Eng. 1, 155–162 (2016). 
305. Lowson, R. T. R. T. Aqueous Oxidation of Pyrite by Molecular Oxygen. Chem. Rev. 82, 
461–497 (1982). 
306. Bai, Y. et al. Universal synthesis of single-phase pyrite FeS2 nanoparticles, nanowires, and 
nanosheets. J. Phys. Chem. C 117, 2567–2573 (2013). 
307. Chen, G., Zhu, Z. & Qin, Y. Synthesis of Pure Micro- and Nanopyrite and Their Application 
for As (III) Removal from Aqueous Solution. Adv. Mater. Sci. Eng. 2016, 1–6 (2016). 
308. Holder, C. F. & Schaak, R. E. Tutorial on Powder X-ray Diffraction for Characterizing 
Nanoscale Materials. ACS Nano 13, 7359–7365 (2019). 
309. Ennaoui, A., Fiechter, S., Goslowsky, H. & Tributsch, H. Photoactive Synthetic 
Polycrystalline Pyrite ( FeS2 ). J. Electrochem. Soc. 132, 1579–1582 (1985). 
310. Ennaoui, A., Fiechter, S., Jaegermann, W. & Tributsch, H. Photoelectrochemistry of Highly 
Quantum Efficient Single-Crystalline n-FeS[sub 2] (Pyrite). J. Electrochem. Soc. 133, 97 
(1986). 
311. Zangeneh Kamali, K., Alagarsamy, P., Huang, N. M., Ong, B. H. & Lim, H. N. Hematite 
Nanoparticles-Modified Electrode Based Electrochemical Sensing Platform for Dopamine. 
Sci. World J. 2014, 1–13 (2014). 
312. Ennaoui, A. et al. Iron disulfide for solar energy conversion. Sol. Energy Mater. Sol. Cells 
29, 289–370 (1993). 
313. Chatzitheodorou, G. et al. Thin photoactive FeS2 (pyrite) films. Mater. Res. Bull. 21, 1481–
1487 (1986). 
314. Chen, K.-L. et al. Influence of magnetoplasmonic γ-Fe2O3/Au core/shell nanoparticles on 
low-field nuclear magnetic resonance. Sci. Rep. 6, 35477 (2016). 
315. Kotov, N. A. Nanoparticle assemblies and superstructures. (Dekker/CRC Press, 2006). 
316. Wu, Z. et al. Self-Assembly of Nanoclusters into Mono-, Few-, and Multilayered Sheets via 
Dipole-Induced Asymmetric van der Waals Attraction. ACS Nano 9, 6315–23 (2015). 
 
 168 
317. Hirai, K. et al. Coordination Assembly of Discoid Nanoparticles. Angew. Chemie Int. Ed. 
54, 8966–8970 (2015). 
318. Lidmar, J., Mirny, L. & Nelson, D. R. Virus shapes and buckling transitions in spherical 
shells. Phys. Rev. E. Stat. Nonlin. Soft Matter Phys. 68, 051910 (2003). 
319. Boschi, F. & De Sanctis, F. Overview of the optical properties of fluorescent nanoparticles 
for optical imaging. Eur. J. Histochem. 61, 2830 (2017). 
320. Alarcón, L. S. et al. Adsorption and thermal stability of 1,4 benzenedimethanethiol on 
InP(110). Surf. Sci. 664, 101–109 (2017). 
321. E.  Mateo Marti, †, Ch.  Methivier,  and & Pradier*, C. M. (S)-Cysteine Chemisorption on 
Cu(110), from the Gas or Liquid Phase:  An FT-RAIRS and XPS Study. (2004). 
doi:10.1021/LA048952W 
322. Ma, Z. & Han, H. One-step synthesis of cystine-coated gold nanoparticles in aqueous 
solution. Colloids Surfaces A Physicochem. Eng. Asp. 317, 229–233 (2008). 
323. Aryal, S. et al. Spectroscopic identification of SAu interaction in cysteine capped gold 
nanoparticles. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 63, 160–163 (2006). 
324. Riel, D. van & Wit, E. de. Next-generation vaccine platforms for COVID-19. Nat. Mater. 
2020 198 19, 810–812 (2020). 
325. de Oliveira, J. F. A. et al. Defeating Bacterial Resistance and Preventing Mammalian Cells 
Toxicity Through Rational Design of Antibiotic-Functionalized Nanoparticles. Sci. Rep. 7, 
1326 (2017). 











Gene products Summary 
Downregulated         
SACOL0200 uhpT 31.92 sugar phosphate antiporter cytoplasmic membrane protein that 
functions as a monomer; catalyzes the 
active transport of sugar-phosphates such 
as glucose-6-phosphate with the obligatory 
exchange of inorganic phosphate or 
organophosphate 
SACOL1173 hlY 11.68 alpha-hemolysin precursor identified by similarity to SP:P09616; 
match to protein family HMM PF01117; 
match to protein family HMM TIGR01002 
SACOL2022 hld 8.13 delta-hemolysin Lyses erythrocytes and other mammalian 
cells 
SACOL1083 purD 7.45 phosphoribosylamine--glycine 
ligase 
catalyzes the formation of N(1)-(5-
phospho-D-ribosyl)glycinamide from 5-
phospho-D-ribosylamine and glycine in 
purine biosynthesis 





involved in de novo purine biosynthesis 
SACOL2146   5.48 PTS system, mannitol-specific 
IIBC components 
identified by match to protein family HMM 
PF02302; match to protein family HMM 




5.22 hypothetical protein 
 
SACOL1081 purN 4.98 phosphoribosylglycinamide 
formyltransferase 
identified by similarity to EGAD:16303; 
match to protein family HMM PF00551; 
match to protein family HMM TIGR00639 
SACOL0095 spa 4.31 immunoglobulin G binding 
protein A precursor 
identified by similarity to SP:P02976; 
match to protein family HMM PF00746; 
match to protein family HMM PF01476; 
match to protein family HMM PF02216; 
match to protein family HMM PF03373; 
match to protein family HMM PF04650; 
match to protein family HMM TIGR01167; 
match to protein family HMM TIGR01168 
SACOL1080 purM 4.22 phosphoribosylaminoimidazole 
synthetase 
catalyzes the formation of 1-(5-
phosphoribosyl)-5-aminoimidazole from 2-
(formamido)-N1-(5-
phosphoribosyl)acetamidine and ATP in 
purine biosynthesis 
SACOL0008 hutH 4.11 histidine ammonia-lyase catalyzes the degradation of histidine to 
urocanate and ammmonia 
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SACOL0882   4.02 ABC transporter ATP-binding 
protein 
identified by match to protein family HMM 
PF00005 
SACOL2422 hlgB 4.01 gamma hemolysin, component 
B 
identified by similarity to SP:P31715; 
match to protein family HMM PF01117; 
match to protein family HMM TIGR01002 
SACOL2395 narG 3.97 respiratory nitrate reductase 
subunit alpha 
identified by similarity to EGAD:30702; 
match to protein family HMM PF00384; 
match to protein family HMM PF01568; 
match to protein family HMM TIGR01580 
SACOL2421 hlgC 3.82 gamma hemolysin, component 
C 
identified by similarity to SP:P31716; 
match to protein family HMM PF01117; 
match to protein family HMM TIGR01002 
SACOL1477 ilvA1 3.71 threonine dehydratase catalyzes the formation of 2-oxobutanoate 
from L-threonine; catabolic 
SACOL2396 
 
3.67 uroporphyrinogen III 
methylase SirB 
identified by similarity to GP:4433641; 
match to protein family HMM PF00590; 
match to protein family HMM TIGR01469 
SACOL0704   3.55 iron compound ABC 
transporter ATP-binding 
protein 
identified by similarity to EGAD:37683; 
match to protein family HMM PF00005 
SACOL0883 
 
3.55 ABC transporter permease identified by match to protein family HMM 
PF00528 
SACOL2044   3.48 acetolactate synthase 1 
regulatory subunit 
with IlvI catalyzes the formation of 2-
acetolactate from pyruvate, this subunit 
subunit is required for full activity and 
valine sensitivity; also known as 
acetolactate synthase small 
SACOL1658 
 
3.29 hypothetical protein 
 
SACOL1478 ald1 3.22 alanine dehydrogenase identified by match to protein family HMM 
PF01262; match to protein family HMM 




3.13 ABC transporter ATP-binding 
protein 
identified by match to protein family HMM 
PF00005 




3.12 hypothetical protein identified by match to protein family HMM 
PF04172 
SACOL2024 agrD 3.08 accessory gene regulator 
protein D 
identified by similarity to EGAD:18902; 
match to protein family HMM PF05931 
SACOL2043 ilvB 3.04 acetolactate synthase large 
subunit 
identified by match to protein family HMM 
PF00205; match to protein family HMM 
PF02776; match to protein family HMM 
TIGR00118 





identified by match to protein family HMM 
PF00583 




3.02 MarR family transcriptional 
regulator 
identified by match to protein family HMM 
PF01047 




3.01 manganese transport protein 
MntH 
identified by match to protein family HMM 




SACOL0994 oppF 3.00 oligopeptide ABC transporter 
ATP-binding protein 
identified by match to protein family HMM 
PF00005 
SACOL2258 sarV 2.95 hypothetical protein identified by similarity to OMNI:SA2258; 
match to protein family HMM TIGR01889 
SACOL2394 narH 2.95 respiratory nitrate reductase 
subunit beta 
identified by similarity to EGAD:16236; 
similarity to EGAD:30703; match to 
protein family HMM TIGR01660 
SACOL1428 lysC 2.91 aspartate kinase catalyzes the formation of 4-phospho-L-
aspartate from L-aspartate and ATP, in 
Bacillus, lysine sensitive; regulated by 
response to starvation. 
SACOL2006   2.89 Aerolysin/leukocidin family 
protein 




2.89 hypothetical protein identified by similarity to GB:AAO06055.1 




2.86 hypothetical protein identified by similarity to GP:4574119 




2.84 hypothetical protein identified by similarity to GB:AAO06012.1 
SACOL1741 icd 2.84 isocitrate dehydrogenase Converts isocitrate to alpha ketoglutarate 
SACOL2020 
 
2.83 hypothetical protein identified by match to protein family HMM 
PF00881 
SACOL1429 asd 2.83 aspartate semialdehyde 
dehydrogenase 
identified by similarity to EGAD:15165; 
match to protein family HMM PF01118; 
match to protein family HMM PF02774; 
match to protein family HMM TIGR01296 
SACOL2042 ilvD 2.81 dihydroxy-acid dehydratase catalyzes the dehydration of 2,3-dihydroxy-
3-methylbutanoate to 3-methyl-2-
oxobutanoate in valine and isoleucine 
biosynthesis 
SACOL0884   2.75 ABC transporter substrate-
binding protein 
identified by match to protein family HMM 
PF03180 
SACOL2023 agrB 2.73 accessory gene regulator 
protein B 
identified by match to protein family HMM 
PF04647 
SACOL2398 nirB 2.73 nitrite reductase [NAD(P)H], 
large subunit 
identified by similarity to EGAD:30822; 
match to protein family HMM PF00070; 
match to protein family HMM PF01077; 
match to protein family HMM PF03460; 





iron regulated; catalyzes the release of 
heme from hemoglobin allowing bacterial 
pathogens to use the host heme as an iron 
source 
SACOL1846   2.71 hypothetical protein   
SACOL0119 
 
2.71 cell wall surface anchor family 
protein 
identified by match to protein family HMM 
PF00746; match to protein family HMM 
TIGR01167 
SACOL1784 acuA 2.70 acetoin utilization protein 
AcuA 
identified by similarity to EGAD:23882 
SACOL2025 argC2 2.69 accessory gene regulator 
protein C 
identified by match to protein family HMM 
PF02518 
SACOL2393 narJ 2.68 respiratory nitrate reductase 
subunit delta 
identified by match to protein family HMM 




SACOL2694 geh 2.66 lipase identified by similarity to SP:Q02510; 
similarity to EGAD:17843; match to 
protein family HMM PF04650; match to 
protein family HMM TIGR01168 
SACOL0707   2.63 dihydroxyacetone kinase 
subunit DhaK 
with DhaL and DhaM forms 
dihydroxyacetone kinase, which is 
responsible for phosphorylating 
dihydroxyacetone; DhaK is the 
dihydroxyacetone binding subunit of the 
dihydroxyacetone kinase 
SACOL1546 proC 2.63 pyrroline-5-carboxylate 
reductase 
identified by similarity to EGAD:45894; 
match to protein family HMM PF01089; 
match to protein family HMM TIGR00112 
SACOL0907 seb 2.62 enterotoxin B identified by similarity to GP:3212819; 
match to protein family HMM PF01123; 
match to protein family HMM PF02876 
SACOL0153 
 
2.62 hypothetical protein identified by match to protein family HMM 
PF04304 
SACOL2386   2.59 nitrite extrusion protein identified by similarity to EGAD:30454; 
match to protein family HMM PF07690 
SACOL0995 
 
2.58 oligopeptide ABC transporter 
oligopeptide-binding protein 
identified by match to protein family HMM 
PF00496 
SACOL1182 arcC1 2.58 carbamate kinase catalyzes the reversible synthesis of 
carbamate and ATP from carbamoyl 
phosphate and ADP 
SACOL0991 oppB 2.57 oligopeptide ABC transporter 
permease 
identified by match to protein family HMM 
PF00528 
SACOL2392 narI 2.56 respiratory nitrate reductase 
subunit gamma 
identified by similarity to EGAD:30704; 
match to protein family HMM PF02665; 
match to protein family HMM TIGR00351 
SACOL2628 betB 2.56 betaine aldehyde 
dehydrogenase 
identified by similarity to EGAD:97843; 
match to protein family HMM PF00171; 
match to protein family HMM TIGR01804 
SACOL2147   2.55 BglG family transcriptional 
antiterminator 
identified by match to protein family HMM 
PF00874 
SACOL2399 nirR 2.53 transcriptional regulator NirR identified by similarity to GP:4433637 
SACOL2145 glmS 2.52 glucosamine--fructose-6-
phosphate aminotransferase 
Catalyzes the first step in hexosamine 
metabolism, converting fructose-6P into 




2.52 hypothetical protein identified by similarity to EGAD:108623 
SACOL2391   2.51 hypothetical protein identified by similarity to GB:AAO05612.1 
SACOL2531 
 
2.51 MarR family transcriptional 
regulator 
identified by match to protein family HMM 
PF01047 
SACOL1711   2.50 DNA-3-methyladenine 
glycosylase 
identified by similarity to EGAD:6433; 
match to protein family HMM PF03352 
SACOL2521 
 
2.49 transporter identified by match to protein family HMM 
PF07690 
SACOL2045 ilvC 2.49 ketol-acid reductoisomerase catalyzes the formation of (R)-2,3-
dihydroxy-3-methylbutanoate from (S)-2-
hydroxy-2-methyl-3-oxobutanoate in valine 
and isoleucine biosynthesis 
SACOL2397 nirD 2.48 nitrite reductase [NAD(P)H], 
small subunit 
identified by similarity to EGAD:30823; 
match to protein family HMM PF00355 
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SACOL0993 oppD 2.47 oligopeptide ABC transporter 
ATP-binding protein 
identified by match to protein family HMM 
PF00005; match to protein family HMM 
TIGR01727 
SACOL2026 agrA 2.46 accessory gene regulator 
protein A 
identified by similarity to EGAD:16137; 
match to protein family HMM PF00072; 
match to protein family HMM PF04397 
SACOL0402   2.46 PTS system, IIA component identified by match to protein family HMM 
PF00359 
SACOL0205 pflA 2.45 pyruvate formate-lyase-
activating enzyme 
identified by similarity to SP:O68575; 
match to protein family HMM PF04055 
SACOL2651   2.45 tributyrin esterase EstA identified by similarity to GP:7453516; 
similarity to OMNI:NTL01LL1811; match 
to protein family HMM PF00756 
SACOL2661 
 
2.43 hypothetical protein identified by similarity to GB:AAO05863.1 
SACOL1432 dapD 2.43 2,3,4,5-tetrahydropyridine-2,6-
dicarboxylate N-
succinyltransferase 
identified by similarity to EGAD:165602; 
match to protein family HMM PF00132 
SACOL2046 leuA 2.42 2-isopropylmalate synthase catalyzes the formation of 2-
isopropylmalate from acetyl-CoA and 2-
oxoisovalerate in leucine biosynthesis 
SACOL1431 dapB 2.42 dihydrodipicolinate reductase catalyzes the reduction of 2,3-
dihydrodipicolinate to 2,3,4,5-
tetrahydrodipicolinate in lysine and 
diaminopimelate biosynthesis 
SACOL2199 budB 2.42 acetolactate synthase catalyzes the formation of 2-acetolactate 
from pyruvate in stationary phase 
SACOL0718   2.42 ABC transporter ATP-binding 
protein 
identified by similarity to EGAD:108398; 
match to protein family HMM PF00005 
SACOL1596 aroK 2.42 shikimate kinase identified by similarity to EGAD:29699; 
match to protein family HMM PF01202 
SACOL1430 dapA 2.41 dihydrodipicolinate synthase catalyzes the formation of 
dihydrodipicolinate from L-aspartate 4-
semialdehyde and pyruvate in lysine and 
diaminopimelate biosynthesis 
SACOL2047 leuB 2.41 3-isopropylmalate 
dehydrogenase 
catalyzes the oxidation of 3-
isopropylmalate to 3-carboxy-4-methyl-2-
oxopentanoate in leucine biosynthesis 
SACOL0821   2.39 HD domain-containing protein   
SACOL2632 cudT 2.38 BCCT family osmoprotectant 
transporter 
identified by similarity to EGAD:45763; 
match to protein family HMM PF02028; 
match to protein family HMM TIGR00842 
SACOL2389   2.37 transcriptional regulatory 
protein DegU 
identified by match to protein family HMM 




2.37 PTS system, IIBC components identified by match to protein family HMM 
PF00367; match to protein family HMM 
PF02378; match to protein family HMM 
TIGR00826; match to protein family HMM 
TIGR01992 




2.34 hypothetical protein identified by similarity to GB:AAO04593.1 
SACOL1043   2.33 glycosyl transferase, group 1 
family protein 
identified by match to protein family HMM 
PF00534 
SACOL2627 betA 2.33 choline dehydrogenase catalyzes the oxidation of choline to 




SACOL2049 leuD 2.32 isopropylmalate isomerase 
small subunit 
catalyzes the isomerization between 2-
isopropylmalate and 3-isopropylmalate in 
leucine biosynthesis; forms a heterodimer 
of LeuC/D 
SACOL2050 ilvA2 2.31 threonine dehydratase catalyzes the formation of 2-oxobutanoate 
from L-threonine; biosynthetic 




2.30 amino acid permease identified by match to protein family HMM 
PF00324 
SACOL2167   2.28 iron compound ABC 
transporter iron compound-
binding protein 
identified by match to protein family HMM 
PF01497 
SACOL1397 msrA 2.28 methionine sulfoxide reductase 
A 
this stereospecific enzymes reduces the S 
isomer of methionine sulfoxide while MsrB 
reduces the R form; provides protection 
against oxidative stress 




2.27 LPXTG cell wall surface 
anchor family protein 
identified by match to protein family HMM 
PF00746; match to protein family HMM 
PF05345; match to protein family HMM 
TIGR01167 
SACOL2565   2.26 FeoA domain-containing 
protein 




2.25 hypothetical protein 
 
SACOL2322   2.23 M20/M25/M40 family 
peptidase 
identified by match to protein family HMM 
PF01546; match to protein family HMM 
PF07687; match to protein family HMM 
TIGR01891 
SACOL0204 pflB 2.22 formate acetyltransferase identified by similarity to SP:P09373; 
match to protein family HMM PF01228; 
match to protein family HMM PF02901; 
match to protein family HMM TIGR01255 
SACOL0992 oppC 2.22 oligopeptide ABC transporter 
permease 
identified by match to protein family HMM 
PF00528 
SACOL2660 isaB 2.22 immunodominant antigen B 
 
SACOL1362 hom 2.21 homoserine dehydrogenase catalyzes the formation of L-aspartate 4-
semialdehyde from L-homoserine 
SACOL1060 
 
2.19 MarR family transcriptional 
regulator 
identified by match to protein family HMM 
PF01047 
SACOL1171   2.19 hypothetical protein   
SACOL0796 
 
2.18 iron compound ABC 
transporter permease 
identified by similarity to EGAD:37681; 
match to protein family HMM PF01032 
SACOL0708   2.17 DAK2 domain-containing 
protein 
identified by similarity to 
OMNI:NTL01BH3400; match to protein 
family HMM PF02734; match to protein 
family HMM TIGR02365 
SACOL1816 putA 2.17 proline dehydrogenase identified by match to protein family HMM 
PF01619 
SACOL0007   2.17 hypothetical protein identified by similarity to EGAD:21908; 
match to protein family HMM PF01256 
SACOL2550 
 
2.16 hypothetical protein 
 








SACOL0458 xpt 2.15 xanthine 
phosphoribosyltransferase 
Catalyzes the transfer of the 
phosphoribosyl moiety from 5-phospho--
D-ribosyl-1-pyrophosphate (PRib-PP) to 
the 6-oxo-guanine and -xanthine 
SACOL2618 ldh2 2.13 L-lactate dehydrogenase identified by similarity to EGAD:16887; 
match to protein family HMM PF00056; 
match to protein family HMM PF02866; 
match to protein family HMM TIGR01771 




2.13 hypothetical protein 
 
SACOL2451   2.13 amino acid ABC transporter 
amino acid-binding protein 
identified by match to protein family HMM 
PF04069 
SACOL2048 leuC 2.13 isopropylmalate isomerase 
large subunit 
dehydratase component, catalyzes the 
isomerization between 2-isopropylmalate 
and 3-isopropylmalate 
SACOL1556   2.12 hypothetical protein   
SACOL1659 
 
2.12 hypothetical protein identified by similarity to GP:10174438; 
similarity to OMNI:NTL01BH1823 
SACOL2569   2.12 1-pyrroline-5-carboxylate 
dehydrogenase 
catalyzes the conversion of 1-proline-5-
carboxylate dehydrogenase to L-glutamate 
SACOL0660 adhP 2.11 alcohol dehydrogenase similar to zinc-dependent eukaryotic ADH 
enzymes and distinct from fermentative 
ADHs 
SACOL0009 serS 2.11 seryl-tRNA synthetase catalyzes a two-step reaction, first charging 
a serine molecule by linking its carboxyl 
group to the alpha-phosphate of ATP, 
followed by transfer of the aminoacyl-
adenylate to its tRNA 
SACOL2453 
 
2.10 amino acid ABC transporter 
ATP-binding protein 
identified by match to protein family HMM 
PF00005; match to protein family HMM 
PF00571; match to protein family HMM 
TIGR01186 




2.08 M20/M25/M40 family 
peptidase 
identified by match to protein family HMM 
PF01546; match to protein family HMM 
PF07687; match to protein family HMM 
TIGR01891 
SACOL1783 acs 2.07 acetyl-CoA synthetase Acs; catalyzes the conversion of acetate 
and CoA to acetyl-CoA 
SACOL1742 gltA 2.07 citrate synthase catalyzes the formation of citrate from 
acetyl-CoA and oxaloacetate 
SACOL0703   2.07 hypothetical protein identified by similarity to EGAD:108622; 
match to protein family HMM PF02588 
SACOL0111 
 
2.06 acetoin reductase identified by match to protein family HMM 
PF00106 
SACOL1175   2.06 hypothetical protein   
SACOL1020 
 
2.05 hypothetical protein similar to 2'-5' RNA ligase 
SACOL2324 hutU 2.04 urocanate hydratase catalyzes the formation of 4-imidazolone-




2.04 ABC transporter permease identified by match to protein family HMM 
PF00950 
SACOL2319   2.03 Na+/H+ antiporter family 
protein 
identified by similarity to 




2.03 hypothetical protein identified by similarity to GB:AAO04611.1 
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SACOL0934   2.03 hypothetical protein identified by similarity to GB:AAO04220.1 
SACOL0700 abcA 2.02 ABC transporter ATP-binding 
protein/permease 
identified by match to protein family HMM 
PF00005; match to protein family HMM 
PF00664 
SACOL2011   2.01 sodium transport family 
protein 
identified by match to protein family HMM 
PF02386 
SACOL2516 gntR 2.01 gluconate operon 
transcriptional repressor 
identified by similarity to EGAD:17516; 
match to protein family HMM PF00392 
SACOL2620   2.00 4-aminobutyrate 
aminotransferase 
catalyzes the formation of succinate 
semialdehyde and glutamate from 4-
aminobutanoate and 2-oxoglutarate 
SACOL0688 
 
1.98 ABC transporter substrate-
binding protein 
identified by match to protein family HMM 
PF01297 
SACOL2448   1.98 2-dehydropantoate 2-reductase ketopantoate reductase; catalyzes the 
NADPH reduction of ketopantoate to 
pantoate; functions in pantothenate 
(vitamin B5) biosynthesis 
SACOL2718 
 
1.97 anion transporter family 
protein 
identified by match to protein family HMM 
PF00939; match to protein family HMM 
TIGR00785 
SACOL2059   1.97 hypothetical protein   
SACOL0314 
 
1.96 hypothetical protein identified by similarity to EGAD:15022; 
match to protein family HMM PF01380 
SACOL0494 nuoF 1.95 NADH dehydrogenase subunit 
5 
Catalyzes the transfer of electrons from 
NADH to ubiquinone 
SACOL1151 
 
1.95 hypothetical protein identified by similarity to EGAD:107725; 
match to protein family HMM PF05164 
SACOL0609 sdrD 1.95 sdrD protein identified by similarity to GP:3550594; 
match to protein family HMM PF00746; 
match to protein family HMM PF02412; 
match to protein family HMM PF04650; 
match to protein family HMM PF05738; 
match to protein family HMM TIGR01167; 
match to protein family HMM TIGR01168 
SACOL1981 
 
1.95 isochorismatase identified by match to protein family HMM 
PF00857 
SACOL0245 lytS 1.94 sensor histidine kinase LytS identified by similarity to EGAD:42940; 
match to protein family HMM PF02518; 
match to protein family HMM PF06580; 




specific family component IIA 
identified by similarity to 
OMNI:NTL01LL0257; match to protein 
family HMM PF03610; match to protein 
family HMM TIGR02364 
SACOL2407   1.93 lipoprotein identified by similarity to EGAD:109043; 
match to protein family HMM PF01323 
SACOL0027 
 
1.93 hypothetical protein 
 
SACOL1181 arcB1 1.92 ornithine carbamoyltransferase catalyzes the formation of L-citrulline from 
carbamoyl phosphate and L-ornithine in 
arginine biosynthesis and degradation 
SACOL1660 
 
1.91 LamB/YcsF family protein identified by match to protein family HMM 
PF03746 
SACOL2552   1.91 PTS system, IIABC 
components 
identified by match to protein family HMM 
PF00358; match to protein family HMM 
PF00367; match to protein family HMM 
PF02378; match to protein family HMM 
TIGR00826; match to protein family HMM 
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TIGR00830; match to protein family HMM 
TIGR02002 
SACOL0961 gluD 1.91 glutamate dehydrogenase identified by match to protein family HMM 
PF00208; match to protein family HMM 
PF02812 
SACOL0546 pth 1.91 peptidyl-tRNA hydrolase Enables the recycling of peptidyl-tRNAs 
produced at termination of translation 
SACOL0960 rocD 1.91 ornithine--oxo-acid 
transaminase 
identified by similarity to EGAD:21835; 
match to protein family HMM PF00202; 
match to protein family HMM TIGR01885 
SACOL0208   1.90 hypothetical protein   
SACOL1033 
 
1.90 hypothetical protein 
 
SACOL0766 saeR 1.90 DNA-binding response 
regulator SaeR 
identified by similarity to GP:5726300; 
match to protein family HMM PF00072; 
match to protein family HMM PF00486 
SACOL2021 
 
1.90 carbon-nitrogen family 
hydrolase 
identified by match to protein family HMM 
PF00795 
SACOL1451 arlR 1.90 DNA-binding response 
regulator ArlR 
identified by similarity to GP:9230552; 
similarity to OMNI:SA1451; match to 
protein family HMM PF00072; match to 
protein family HMM PF00486 
SACOL0459 pbuX 1.89 xanthine permease identified by similarity to EGAD:30678; 
match to protein family HMM PF00860; 
match to protein family HMM TIGR00801 
SACOL1908 fumC 1.89 fumarate hydratase class II family (does not require metal); 
tetrameric enzyme; fumarase C; reversibly 
converts (S)-malate to fumarate and water; 
functions in the TCA cycle 
SACOL0403 
 
1.89 BglG family transcriptional 
antiterminator 
identified by match to protein family HMM 
PF00359; match to protein family HMM 
PF00874 
SACOL0730   1.87 hypothetical protein identified by similarity to EGAD:173390; 
match to protein family HMM PF04167 
SACOL1113 
 
1.86 hypothetical protein 
 
SACOL2154 rocF 1.86 arginase identified by similarity to EGAD:14086; 
match to protein family HMM PF00491; 





identified by match to protein family HMM 
PF00561 
SACOL2198 budA1 1.84 alpha-acetolactate 
decarboxylase 
identified by similarity to EGAD:17067; 
match to protein family HMM PF03306; 
match to protein family HMM TIGR01252 
SACOL1351 cls1 1.84 cardiolipin synthetase identified by similarity to SP:O66043; 
match to protein family HMM PF00614 
SACOL2331   1.84 hypothetical protein   
SACOL1988 
 
1.84 hypothetical protein identified by match to protein family HMM 
PF03417 
SACOL0456   1.84 hypothetical protein identified by similarity to GB:AAO05995.1 
SACOL1349 
 
1.83 hypothetical protein identified by similarity to OMNI:PG0474 
SACOL0460 guaB 1.83 inosine-5'-monophosphate 
dehydrogenase 
identified by similarity to SP:P21879; 
match to protein family HMM PF00478; 
match to protein family HMM PF00571; 
match to protein family HMM TIGR01302 
 
 178 
SACOL2188 lacR 1.83 lactose phosphotransferase 
system repressor 
identified by similarity to SP:P16644; 
match to protein family HMM PF00455 




1.82 formate/nitrite transporter 
family protein 
identified by match to protein family HMM 
PF01226 
SACOL0096 sarS 1.82 accessory regulator S identified by similarity to OMNI:SA0096; 
match to protein family HMM TIGR01889 
SACOL0750 
 
1.82 anion transporter family 
protein 
identified by match to protein family HMM 
PF00939; match to protein family HMM 
TIGR00785 




1.82 hypothetical protein 
 
SACOL1324   1.81 hfq protein identified by similarity to EGAD:12661; 
match to protein family HMM PF01423 
SACOL2615 panB 1.81 3-methyl-2-oxobutanoate 
hydroxymethyltransferase 
catalyzes the formation of tetrahydrofolate 
and 2-dehydropantoate from 5,10-
methylenetetrahydrofolate and 3-methyl-2-
oxobutanoate 
SACOL2086   1.81 TenA family transcription 
regulator 
identified by similarity to EGAD:24145; 
match to protein family HMM PF03070 
SACOL1450 arlS 1.81 sensor histidine kinase ArlS identified by similarity to GP:9230553; 
similarity to OMNI:SA1450; match to 
protein family HMM PF00512; match to 
protein family HMM PF00672; match to 
protein family HMM PF02518 
SACOL1308   1.81 pyruvate ferredoxin 
oxidoreductase subunit alpha 
identified by match to protein family HMM 
PF01558; match to protein family HMM 
PF01855 
SACOL2070 kdpD 1.80 sensor histidine kinase KdpD identified by similarity to EGAD:149594; 
match to protein family HMM PF00512; 
match to protein family HMM PF02518; 
match to protein family HMM PF02702 
SACOL2272 modA 1.80 molybdenum ABC transporter 
molybdenum-binding protein 
ModA 
identified by similarity to EGAD:13554; 
match to protein family HMM PF01547; 
match to protein family HMM TIGR01256 
SACOL2505 
 
1.80 cell wall surface anchor family 
protein 
identified by match to protein family HMM 
PF00746; match to protein family HMM 
PF04650; match to protein family HMM 
PF07501; match to protein family HMM 
TIGR01167; match to protein family HMM 
TIGR01168 
SACOL0190 acpD 1.80 azoreductase FMN-dependent; requires NADH; 
catalyzes the cleavage of azo bond in 
aromatic azo compounds 
SACOL2514 gntP 1.79 gluconate transporter, 
permease 
identified by similarity to EGAD:19179; 
match to protein family HMM PF02447; 
match to protein family HMM TIGR00791 




1.79 amino acid ABC transporter 
permease 
identified by match to protein family HMM 
PF00528 
SACOL1434   1.79 alanine racemase identified by match to protein family HMM 




SACOL2437 bcr 1.78 bicyclomycin resistance 
protein 
identified by similarity to SP:P28246; 
match to protein family HMM PF00083; 
match to protein family HMM PF07690; 
match to protein family HMM TIGR00710 
SACOL2585   1.77 hypothetical protein   
SACOL1338 
 
1.77 hypothetical protein 
 
SACOL1661   1.76 acetyl-CoA carboxylase, biotin 
carboxylase 
identified by similarity to SP:P49787; 
match to protein family HMM PF00289; 
match to protein family HMM PF02785; 
match to protein family HMM PF02786 
SACOL0244 scdA 1.76 cell wall biosynthesis protein 
ScdA 
involved in peptidoglycan cross-linking 
SACOL1323 miaA 1.75 tRNA delta(2)-
isopentenylpyrophosphate 
transferase 
IPP transferase; isopentenyltransferase; 
involved in tRNA modification; in 
Escherichia coli this enzyme catalyzes the 
addition of a delta2-isopentenyl group from 
dimethylallyl diphosphate to the N6-
nitrogen of adenosine adjacent to the 
anticodon of tRNA species that read 
codons starting with uracil; further tRNA 
modifications may occur; mutations in 
miaA result in defects in translation 
efficiency and fidelity 
SACOL1165 
 
1.75 hypothetical protein 
 
SACOL1321 glpD 1.75 aerobic glycerol-3-phosphate 
dehydrogenase 
identified by similarity to EGAD:18115; 
match to protein family HMM PF01266 
SACOL1850 
 
1.75 hypothetical protein 
 
SACOL2449   1.75 drug transporter identified by match to protein family HMM 
PF00083; match to protein family HMM 
PF07690 
SACOL1010 relA1 1.74 GTP pyrophosphokinase identified by match to protein family HMM 
PF04607 
SACOL2587   1.74 hypothetical protein   
SACOL0724 
 
1.74 hypothetical protein identified by similarity to GB:AAO04031.1 
SACOL1159 sdhA 1.74 succinate dehydrogenase 
flavoprotein subunit 
part of four member succinate 
dehydrogenase enzyme complex that forms 
a trimeric complex (trimer of tetramers); 
SdhA/B are the catalytic subcomplex and 
can exhibit succinate dehydrogenase 
activity in the absence of SdhC/D which 
are the membrane components and form 
cytochrome b556; SdhC binds ubiquinone; 
oxidizes succinate to fumarate while 
reducing ubiquinone to ubiquinol 





catalyzes the formation of 5,10-
methenyltetrahydrofolate from 5,10-
methylenetetrahydrofolate and subsequent 
formation of 10-formyltetrahydrofolate 
from 5,10-methenyltetrahydrofolate 
SACOL0506   1.74 ABC transporter substrate-
binding protein 




1.73 hypothetical protein 
 
SACOL0959   1.72 Oye family NADH-dependent 
flavin oxidoreductase 




1.72 esterase identified by similarity to EGAD:16024 
 
 180 
SACOL1368 kataA 1.72 catalase identified by similarity to EGAD:29401; 
match to protein family HMM PF00199 
SACOL2133 
 
1.71 hypothetical protein identified by similarity to GB:AAO05339.1 
SACOL1001 trpS 1.71 tryptophanyl-tRNA synthetase catalyzes a two-step reaction, first charging 
a tryptophan molecule by linking its 
carboxyl group to the alpha-phosphate of 
ATP, followed by transfer of the 





identified by match to protein family HMM 
PF01553; match to protein family HMM 
TIGR00530 
SACOL2019   1.70 sdrH protein identified by similarity to GP:8101009 
SACOL0667 
 
1.70 HAD superfamily hydrolase identified by match to protein family HMM 
PF00702; match to protein family HMM 
TIGR01509; match to protein family HMM 
TIGR01549 
SACOL2323 hutI 1.70 imidazolonepropionase catalyzing the hydrolysis of 4-imidazolone-
5-propionate to N-formimidoyl-L-
glutamate, the third step in the histidine 
degradation pathway 
SACOL1812 rot 1.70 repressor of toxins identified by similarity to GP:6651452; 
match to protein family HMM TIGR01889 
SACOL2483   1.70 transporter identified by match to protein family HMM 
PF03806 
SACOL2534 frp 1.69 NAD(P)H-flavin 
oxidoreductase 
identified by match to protein family HMM 
PF00881 





identified by similarity to SP:P17547; 
match to protein family HMM PF00465 




1.69 hypothetical protein identified by similarity to 
OMNI:NTL01BH2853 
SACOL2441   1.69 amino acid permease identified by match to protein family HMM 
PF00324 
SACOL1785 acuC 1.69 acetoin utilization protein 
AcuC 
identified by similarity to EGAD:19784; 
match to protein family HMM PF00850 
SACOL2332 galM 1.68 aldose 1-epimerase identified by match to protein family HMM 
PF01263 
SACOL0312 nanA 1.68 N-acetylneuraminate lyase catalyzes the formation of pyruvate and N-
acetylmannosamine from N-
acetylneuraminic acid 
SACOL1222 rpoZ 1.68 DNA-directed RNA 
polymerase subunit omega 
Promotes RNA polymerase assembly; 
latches the N- and C-terminal regions of 
the beta' subunit thereby facilitating its 
interaction with the beta and alpha subunits 
SACOL1167 
 
1.68 hypothetical protein 
 
SACOL1158 sdhC 1.68 succinate dehydrogenase, 
cytochrome b558 subunit 
identified by similarity to EGAD:20778; 
match to protein family HMM TIGR02046 
SACOL0797 
 
1.68 iron compound ABC 
transporter permease 
identified by similarity to EGAD:37682; 
match to protein family HMM PF01032 
SACOL2715   1.68 hypothetical protein   
SACOL0643 
 
1.67 hypothetical protein identified by similarity to GP:11230708 
SACOL1935   1.67 hypothetical protein identified by similarity to GP:10173504; 





1.67 hypothetical protein 
 
SACOL2644   1.66 ABC transporter ATP-binding 
protein 




1.66 transcription antiterminator identified by similarity to SP:P39805; 
match to protein family HMM PF00874; 
match to protein family HMM PF03123 




1.65 L-lactate permease identified by similarity to EGAD:8633; 
match to protein family HMM PF02652; 
match to protein family HMM TIGR00795 
SACOL2439   1.64 hypothetical protein identified by similarity to GB:AAO05643.1 
SACOL1848 
 
1.64 hypothetical protein 
 
SACOL0179   1.64 RpiR family phosphosugar-
binding transcriptional 
regulator 
identified by match to protein family HMM 




1.64 hypothetical protein identified by similarity to GP:10174364; 
match to protein family HMM PF00702; 
match to protein family HMM TIGR00099; 
match to protein family HMM TIGR01484 
SACOL1436   1.64 hypothetical protein   
SACOL0505 
 
1.64 ABC transporter permease identified by match to protein family HMM 
PF00528 
SACOL0307 pfoR 1.64 perfringolysin O regulator 
protein 
identified by similarity to EGAD:33437 
SACOL2124 
 
1.64 hypothetical protein identified by similarity to GB:AAO05329.1 
SACOL1322   1.63 alpha/beta fold family 
hydrolase 




1.63 hypothetical protein 
 
SACOL1891   1.63 RNAIII-activating protein 
TRAP 
identified by similarity to OMNI:SA1891 
SACOL0818 prfB 1.63 peptide chain release factor 2 recognizes the termination signals UGA 
and UAA during protein translation a 
specificity which is dependent on amino 
acid residues residing in loops of the L-
shaped tRNA-like molecule of RF2; in 
some organisms control of PrfB protein 
levels is maintained through a +1 
ribosomal frameshifting mechanism; this 
protein is similar to release factor 1 
SACOL1804   1.63 polysaccharide biosynthesis 
protein 




1.63 amino acid permease identified by match to protein family HMM 
PF00324 
SACOL0788   1.63 proton-dependent oligopeptide 
transporter family protein 
identified by match to protein family HMM 
PF00854; match to protein family HMM 




1.63 lipoate-protein ligase A family 
protein 
identified by match to protein family HMM 
PF03099 
SACOL2058   1.63 PemK family protein identified by similarity to GP:10834755; 
match to protein family HMM PF02452 
SACOL1161 murI 1.63 glutamate racemase converts L-glutamate to D-glutamate, a 
component of peptidoglycan 




SACOL0600 ilvE 1.62 branched-chain amino acid 
aminotransferase 
catalyzes the transamination of the 
branched-chain amino acids to their 
respective alpha-keto acids 
SACOL2408   1.62 lipoprotein identified by similarity to GB:AAO05629.1 
SACOL2567 
 
1.62 hypothetical protein 
 
SACOL1734 gapA2 1.62 glyceraldehyde 3-phosphate 
dehydrogenase 2 
identified by similarity to EGAD:107759; 
match to protein family HMM PF00044; 
match to protein family HMM PF02800; 
match to protein family HMM TIGR01534 
SACOL0720 
 
1.62 ABC transporter permease 
 
SACOL0418   1.61 mttA/Hcf106 family protein identified by match to protein family HMM 




1.61 5' nucleotidase identified by match to protein family HMM 
PF02872 
SACOL1826   1.61 hypothetical protein identified by similarity to GB:AAN32737.1 
SACOL1396 fmtC 1.61 fmtC protein identified by match to protein family HMM 
PF04329; match to protein family HMM 
PF04330; match to protein family HMM 
PF04331 
SACOL0616 nagB 1.61 glucosamine-6-phosphate 
isomerase 
identified by similarity to EGAD:107403; 
match to protein family HMM PF01182 
SACOL0608 sdrC 1.61 sdrC protein identified by similarity to GP:3550592; 
match to protein family HMM PF00746; 
match to protein family HMM PF04650; 
match to protein family HMM PF05738; 
match to protein family HMM TIGR01167; 
match to protein family HMM TIGR01168 
SACOL0668   1.61 alpha/beta fold family 
hydrolase 
identified by match to protein family HMM 
PF00561 
SACOL1878 epiA 1.61 lantibiotic epidermin precursor 
EpiA 
identified by similarity to EGAD:6281; 
match to protein family HMM PF02052 
SACOL0281   1.61 hypothetical protein   
SACOL1412 
 
1.61 hydrolase-like protein identified by match to protein family HMM 
TIGR00099; match to protein family HMM 
TIGR01484 
SACOL1772   1.61 class V aminotransferase identified by match to protein family HMM 
PF00266 
SACOL0513 gltC 1.60 transcriptional regulatory 
protein GltC 
identified by similarity to EGAD:6257; 
match to protein family HMM PF00126 
SACOL2064   1.60 hypothetical protein   
SACOL2338 
 
1.60 hypothetical protein 
 
SACOL0319   1.60 hypothetical protein   
SACOL1539 
 
1.60 hypothetical protein identified by similarity to EGAD:12647; 
match to protein family HMM PF03745 




1.59 acetyl-CoA carboxylase, biotin 
carboxyl carrier protein 
identified by similarity to SP:P49786; 
match to protein family HMM PF00364 
SACOL0171 brnQ1 1.59 branched-chain amino acid 
transport system II carrier 
protein 
identified by match to protein family HMM 




1.59 pyridine nucleotide-disulfide 
oxidoreductase 




SACOL0072   1.59 hypothetical protein identified by match to protein family HMM 




1.59 hypothetical protein identified by match to protein family HMM 
PF06738 




1.59 hypothetical protein identified by match to protein family HMM 
PF07274 




1.58 hypothetical protein identified by match to protein family HMM 
PF02583 
SACOL0161   1.58 hypothetical protein   
SACOL1842 
 
1.58 hypothetical protein identified by similarity to 
OMNI:NTL01BH2832; match to protein 
family HMM PF01809; match to protein 
family HMM TIGR00278 




1.58 MerR family transcriptional 
regulator 
identified by match to protein family HMM 
PF00376 
SACOL2502   1.58 hypothetical protein   
SACOL1992 
 
1.57 hypothetical protein identified by similarity to GB:BAC14289.1 
SACOL1304 recA 1.57 recombinase A catalyzes the hydrolysis of ATP in the 
presence of single-stranded DNA, the ATP-
dependent uptake of single-stranded DNA 
by duplex DNA, and the ATP-dependent 
hybridization of homologous single-
stranded DNAs 
SACOL0566 nupC 1.57 nucleoside permease NupC identified by similarity to EGAD:6216; 
match to protein family HMM PF01773; 
match to protein family HMM PF07662; 
match to protein family HMM PF07670 
SACOL1042   1.57 hypothetical protein   
SACOL2527 
 
1.57 fructose-1,6-bisphosphatase identified by similarity to EGAD:37656; 
match to protein family HMM PF06874 
SACOL1364 thrB 1.57 homoserine kinase catalyzes the formation of O-phospho-L-
homoserine from L-homoserine in 
threonine biosynthesis from asparate 
SACOL0514 gltB 1.57 glutamate synthase identified by similarity to EGAD:109137; 
match to protein family HMM PF01493; 
match to protein family HMM PF01645; 
match to protein family HMM PF04897; 
match to protein family HMM PF04898 




1.56 hypothetical protein 
 
SACOL1435 lysA 1.56 diaminopimelate 
decarboxylase 
identified by similarity to SP:P23630; 
match to protein family HMM PF00278; 
match to protein family HMM PF02784; 
match to protein family HMM TIGR01048 
SACOL0870 
 
1.56 LysE/YggA family protein identified by match to protein family HMM 
PF01810 
SACOL2551   1.56 hypothetical protein identified by similarity to OMNI:VC1938 
SACOL2672 
 
1.56 hypothetical protein identified by similarity to GB:AAK17000.1 
 
 184 
SACOL1374 lexA 1.56 LexA repressor Represses a number of genes involved in 
the response to DNA damage 
SACOL1164 
 
1.56 fibrinogen binding-like protein identified by similarity to EGAD:16905 
SACOL2673   1.55 hypothetical protein identified by similarity to GB:AAK16999.1 
SACOL2142 
 
1.55 SAP domain-containing 
protein 
 
SACOL2296   1.55 glycerate dehydrogenase Catalyzes the reduction of hydroxypyruvate 
to form D-glycerate, using NADH as an 
electron donor 
SACOL1689 relA2 1.55 GTP pyrophosphokinase identified by similarity to EGAD:107375; 
match to protein family HMM PF01842; 
match to protein family HMM PF01966; 
match to protein family HMM PF02824; 
match to protein family HMM PF04607; 
match to protein family HMM TIGR00691 
SACOL0611   1.55 glycosyl transferase, group 1 
family protein 




1.55 lipase precursor, interruption-
N 
identified by similarity to EGAD:17843; 
match to protein family HMM PF04650; 
match to protein family HMM TIGR01168 
SACOL2733   1.55 hypothetical protein identified by similarity to GB:AAO06054.1 
SACOL0455 
 
1.54 hypothetical protein identified by similarity to SP:Q8CQQ7 
SACOL2549   1.54 hypothetical protein identified by similarity to EGAD:16024 
SACOL1645 
 
1.54 comE operon protein 2 identified by similarity to EGAD:23914; 
match to protein family HMM PF00383 
SACOL0756   1.54 ebsC protein identified by similarity to SP:P36922; 
match to protein family HMM PF04073; 
match to protein family HMM TIGR00011 
SACOL1058 
 
1.54 aminotransferase, class I identified by match to protein family HMM 
PF00155 
SACOL2450   1.54 amino acid ABC transporter 
permease 
identified by match to protein family HMM 
PF00528 
SACOL1758 ald2 1.54 alanine dehydrogenase identified by similarity to EGAD:15508; 
match to protein family HMM PF01262; 
match to protein family HMM PF05222; 
match to protein family HMM TIGR00518 
SACOL0715   1.53 hypothetical protein identified by similarity to GB:AAO04023.1 
SACOL2639 cysJ 1.53 sulfite reductase (NADPH) 
flavoprotein alpha-component 
identified by similarity to SP:P38038; 
match to protein family HMM PF00175; 
match to protein family HMM PF00258; 
match to protein family HMM PF00667; 
match to protein family HMM TIGR01931 
SACOL2144   1.53 ABC transporter ATP-binding 
protein 




1.53 cobalamin synthesis 
protein/P47K family protein 
identified by match to protein family HMM 
PF02492; match to protein family HMM 
PF07683 
SACOL0666   1.53 iron compound ABC 
transporter permease 




1.53 ArgR family transcriptional 
regulator 
identified by similarity to EGAD:18464; 
match to protein family HMM PF02863 
SACOL2522   1.53 DedA family protein identified by match to protein family HMM 
PF00597 
SACOL1549 zwf 1.52 glucose-6-phosphate 1-
dehydrogenase 
catalyzes the formation of D-glucono-1,5-




SACOL1448 sucB 1.52 dihydrolipoamide 
succinyltransferase 
component of 2-oxoglutarate 
dehydrogenase complex; catalyzes the 
transfer of succinyl coenzyme A to form 
succinyl CoA as part of the conversion of 
2-oxoglutarate to succinyl-CoA 
SACOL2459 pnbA 1.52 para-nitrobenzyl esterase identified by similarity to SP:P37967; 
match to protein family HMM PF00135 
SACOL0180   1.52 type I restriction-modification 
enzyme, R subunit 
identified by match to protein family HMM 
PF00270; match to protein family HMM 
PF04313; match to protein family HMM 




1.52 hypothetical protein 
 
SACOL2491   1.51 hypothetical protein identified by similarity to GB:AAO05679.1 
SACOL2562 ogt 1.51 methylated-DNA--protein-
cysteine methyltransferase 
identified by similarity to EGAD:29038; 
match to protein family HMM PF01035; 
match to protein family HMM PF02870; 
match to protein family HMM TIGR00589 




1.51 PTS system, IIBC components identified by match to protein family HMM 
PF00367; match to protein family HMM 
PF02378; match to protein family HMM 
TIGR01998 
SACOL2077   1.51 hypothetical protein identified by similarity to 




1.51 hypothetical protein identified by similarity to EGAD:108574; 
match to protein family HMM PF00149; 
match to protein family HMM TIGR00282 
SACOL0512   1.51 hypothetical protein   
SACOL0120 
 
1.51 GntR family transcriptional 
regulator 
identified by similarity to EGAD:37606; 
match to protein family HMM PF00392 
SACOL2278   1.51 acyl-CoA dehydrogenase-like 
protein 
identified by match to protein family HMM 




1.51 glycosyl transferase, group 1 
family protein 
identified by match to protein family HMM 
PF00534 





identified by match to protein family HMM 
PF03441 
SACOL2063   1.50 hypothetical protein identified by match to protein family HMM 
PF03703 
 
